archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,2.8267e-05,0.37482,0.39329,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,4.5779e-05,0.26399,0.29881,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0017696,0.23345,0.1917,1,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0172,0.16968,0.15484,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.045233,0.15438,0.091879,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0015882,0.088582,0.13856,1,1
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,4.5779e-05,1.3473,1.2283,1,1
2,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,2.8267e-05,1.3162,1.2983,1,1
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.00010181,1.2871,1.1126,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,2.8267e-05,1.2695,1.2171,1,1
2,GO DENDRITIC CELL APOPTOTIC PROCESS,4.5779e-05,1.2502,1.1888,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,1.6059e-05,1.1976,1.1257,1,1
2,GO CHRONIC INFLAMMATORY RESPONSE,1.2035e-05,1.166,1.0039,1,1
2,GO TOLERANCE INDUCTION,8.3641e-05,1.0921,0.9378,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.1191e-05,1.0774,1.0385,1,1
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,5.6086e-05,1.0762,0.93325,1,1
2,GO HYPERSENSITIVITY,3.248e-05,1.075,1.0001,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.6689e-06,1.0566,1.023,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.4947e-05,1.0462,1.0267,1,1
2,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00015974,1.0434,1.0145,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,7.3279e-05,1.0397,0.9764,1,1
2,GO T CELL TOLERANCE INDUCTION,0.00012367,1.0309,0.94207,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,8.9843e-06,1.0303,1.0168,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.00020554,1.0295,0.86245,1,1
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,6.8565e-05,1.0293,0.91249,1,1
2,GO NEGATIVE T CELL SELECTION,4.5779e-05,1.0182,0.97037,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.9888e-05,0.99862,0.94811,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,4.8997e-05,0.99143,0.95855,1,1
2,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.00017019,0.99107,0.77769,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,5.7533e-06,0.98813,0.99596,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.1191e-05,0.98527,0.95856,1,1
2,GO DENDRITIC CELL MIGRATION,3.4805e-05,0.97983,0.86374,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,3.7287e-05,0.97669,0.89033,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.5779e-05,0.9764,0.89471,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0304e-05,0.9754,0.94601,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2939e-05,0.96391,0.87601,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,1.0403e-05,0.94512,0.87876,1,1
2,GO SYNAPSE PRUNING,3.4805e-05,0.94434,1.0171,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.8524e-05,0.93451,0.90261,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.2907e-05,0.9336,0.80445,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.8997e-05,0.93239,0.84768,1,1
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,3.0304e-05,0.93037,0.89165,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,3.9936e-05,0.92589,0.81245,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.6059e-05,0.92497,0.85597,1,1
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00013188,0.92431,0.967,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7287e-05,0.92033,0.84674,1,1
2,GO T CELL CHEMOTAXIS,3.0304e-05,0.91746,0.82836,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,2.4576e-05,0.91309,0.81386,1,1
2,GO RESPONSE TO PROTOZOAN,2.2907e-05,0.91174,0.80392,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,1.3909e-05,0.91136,0.85793,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.9095,0.86753,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,2.8267e-05,0.90882,0.85178,1,1
2,GO DENDRITIC CELL DIFFERENTIATION,3.7287e-05,0.90857,0.81405,1,1
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.7287e-05,0.90013,0.83762,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,8.9327e-05,0.89968,0.83641,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.2939e-05,0.89764,0.80491,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,2.636e-05,0.89692,0.83488,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.1191e-05,0.88948,0.88765,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,3.9936e-05,0.8884,0.89315,1,1
2,GO DETECTION OF OTHER ORGANISM,2.2907e-05,0.88355,0.81017,1,1
2,GO INTERLEUKIN 10 PRODUCTION,1.6059e-05,0.88275,0.76367,1,1
2,GO POSITIVE T CELL SELECTION,5.9985e-05,0.88118,0.77332,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,4.5779e-05,0.87903,0.79836,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.2939e-05,0.87738,0.80534,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,2.1347e-05,0.87504,0.81521,1,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.4576e-05,0.87226,0.84793,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,3.7287e-05,0.87117,0.76319,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.9888e-05,0.86576,0.81785,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.1347e-05,0.8647,0.81937,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.8997e-05,0.8626,0.7323,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.86101,0.80064,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,2.1347e-05,0.8599,0.82795,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.2939e-05,0.85721,0.83104,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,4.2763e-05,0.85506,0.78494,1,1
2,GO POSITIVE THYMIC T CELL SELECTION,0.00010866,0.85384,0.8319,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,2.636e-05,0.85309,0.84855,1,1
2,GO LEUKOCYTE AGGREGATION,3.248e-05,0.8515,0.88935,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,6.6813e-06,0.84808,0.84406,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.8565e-05,0.84441,0.82511,1,1
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.2428e-05,0.84301,0.73001,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,3.248e-05,0.84084,0.71004,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,1.2939e-05,0.83957,0.78879,1,1
2,GO CYTOLYSIS,3.7287e-05,0.83877,0.87952,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,1.2939e-05,0.83775,0.81036,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.4576e-05,0.83633,0.73997,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,1.2035e-05,0.83629,0.82087,1,1
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0010209,0.83371,0.71117,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.7249e-05,0.83206,0.72692,1,1
2,GO RESPONSE TO CHEMOKINE,7.7514e-06,0.83105,0.80893,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.2907e-05,0.8309,0.74977,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,5.6086e-05,0.83075,0.8456,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.9936e-05,0.82915,0.75125,1,1
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.8267e-05,0.82835,0.81143,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,2.636e-05,0.8282,0.86888,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.8524e-05,0.82699,0.80281,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,3.0304e-05,0.82687,0.73068,1,1
2,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,4.5779e-05,0.8252,0.83529,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.7249e-05,0.82352,0.76222,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.8524e-05,0.82258,0.80996,1,1
2,GO MONOCYTE CHEMOTAXIS,8.3461e-06,0.82228,0.85929,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,3.248e-05,0.82211,0.73301,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.8267e-05,0.82057,0.76082,1,1
2,GO CYCLOOXYGENASE PATHWAY,1.3909e-05,0.81668,0.85515,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.2939e-05,0.81658,0.82124,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,3.248e-05,0.81415,0.83447,1,1
2,GO CELLULAR DEFENSE RESPONSE,3.248e-05,0.81281,0.77619,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,2.4576e-05,0.81242,0.70661,1,1
2,GO B CELL PROLIFERATION,4.2763e-05,0.81081,0.74896,1,1
2,GO T CELL SELECTION,6.8565e-05,0.81056,0.72635,1,1
2,GO TYPE 2 IMMUNE RESPONSE,1.1191e-05,0.80958,0.77421,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,3.9936e-05,0.80914,0.72671,1,1
2,GO DETECTION OF BIOTIC STIMULUS,1.6059e-05,0.80884,0.71302,1,1
2,GO LYMPHOCYTE MIGRATION,3.248e-05,0.80883,0.74924,1,1
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,2.8267e-05,0.80765,0.80169,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.80703,0.72476,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.2939e-05,0.80686,0.7535,1,1
2,GO T CELL MIGRATION,3.248e-05,0.80663,0.76849,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.5779e-05,0.80654,0.72615,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4947e-05,0.80527,0.77117,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.9936e-05,0.80454,0.79313,1,1
2,GO COMPLEMENT ACTIVATION,2.4576e-05,0.80439,0.83768,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,4.8997e-05,0.80309,0.7659,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,1.1191e-05,0.80302,0.75255,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,8.9327e-05,0.80283,0.79908,1,1
2,GO INTERLEUKIN 2 PRODUCTION,1.0403e-05,0.80167,0.7572,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.80104,0.72416,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.4576e-05,0.79816,0.79601,1,1
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010181,0.79672,0.68776,1,1
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00015974,0.79581,0.71695,1,1
2,GO T CELL EXTRAVASATION,1.6059e-05,0.79425,0.71614,1,1
2,GO THYMIC T CELL SELECTION,8.3641e-05,0.79367,0.7488,1,1
2,GO INTERLEUKIN 4 PRODUCTION,2.2907e-05,0.79312,0.75416,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.3909e-05,0.79266,0.81239,1,1
2,GO RESPONSE TO INTERLEUKIN 18,7.8298e-05,0.79218,0.70904,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,2.4576e-05,0.79089,0.757,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.8267e-05,0.79083,0.73372,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.9888e-05,0.78892,0.74893,1,1
2,GO NEUTROPHIL MIGRATION,1.6059e-05,0.78851,0.71299,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.636e-05,0.78812,0.7516,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,3.7287e-05,0.78783,0.71936,1,1
2,GO NEUTROPHIL CHEMOTAXIS,2.636e-05,0.78756,0.74537,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,1.3909e-05,0.78715,0.72733,1,1
2,GO IMMUNOGLOBULIN SECRETION,3.248e-05,0.78338,0.65095,1,1
2,GO INTERLEUKIN 13 PRODUCTION,1.1191e-05,0.77998,0.80081,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,2.2907e-05,0.77742,0.6935,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,3.9936e-05,0.77586,0.72395,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.8997e-05,0.77577,0.71094,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.248e-05,0.77505,0.68889,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00013188,0.77393,0.71105,1,1
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00011593,0.77306,0.70804,1,1
2,GO GLIAL CELL ACTIVATION,2.636e-05,0.77237,0.75713,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.9936e-05,0.77101,0.80299,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.3461e-06,0.77099,0.77697,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,1.9888e-05,0.76966,0.73984,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,3.7287e-05,0.76926,0.75334,1,1
2,GO CHEMOKINE SECRETION,2.1347e-05,0.76716,0.81212,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.8524e-05,0.76553,0.72215,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,0.76467,0.75596,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.7287e-05,0.76426,0.71544,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.8524e-05,0.76364,0.76986,1,1
2,GO T CELL CYTOKINE PRODUCTION,1.9888e-05,0.76265,0.70028,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.7249e-05,0.76081,0.69732,1,1
2,GO RESPONSE TO INTERLEUKIN 15,1.6059e-05,0.75858,0.78503,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,1.6059e-05,0.75836,0.75628,1,1
2,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,3.4805e-05,0.75796,0.79923,1,1
2,GO OPSONIZATION,0.00045436,0.75704,0.64349,1,1
2,GO INTERLEUKIN 12 PRODUCTION,7.8298e-05,0.75702,0.70856,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,5.2428e-05,0.75689,0.76227,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00010866,0.75646,0.65538,1,1
2,GO REGULATION OF B CELL PROLIFERATION,3.7287e-05,0.75617,0.71515,1,1
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00031664,0.75557,0.65015,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.0403e-05,0.75529,0.71717,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.636e-05,0.75471,0.80441,1,1
2,GO T CELL MEDIATED IMMUNITY,1.8524e-05,0.75431,0.67381,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,5.9985e-05,0.75408,0.68168,1,1
2,GO MONONUCLEAR CELL MIGRATION,6.2007e-06,0.75404,0.77834,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.7287e-05,0.75377,0.65896,1,1
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,8.3641e-05,0.75364,0.70354,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00010866,0.75347,0.66921,1,1
2,GO ALPHA BETA T CELL PROLIFERATION,0.00010866,0.75338,0.67269,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,9.5377e-05,0.74968,0.6358,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.8997e-05,0.74944,0.66551,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.00012367,0.74888,0.63003,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.1347e-05,0.74778,0.68556,1,1
2,GO REGULATION OF CELL KILLING,2.636e-05,0.74758,0.6975,1,1
2,GO GRANULOCYTE MIGRATION,1.6059e-05,0.74623,0.67435,1,1
2,GO REGULATORY T CELL DIFFERENTIATION,0.00033648,0.7449,0.59968,1,1
2,GO RESPONSE TO INTERFERON GAMMA,1.9888e-05,0.74021,0.69987,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,3.7287e-05,0.73976,0.69275,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.2763e-05,0.73953,0.7064,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8267e-05,0.73918,0.65364,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.2907e-05,0.73834,0.70131,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,3.0304e-05,0.7376,0.66721,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.7287e-05,0.73717,0.84769,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.2939e-05,0.73693,0.75417,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.337e-06,0.73651,0.71558,1,1
2,GO INTERFERON GAMMA PRODUCTION,3.248e-05,0.7357,0.71789,1,1
2,GO INTERLEUKIN 1 PRODUCTION,9.6689e-06,0.73515,0.71667,1,1
2,GO MATURE B CELL DIFFERENTIATION,2.4576e-05,0.73315,0.7216,1,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,5.2428e-05,0.73235,0.70215,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,8.3641e-05,0.73203,0.71705,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.7249e-05,0.73193,0.68311,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.7287e-05,0.73075,0.63989,1,1
2,GO GRANULOCYTE CHEMOTAXIS,1.8524e-05,0.73075,0.6961,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.3909e-05,0.73064,0.67259,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.2907e-05,0.73027,0.64984,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.248e-05,0.72959,0.68593,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,9.5377e-05,0.72753,0.64353,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.8267e-05,0.72707,0.66325,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00011593,0.72702,0.68119,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.9936e-05,0.72583,0.64883,1,1
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00013188,0.72461,0.69886,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.0304e-05,0.72417,0.67494,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.2907e-05,0.72409,0.66144,1,1
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,3.248e-05,0.72384,0.68501,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.00011593,0.72341,0.63273,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.9422e-06,0.72219,0.83473,1,1
2,GO ALPHA BETA T CELL ACTIVATION,4.2763e-05,0.722,0.6646,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.3641e-05,0.72172,0.64935,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.0304e-05,0.71912,0.67409,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,9.6689e-06,0.71875,0.73589,1,1
2,GO GERMINAL CENTER FORMATION,9.5377e-05,0.71872,0.76418,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,7.3279e-05,0.71844,0.75009,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,1.1191e-05,0.7175,0.75615,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.0403e-05,0.71699,0.75208,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.0304e-05,0.71633,0.68165,1,1
2,GO NEUROINFLAMMATORY RESPONSE,4.5779e-05,0.71617,0.68949,1,1
2,GO ETHANOL OXIDATION,1.4947e-05,0.71519,0.88788,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,4.5779e-05,0.71507,0.71252,1,1
2,GO NEGATIVE REGULATION OF BONE REMODELING,9.5377e-05,0.71436,0.67209,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.5779e-05,0.71199,0.63512,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,4.5779e-05,0.71159,0.6646,1,1
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.00020554,0.71148,0.62274,1,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00024771,0.71118,0.616,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,4.2763e-05,0.70961,0.63487,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.7249e-05,0.70949,0.67183,1,1
2,GO INTERLEUKIN 17 PRODUCTION,2.2907e-05,0.7081,0.69287,1,1
2,GO B CELL MEDIATED IMMUNITY,2.4576e-05,0.70792,0.68193,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0304e-05,0.70764,0.66184,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.0304e-05,0.70764,0.63855,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.8267e-05,0.70648,0.69172,1,1
2,GO INTERLEUKIN 8 PRODUCTION,7.7514e-06,0.70617,0.66196,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,3.0304e-05,0.70563,0.64369,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1347e-05,0.70397,0.65827,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,2.1347e-05,0.7031,0.68256,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.8267e-05,0.70186,0.62624,1,1
2,GO REGULATION OF LYMPHOCYTE MIGRATION,4.2763e-05,0.70117,0.63466,1,1
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.4576e-05,0.70092,0.68583,1,1
2,GO REGULATION OF MYOBLAST FUSION,9.5377e-05,0.69786,0.67848,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.2428e-05,0.69762,0.69722,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.2763e-05,0.69066,0.63472,1,1
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,9.5377e-05,0.68752,0.70044,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.0304e-05,0.68695,0.61404,1,1
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,0.68497,0.64268,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,6.4139e-05,0.68431,0.64906,1,1
2,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00014989,0.68287,0.70225,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,7.3279e-05,0.68248,0.64424,1,1
2,GO RESPONSE TO INTERFERON BETA,7.8298e-05,0.68045,0.59917,1,1
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.6086e-05,0.68044,0.59768,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,5.6086e-05,0.67956,0.65142,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.9936e-05,0.6788,0.6033,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,3.7287e-05,0.67761,0.61084,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,8.3641e-05,0.6765,0.60404,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.248e-05,0.67622,0.62949,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,3.4805e-05,0.67518,0.61479,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.00018128,0.67389,0.62311,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,7.1973e-06,0.67352,0.69965,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.0017696,0.6724,0.56066,1,1
2,GO MACROPHAGE MIGRATION,1.0403e-05,0.67221,0.65438,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00010866,0.67177,0.66531,1,1
2,GO REGULATION OF T CELL MIGRATION,5.2428e-05,0.67168,0.62863,1,1
2,GO CELLULAR EXTRAVASATION,4.5779e-05,0.67092,0.62752,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.3279e-05,0.66864,0.73163,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.9936e-05,0.66683,0.60472,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00042807,0.66612,0.64876,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,6.8565e-05,0.66463,0.73663,1,1
2,GO REGULATION OF PHAGOCYTOSIS,2.4576e-05,0.66416,0.63299,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.636e-05,0.66366,0.63577,1,1
2,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.3909e-05,0.66318,0.66096,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.66198,0.60946,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,3.9936e-05,0.66066,0.57802,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.2763e-05,0.66043,0.59934,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.7287e-05,0.66021,0.60971,1,1
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,9.5377e-05,0.65941,0.63805,1,1
2,GO INTERLEUKIN 5 PRODUCTION,0.00024771,0.65937,0.62274,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.00012367,0.6588,0.56426,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,7.3279e-05,0.6587,0.61988,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00045436,0.65848,0.58212,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,2.8267e-05,0.65759,0.64415,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,5.9985e-05,0.65699,0.57445,1,1
2,GO MACROPHAGE PROLIFERATION,0.00010181,0.65682,0.7491,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.4576e-05,0.65652,0.58519,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.0304e-05,0.65573,0.70362,1,1
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00013188,0.65519,0.55971,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.8997e-05,0.65423,0.60948,1,1
2,GO APOPTOTIC CELL CLEARANCE,4.5779e-05,0.65404,0.62467,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.4576e-05,0.65264,0.59716,1,1
2,GO CYTOKINE METABOLIC PROCESS,1.0403e-05,0.65137,0.64236,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010866,0.6512,0.6616,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.9985e-05,0.64989,0.56002,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,1.2035e-05,0.64975,0.63884,1,1
2,GO RESPONSE TO LIPOTEICHOIC ACID,1.4947e-05,0.64947,0.70589,1,1
2,GO LEUKOCYTE PROLIFERATION,4.8997e-05,0.64868,0.6048,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,1.7249e-05,0.64742,0.66419,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,6.4139e-05,0.64733,0.65464,1,1
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00076864,0.64651,0.54466,1,1
2,GO REGULATION OF B CELL ACTIVATION,6.4139e-05,0.64634,0.61517,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,2.2907e-05,0.64531,0.59818,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,0.64514,0.61362,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.4947e-05,0.64507,0.62117,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,2.4576e-05,0.64507,0.64636,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.8997e-05,0.64424,0.59552,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.248e-05,0.64337,0.57819,1,1
2,GO CELL KILLING,2.4576e-05,0.64267,0.59131,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,3.7287e-05,0.64237,0.60292,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.4576e-05,0.64236,0.59116,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,3.0304e-05,0.64214,0.57907,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00019306,0.64131,0.58758,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,3.248e-05,0.64066,0.58617,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,2.636e-05,0.64033,0.60829,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.00014989,0.63892,0.64357,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,0.63831,0.59545,1,1
2,GO T CELL DIFFERENTIATION,7.3279e-05,0.63685,0.55968,1,1
2,GO FIBRINOLYSIS,3.248e-05,0.63618,0.65434,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,0.63616,0.59402,1,1
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.8267e-05,0.63443,0.69973,1,1
2,GO INTEGRIN ACTIVATION,5.6086e-05,0.63386,0.64811,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.4805e-05,0.63376,0.59177,1,1
2,GO PHAGOCYTOSIS RECOGNITION,2.4576e-05,0.63362,0.65388,1,1
2,GO ASTROCYTE ACTIVATION,2.4576e-05,0.6335,0.58124,1,1
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.0304e-05,0.63333,0.66519,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.2907e-05,0.63321,0.58376,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.2907e-05,0.63239,0.57729,1,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00019306,0.63232,0.62451,1,1
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00014989,0.63208,0.52656,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.2907e-05,0.63149,0.59317,1,1
2,GO NEUTROPHIL EXTRAVASATION,8.9327e-05,0.63109,0.62741,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.00015974,0.63089,0.57172,1,1
2,GO REGULATION OF T CELL ACTIVATION,5.9985e-05,0.63023,0.58345,1,1
2,GO HUMORAL IMMUNE RESPONSE,2.8267e-05,0.63002,0.64573,1,1
2,GO LEUKOCYTE CHEMOTAXIS,2.4576e-05,0.62995,0.61602,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00024771,0.62969,0.54539,1,1
2,GO T CELL PROLIFERATION,3.9936e-05,0.62849,0.6119,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1347e-05,0.62826,0.58326,1,1
2,GO MACROPHAGE ACTIVATION,2.4576e-05,0.62825,0.66339,1,1
2,GO REGULATION OF PLATELET ACTIVATION,0.00020554,0.62786,0.58465,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.6059e-05,0.62769,0.58924,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,4.2763e-05,0.62699,0.58142,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.62692,0.59663,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.8997e-05,0.62679,0.57455,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.8997e-05,0.62652,0.5948,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.62558,0.6036,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.4139e-05,0.6253,0.58564,1,1
2,GO REGULATION OF CELLULAR EXTRAVASATION,1.8524e-05,0.62503,0.67913,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,8.3461e-06,0.62417,0.67401,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.1347e-05,0.62331,0.66909,1,1
2,GO REGULATION OF BONE DEVELOPMENT,4.8997e-05,0.6231,0.60402,1,1
2,GO NATURAL KILLER CELL ACTIVATION,6.8565e-05,0.62307,0.55228,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.62301,0.55609,1,1
2,GO CD40 SIGNALING PATHWAY,3.4805e-05,0.62102,0.562,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,4.2763e-05,0.62092,0.62074,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00012367,0.61864,0.59619,1,1
2,GO T CELL APOPTOTIC PROCESS,2.8267e-05,0.61848,0.58317,1,1
2,GO PLASMINOGEN ACTIVATION,0.00011593,0.61677,0.57251,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00031664,0.61619,0.56108,1,1
2,GO MACROPHAGE CHEMOTAXIS,1.2035e-05,0.61536,0.61972,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,5.2428e-05,0.61532,0.55551,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.9888e-05,0.61334,0.58018,1,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.61318,0.56982,1,1
2,GO REGULATION OF MEMBRANE INVAGINATION,0.00011593,0.61282,0.66037,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.7287e-05,0.61266,0.61071,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00033648,0.61219,0.56887,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.611,0.54737,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,5.9985e-05,0.61076,0.55634,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00015974,0.60961,0.55391,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2428e-05,0.6096,0.54213,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00011593,0.60959,0.60708,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,0.60948,0.63809,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,5.337e-06,0.60911,0.67395,1,1
2,GO PROTEIN ACTIVATION CASCADE,6.4139e-05,0.6089,0.64773,1,1
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,6.8565e-05,0.60883,0.56265,1,1
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,5.6086e-05,0.60871,0.53802,1,1
2,GO ETHANOL METABOLIC PROCESS,3.7287e-05,0.6083,0.67563,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011593,0.60829,0.57189,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.1347e-05,0.60823,0.63377,1,1
2,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.00029789,0.60811,0.53622,1,1
2,GO AMYLOID BETA CLEARANCE,5.9985e-05,0.608,0.57513,1,1
2,GO T CELL ACTIVATION,5.2428e-05,0.60757,0.56083,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,5.9985e-05,0.60722,0.62094,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.6059e-05,0.60645,0.59759,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,2.1347e-05,0.60638,0.57897,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.4805e-05,0.60589,0.58218,1,1
2,GO INTERLEUKIN 6 PRODUCTION,3.4805e-05,0.60544,0.55368,1,1
2,GO I KAPPAB PHOSPHORYLATION,3.248e-05,0.60299,0.57211,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00020554,0.60298,0.56876,1,1
2,GO REGULATION OF CELL ACTIVATION,4.8997e-05,0.60224,0.54448,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.636e-05,0.60138,0.60424,1,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0054671,0.60137,0.48391,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0003797,0.59959,0.5357,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,3.9936e-05,0.59809,0.62867,1,1
2,GO CYTOKINE SECRETION,2.8267e-05,0.59783,0.54156,1,1
2,GO ACUTE PHASE RESPONSE,1.9888e-05,0.59743,0.56648,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.9888e-05,0.597,0.58972,1,1
2,GO NEUTROPHIL HOMEOSTASIS,1.3909e-05,0.59535,0.60654,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,3.7287e-05,0.59507,0.52201,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,1.8524e-05,0.59481,0.57773,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00010866,0.59479,0.55538,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.0304e-05,0.59439,0.6054,1,1
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,1.9888e-05,0.59437,0.65703,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.9936e-05,0.59165,0.63099,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,6.4139e-05,0.59157,0.54716,1,1
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9888e-05,0.59156,0.58749,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,3.0304e-05,0.59059,0.53944,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,1.7249e-05,0.58896,0.54794,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,6.8565e-05,0.58857,0.53294,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,1.8524e-05,0.58815,0.58737,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,1.8524e-05,0.58618,0.59086,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.2428e-05,0.58501,0.55198,1,1
2,GO T CELL LINEAGE COMMITMENT,0.00013188,0.58392,0.53572,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,4.5779e-05,0.58386,0.53937,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00019306,0.58336,0.58057,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00029789,0.58276,0.55044,1,1
2,GO BLEB ASSEMBLY,0.00045436,0.58221,0.56816,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,7.8298e-05,0.58098,0.56617,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.6086e-05,0.58077,0.60076,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,2.2907e-05,0.57871,0.59244,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.5779e-05,0.57643,0.53995,1,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.248e-05,0.57587,0.58797,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,6.4139e-05,0.57557,0.5097,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.4576e-05,0.57441,0.56233,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.2939e-05,0.57399,0.63602,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.8997e-05,0.57364,0.50677,1,1
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00010866,0.57351,0.5385,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,8.9843e-06,0.57303,0.61535,1,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00024771,0.57242,0.53645,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.248e-05,0.57206,0.6513,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,8.9327e-05,0.57144,0.51595,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00010866,0.571,0.6585,1,1
2,GO MACROPHAGE DIFFERENTIATION,4.2763e-05,0.57069,0.55584,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,2.8267e-05,0.57045,0.61298,1,1
2,GO RESPONSE TO MURAMYL DIPEPTIDE,4.8997e-05,0.57023,0.547,1,1
2,GO RESPONSE TO INTERLEUKIN 2,0.00072571,0.56997,0.54797,1,1
2,GO OSTEOCLAST DEVELOPMENT,8.3641e-05,0.56948,0.60491,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,5.2428e-05,0.56937,0.58923,1,1
2,GO INTERFERON ALPHA PRODUCTION,9.5377e-05,0.56887,0.50604,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,2.2907e-05,0.56619,0.53571,1,1
2,GO RESPIRATORY BURST,0.00010866,0.56573,0.56145,1,1
2,GO REGULATION OF IMMUNE RESPONSE,3.7287e-05,0.56336,0.50675,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00045436,0.56285,0.5528,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00018128,0.56218,0.50159,1,1
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,5.6086e-05,0.5604,0.52112,1,1
2,GO LYMPHOCYTE ACTIVATION,6.4139e-05,0.56029,0.51623,1,1
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00012367,0.55914,0.55253,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.1191e-05,0.55708,0.63956,1,1
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00024771,0.55706,0.57975,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.1347e-05,0.55698,0.54351,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.6086e-05,0.55611,0.50812,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.7287e-05,0.55541,0.5329,1,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4139e-05,0.55486,0.53859,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00035748,0.55466,0.48041,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00033648,0.55465,0.47865,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00042807,0.55437,0.53658,1,1
2,GO PHAGOCYTOSIS,3.248e-05,0.55287,0.53318,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,5.2428e-05,0.55263,0.55701,1,1
2,GO BONE TRABECULA MORPHOGENESIS,0.0063209,0.55227,0.44507,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00014989,0.55176,0.51257,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.7287e-05,0.5511,0.52551,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.00010866,0.55089,0.65717,1,1
2,GO LEUKOCYTE HOMEOSTASIS,8.9327e-05,0.55036,0.49484,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9888e-05,0.5499,0.6582,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,0.54956,0.50555,1,1
2,GO LYMPH NODE DEVELOPMENT,0.00033648,0.54951,0.53371,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.0304e-05,0.54816,0.51436,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.8267e-05,0.54793,0.53692,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.9888e-05,0.54791,0.53644,1,1
2,GO ZYMOGEN INHIBITION,3.248e-05,0.54752,0.5746,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.5779e-05,0.54516,0.50092,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.8524e-05,0.54511,0.54365,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00014989,0.54401,0.53361,1,1
2,GO NAD BIOSYNTHETIC PROCESS,1.4947e-05,0.54313,0.51579,1,1
2,GO REGULATION OF AMYLOID BETA CLEARANCE,6.4139e-05,0.54272,0.54439,1,1
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,9.5377e-05,0.5424,0.4713,1,1
2,GO CHEMOKINE PRODUCTION,1.1191e-05,0.54219,0.56471,1,1
2,GO B CELL HOMEOSTASIS,0.00026348,0.542,0.47315,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,9.6689e-06,0.54156,0.57814,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.1347e-05,0.5415,0.52839,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.248e-05,0.54133,0.52863,1,1
2,GO CYTIDINE TO URIDINE EDITING,7.8298e-05,0.54114,0.57808,1,1
2,GO CELL CHEMOTAXIS,3.7287e-05,0.54109,0.54591,1,1
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.00024771,0.54108,0.58595,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.6086e-05,0.5397,0.49699,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.2907e-05,0.53873,0.54753,1,1
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.6059e-05,0.53743,0.61079,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,3.7287e-05,0.53583,0.65821,1,1
2,GO REGULATION OF CELL CELL ADHESION,5.6086e-05,0.53525,0.50452,1,1
2,GO LEUKOCYTE DIFFERENTIATION,4.8997e-05,0.53514,0.50324,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,7.3279e-05,0.53478,0.45948,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.00013188,0.53394,0.47185,1,1
2,GO INFLAMMATORY RESPONSE,3.0304e-05,0.53273,0.51498,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00010866,0.53193,0.49252,1,1
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00013188,0.5319,0.45725,1,1
2,GO B CELL ACTIVATION,7.3279e-05,0.53161,0.52375,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,2.8267e-05,0.5309,0.60446,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,3.9936e-05,0.53061,0.48792,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,3.7287e-05,0.5306,0.46415,1,1
2,GO INNATE IMMUNE RESPONSE,2.4576e-05,0.53059,0.50048,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,3.4805e-05,0.5291,0.4897,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7287e-05,0.52857,0.48186,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.6086e-05,0.52857,0.50973,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.8298e-05,0.52843,0.57684,1,1
2,GO LEUKOCYTE MIGRATION,4.5779e-05,0.52827,0.52824,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,8.3641e-05,0.52814,0.52969,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,3.7287e-05,0.52669,0.49015,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,1.6059e-05,0.5265,0.54687,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0304e-05,0.52575,0.49656,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,3.0304e-05,0.52428,0.47679,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00020554,0.5236,0.5211,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010181,0.52291,0.49847,1,1
2,GO IMMUNOGLOBULIN PRODUCTION,4.2763e-05,0.52276,0.51178,1,1
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.248e-05,0.52195,0.53712,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.9888e-05,0.52151,0.59126,1,1
2,GO MEMBRANE RAFT ORGANIZATION,0.00013188,0.52139,0.54146,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,1.6059e-05,0.52046,0.55191,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.00010866,0.52021,0.49008,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,6.8565e-05,0.51935,0.50516,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.8267e-05,0.51909,0.47829,1,1
2,GO HEMIDESMOSOME ASSEMBLY,0.025096,0.51853,0.4636,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00020554,0.51803,0.48462,1,1
2,GO RESPONSE TO HYDROPEROXIDE,0.00023283,0.51676,0.50702,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.248e-05,0.5157,0.46958,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.0304e-05,0.51569,0.47744,1,1
2,GO REGULATION OF INTEGRIN ACTIVATION,0.00023283,0.51522,0.49913,1,1
2,GO RESPONSE TO BACTERIUM,3.0304e-05,0.51498,0.51207,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.5377e-05,0.51457,0.60263,1,1
2,GO PEPTIDE CROSS LINKING,0.00017019,0.51417,0.52923,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,5.9985e-05,0.51303,0.47798,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.0403e-05,0.51163,0.53197,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,4.5779e-05,0.5114,0.51216,1,1
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0011418,0.51129,0.49503,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.4576e-05,0.5088,0.50547,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,5.6086e-05,0.50873,0.51732,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00010181,0.50872,0.49725,1,1
2,GO SUPEROXIDE ANION GENERATION,8.3641e-05,0.50857,0.48325,1,1
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00029789,0.50816,0.48153,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.00010181,0.50758,0.47548,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00035748,0.50604,0.4735,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,2.636e-05,0.50514,0.47225,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,4.2763e-05,0.5049,0.58574,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00015974,0.50483,0.52554,1,1
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.00045436,0.50288,0.50441,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,3.0304e-05,0.50145,0.49056,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.50118,0.49589,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,3.4805e-05,0.50056,0.52049,1,1
2,GO CYTOKINE PRODUCTION,3.4805e-05,0.49999,0.47201,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00014989,0.49906,0.49225,1,1
2,GO REGULATION OF FIBRINOLYSIS,3.7287e-05,0.49864,0.60673,1,1
2,GO MYOBLAST FUSION,9.5377e-05,0.49827,0.4944,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.0304e-05,0.49686,0.49937,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,0.49643,0.45298,1,1
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0063209,0.49638,0.38045,1,1
2,GO RESPONSE TO TUMOR CELL,9.5377e-05,0.4963,0.48504,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.7287e-05,0.49596,0.4867,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,4.5779e-05,0.49569,0.44616,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00018128,0.4952,0.45723,1,1
2,GO T CELL DIFFERENTIATION IN THYMUS,0.00014062,0.49444,0.47779,1,1
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0017696,0.49403,0.47776,1,1
2,GO IMMUNE EFFECTOR PROCESS,3.248e-05,0.4922,0.46035,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8267e-05,0.49112,0.46195,1,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00014989,0.49108,0.56386,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.248e-05,0.49008,0.48596,1,1
2,GO MAST CELL ACTIVATION,0.00076864,0.4898,0.43703,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,7.8298e-05,0.48953,0.42857,1,1
2,GO MULTI ORGANISM CELLULAR PROCESS,6.4139e-05,0.48904,0.55183,1,1
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,3.248e-05,0.48838,0.50366,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.00054254,0.48837,0.51522,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0012071,0.48831,0.42745,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00040321,0.48773,0.47555,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.00081392,0.48616,0.4243,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00014989,0.48582,0.49622,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00040321,0.48529,0.46756,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00010866,0.48488,0.49952,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,2.636e-05,0.48379,0.48654,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.00081392,0.48368,0.48866,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,3.9936e-05,0.48285,0.57414,1,1
2,GO OSTEOCLAST DIFFERENTIATION,7.8298e-05,0.48228,0.44798,1,1
2,GO MACROPHAGE APOPTOTIC PROCESS,0.00096503,0.48226,0.44079,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00010181,0.48193,0.47228,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00013188,0.4819,0.47982,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00014989,0.48174,0.53699,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.1347e-05,0.48164,0.53693,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,2.2907e-05,0.48154,0.48605,1,1
2,GO SEROTONIN SECRETION,0.00096503,0.48105,0.43873,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,3.4805e-05,0.48047,0.4638,1,1
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,1.7249e-05,0.48021,0.56977,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,6.4139e-05,0.48006,0.7158,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00021879,0.47943,0.51382,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00086166,0.47888,0.43904,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.00014989,0.4774,0.43259,1,1
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00024771,0.47696,0.51866,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.47679,0.43046,1,1
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0013481,0.47659,0.47204,1,1
2,GO FLUID TRANSPORT,0.00048214,0.47543,0.46087,1,1
2,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00057531,0.47522,0.41342,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.3279e-05,0.47516,0.46404,1,1
2,GO DEFENSE RESPONSE,3.4805e-05,0.47446,0.44326,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00017019,0.47442,0.47669,1,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00081392,0.47409,0.40082,1,1
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00060992,0.47366,0.50421,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.7287e-05,0.47361,0.47335,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,8.3641e-05,0.47238,0.43887,1,1
2,GO RESPONSE TO PROSTAGLANDIN,0.00035748,0.47232,0.42937,1,1
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,3.7287e-05,0.47196,0.50241,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,0.00057531,0.47156,0.47113,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013188,0.47097,0.5539,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,3.0304e-05,0.47083,0.4372,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.0011418,0.47059,0.71244,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,2.4576e-05,0.47043,0.56401,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.7249e-05,0.4703,0.53471,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,6.8565e-05,0.47019,0.58748,1,1
2,GO ASTROCYTE DEVELOPMENT,0.00010181,0.46927,0.46586,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,4.8997e-05,0.46849,0.53012,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00026348,0.46792,0.49154,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00031664,0.46747,0.42678,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.00042807,0.46713,0.40861,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,2.8267e-05,0.46645,0.47636,1,1
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00012367,0.4662,0.65655,1,1
2,GO FOAM CELL DIFFERENTIATION,8.9327e-05,0.46611,0.47587,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.0304e-05,0.46413,0.53923,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00048214,0.46401,0.47551,1,1
2,GO BONE RESORPTION,0.00017019,0.46383,0.45217,1,1
2,GO RESPONSE TO VIRUS,9.5377e-05,0.46369,0.41607,1,1
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00024771,0.46333,0.4547,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00015974,0.46224,0.47291,1,1
2,GO ACTIVATED T CELL PROLIFERATION,0.00048214,0.46164,0.40864,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.2763e-05,0.46155,0.45582,1,1
2,GO T CELL HOMEOSTASIS,0.00031664,0.46128,0.37867,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,4.8997e-05,0.46098,0.57882,1,1
2,GO B CELL DIFFERENTIATION,8.9327e-05,0.46088,0.5043,1,1
2,GO CELL ACTIVATION,5.2428e-05,0.4602,0.43512,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00020554,0.46011,0.45794,1,1
2,GO MEMBRANE INVAGINATION,0.00012367,0.45862,0.47625,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.0016767,0.45683,0.39525,1,1
2,GO SYNCYTIUM FORMATION,5.6086e-05,0.45674,0.47059,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,1.2939e-05,0.45658,0.46506,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.3279e-05,0.45608,0.41132,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,4.8997e-05,0.45583,0.50689,1,1
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,9.5377e-05,0.45579,0.47011,1,1
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00021879,0.45535,0.47787,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00023283,0.45503,0.47201,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,9.5377e-05,0.45342,0.44711,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,0.4519,0.50232,1,1
2,GO FEVER GENERATION,4.8997e-05,0.45184,0.46227,1,1
2,GO WATER TRANSPORT,0.00086166,0.45183,0.49776,1,1
2,GO MITRAL VALVE DEVELOPMENT,0.0042727,0.45166,0.36565,1,1
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00023283,0.45042,0.50416,1,1
2,GO STORE OPERATED CALCIUM ENTRY,0.00020554,0.44999,0.40098,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00014989,0.44938,0.53801,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.0003797,0.44937,0.39995,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,5.9985e-05,0.44839,0.48746,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,0.44791,0.423,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.3909e-05,0.4476,0.44721,1,1
2,GO HETEROTYPIC CELL CELL ADHESION,3.9936e-05,0.44626,0.4721,1,1
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00028019,0.44595,0.40846,1,1
2,GO AMINE CATABOLIC PROCESS,0.00010866,0.44578,0.40322,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00013188,0.44559,0.42335,1,1
2,GO ZYMOGEN ACTIVATION,5.9985e-05,0.44555,0.46886,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.8524e-05,0.44524,0.48846,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,8.9327e-05,0.44521,0.42849,1,1
2,GO RESPONSE TO FUNGUS,0.00054254,0.44512,0.43821,1,1
2,GO GAS TRANSPORT,0.0047188,0.44507,0.40175,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00020554,0.44451,0.37176,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.7287e-05,0.44395,0.4765,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0015041,0.44346,0.39612,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,7.3279e-05,0.44232,0.42028,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1347e-05,0.44166,0.45446,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00054254,0.44103,0.44536,1,1
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00042807,0.4406,0.44712,1,1
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.00026348,0.4404,0.44212,1,1
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00012367,0.43965,0.44685,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.4805e-05,0.43948,0.45918,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00011593,0.43751,0.48274,1,1
2,GO GRANULOCYTE DIFFERENTIATION,2.2907e-05,0.43724,0.50416,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.0304e-05,0.43409,0.40023,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00014989,0.43392,0.43094,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.248e-05,0.43337,0.48752,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.00018128,0.43284,0.42296,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.00031664,0.43275,0.60902,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00060992,0.43254,0.43959,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00024771,0.43174,0.41076,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00026348,0.43156,0.42036,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,8.9327e-05,0.43077,0.52889,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00033648,0.43045,0.52092,1,1
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.4576e-05,0.43021,0.52029,1,1
2,GO PYROPTOSIS,0.00054254,0.42978,0.4244,1,1
2,GO COLLAGEN CATABOLIC PROCESS,0.00012367,0.42972,0.50646,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00010181,0.42909,0.45752,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,1.6059e-05,0.42901,0.47218,1,1
2,GO ACTIN FILAMENT SEVERING,0.00012367,0.42772,0.48839,1,1
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0018673,0.42767,0.40958,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.7287e-05,0.42732,0.41532,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00035748,0.42695,0.42284,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,8.9327e-05,0.42692,0.46679,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00012367,0.42641,0.4579,1,1
2,GO CHOLESTEROL STORAGE,0.00014062,0.42593,0.47662,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00057531,0.4254,0.41427,1,1
2,GO POSITIVE REGULATION OF COAGULATION,2.8267e-05,0.42487,0.49125,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.1347e-05,0.42395,0.41974,1,1
2,GO REGULATION OF DEFENSE RESPONSE,3.9936e-05,0.42366,0.40207,1,1
2,GO BONE CELL DEVELOPMENT,0.00019306,0.4236,0.4434,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1191e-05,0.42302,0.44379,1,1
2,GO ENTRY INTO HOST,5.2428e-05,0.42232,0.43798,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.8524e-05,0.42193,0.45561,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00023283,0.42137,0.43142,1,1
2,GO RESPONSE TO INTERLEUKIN 1,1.4947e-05,0.42127,0.39844,1,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00026348,0.42085,0.40546,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00018128,0.42084,0.40535,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00013188,0.42061,0.37633,1,1
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00060992,0.41928,0.38858,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.7287e-05,0.41893,0.40863,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3909e-05,0.41869,0.46964,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0021907,0.41803,0.37609,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.00096503,0.41793,0.36681,1,1
2,GO REGULATION OF CHEMOTAXIS,7.3279e-05,0.41756,0.42905,1,1
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00019306,0.41745,0.46832,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00014989,0.41714,0.44372,1,1
2,GO RESPONSE TO INTERLEUKIN 4,5.6086e-05,0.41708,0.43033,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,4.8997e-05,0.41704,0.39548,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00021879,0.41633,0.46514,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00018128,0.41585,0.37368,1,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0012071,0.41579,0.36245,1,1
2,GO SOMATIC STEM CELL DIVISION,0.0049572,0.41521,0.40119,1,1
2,GO ERK1 AND ERK2 CASCADE,3.9936e-05,0.41451,0.42944,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.2428e-05,0.4145,0.40318,1,1
2,GO DNA DEAMINATION,0.00068502,0.4142,0.3932,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00035748,0.41369,0.35744,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00091199,0.41347,0.40178,1,1
2,GO CELL ADHESION MOLECULE PRODUCTION,0.00020554,0.41347,0.49609,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,4.5779e-05,0.41089,0.44497,1,1
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00018128,0.41079,0.47231,1,1
2,GO RESPONSE TO INTERLEUKIN 6,0.0003797,0.41071,0.41745,1,1
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00013188,0.41066,0.4412,1,1
2,GO RETINOL METABOLIC PROCESS,2.2907e-05,0.41023,0.40895,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,6.8565e-05,0.40941,0.40826,1,1
2,GO HYALURONAN CATABOLIC PROCESS,4.8997e-05,0.40868,0.49562,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.4805e-05,0.40768,0.37936,1,1
2,GO RESPONSE TO CYTOKINE,4.2763e-05,0.40741,0.39594,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,3.0304e-05,0.40689,0.42028,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00019306,0.40656,0.41033,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00064645,0.40645,0.42883,1,1
2,GO MUCUS SECRETION,5.2428e-05,0.40541,0.46475,1,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00057531,0.40496,0.36708,1,1
2,GO OXYGEN TRANSPORT,0.058535,0.40474,0.26083,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.636e-05,0.4045,0.39682,1,1
2,GO TRANSCYTOSIS,0.0021907,0.40449,0.40308,1,1
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00096503,0.40385,0.42519,1,1
2,GO PINOCYTOSIS,0.00031664,0.40306,0.40551,1,1
2,GO LIPOXYGENASE PATHWAY,0.0023095,0.40304,0.42043,1,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.00031664,0.403,0.45278,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.7249e-05,0.40294,0.45891,1,1
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00014989,0.40281,0.42228,1,1
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.00064645,0.40257,0.56703,1,1
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00013188,0.40165,0.46604,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00086166,0.40078,0.46263,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00042807,0.39956,0.43074,1,1
2,GO GAP JUNCTION ASSEMBLY,0.0010209,0.39927,0.49937,1,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00021879,0.39882,0.44881,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00024771,0.39776,0.40649,1,1
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00057531,0.39768,0.4487,1,1
2,GO SKIN MORPHOGENESIS,0.006955,0.39753,0.37316,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,4.5779e-05,0.39741,0.453,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.00068502,0.39521,0.39044,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00023283,0.39477,0.40549,1,1
2,GO DIET INDUCED THERMOGENESIS,0.0018673,0.39475,0.34895,1,1
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,4.5779e-05,0.39417,0.50116,1,1
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.3279e-05,0.39414,0.3911,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,7.3279e-05,0.39357,0.38018,1,1
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.00014989,0.39323,0.32253,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00012367,0.39281,0.37871,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,8.3641e-05,0.39258,0.41383,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00060992,0.3921,0.40072,1,1
2,GO PROTEIN TRIMERIZATION,0.00011593,0.3914,0.47523,1,1
2,GO REGULATION OF STEROL TRANSPORT,0.00010866,0.38989,0.39555,1,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00012367,0.38985,0.54124,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.4576e-05,0.3891,0.41073,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,5.9985e-05,0.38845,0.45302,1,1
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00076864,0.38827,0.3759,1,1
2,GO AMYLOID FIBRIL FORMATION,0.00026348,0.38768,0.39591,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,7.7514e-06,0.38766,0.48411,1,1
2,GO LIVER MORPHOGENESIS,8.9327e-05,0.3875,0.39812,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00042807,0.38709,0.39981,1,1
2,GO ETHANOL CATABOLIC PROCESS,0.00017019,0.3862,0.41468,1,1
2,GO REGULATION OF BONE REMODELING,0.0010798,0.38608,0.36484,1,1
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00332,0.38604,0.42696,1,1
2,GO PODOSOME ASSEMBLY,0.00045436,0.38602,0.43875,1,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0013481,0.38574,0.39104,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.4947e-05,0.38556,0.41645,1,1
2,GO REGULATION OF HEMOPOIESIS,6.4139e-05,0.38543,0.38529,1,1
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00017019,0.38528,0.46334,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0038653,0.38509,0.35434,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,3.7287e-05,0.38484,0.42966,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.00054254,0.38455,0.42192,1,1
2,GO REGULATION OF COAGULATION,0.00021879,0.38438,0.4502,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00035748,0.3838,0.46897,1,1
2,GO PLATELET DEGRANULATION,0.00020554,0.38373,0.45276,1,1
2,GO COLLAGEN METABOLIC PROCESS,0.00026348,0.38316,0.45905,1,1
2,GO NEGATIVE REGULATION OF COAGULATION,0.00029789,0.38286,0.47658,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00010866,0.38218,0.4444,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00026348,0.382,0.32691,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.4576e-05,0.3815,0.4431,1,1
2,GO STEROL HOMEOSTASIS,3.248e-05,0.3805,0.3983,1,1
2,GO REGULATION OF PLATELET AGGREGATION,0.0025648,0.38023,0.38472,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00040321,0.38002,0.3017,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0034935,0.37938,0.31014,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0003797,0.3792,0.34681,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.0029965,0.379,0.30779,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.9936e-05,0.37863,0.42332,1,1
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0010209,0.37853,0.40023,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00040321,0.37805,0.41589,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00019306,0.37791,0.38616,1,1
2,GO PLATELET AGGREGATION,0.0012071,0.37778,0.38801,1,1
2,GO INTERFERON BETA PRODUCTION,0.00033648,0.37732,0.38043,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.0003797,0.37719,0.3729,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.8267e-05,0.37636,0.41638,1,1
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0025648,0.37621,0.35582,1,1
2,GO NIK NF KAPPAB SIGNALING,3.4805e-05,0.37614,0.35308,1,1
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0024341,0.37604,0.53149,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3909e-05,0.37545,0.44605,1,1
2,GO REGULATION OF TISSUE REMODELING,0.00081392,0.37476,0.36558,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,2.636e-05,0.3747,0.48167,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,6.8565e-05,0.37463,0.43234,1,1
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0042727,0.37427,0.35736,1,1
2,GO PLATELET ACTIVATION,0.0015882,0.37396,0.35793,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00026348,0.37369,0.40196,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.008797,0.37361,0.37169,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00060992,0.37319,0.4425,1,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.0010209,0.37271,0.38821,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.8997e-05,0.37237,0.40201,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,8.9327e-05,0.37203,0.35954,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.8298e-05,0.37148,0.35641,1,1
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00010181,0.37099,0.38734,1,1
2,GO REGULATION OF RECEPTOR BINDING,0.00054254,0.37078,0.37673,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.7287e-05,0.37077,0.38062,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00033648,0.37067,0.36992,1,1
2,GO VAGINA DEVELOPMENT,0.0019699,0.36992,0.36644,1,1
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0029965,0.3699,0.41923,1,1
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00033648,0.36964,0.39603,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00048214,0.36953,0.43107,1,1
2,GO REGULATION OF CELL ADHESION,0.00014062,0.36924,0.41025,1,1
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00014062,0.36922,0.35307,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00024771,0.36833,0.46724,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.4947e-05,0.36804,0.43513,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.4805e-05,0.36738,0.36099,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.00060992,0.36718,0.34437,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00010181,0.36706,0.4874,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00054254,0.36687,0.39156,1,1
2,GO RENAL ABSORPTION,5.2428e-05,0.3662,0.51471,1,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00031664,0.36611,0.43466,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.6689e-06,0.36601,0.42174,1,1
2,GO RESPONSE TO FLUID SHEAR STRESS,0.00011593,0.3659,0.46504,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.7287e-05,0.36557,0.43218,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00040321,0.3651,0.3626,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,8.9327e-05,0.36477,0.38567,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0016767,0.36452,0.35764,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.9936e-05,0.3645,0.37139,1,1
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0027019,0.36407,0.33605,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00018128,0.36288,0.38427,1,1
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00035748,0.36271,0.38478,1,1
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00064645,0.3613,0.38347,1,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,5.6086e-05,0.36074,0.38299,1,1
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,8.3641e-05,0.36059,0.40507,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00051151,0.36017,0.43928,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,6.4139e-05,0.35982,0.37444,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.2907e-05,0.35971,0.43984,1,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0052065,0.3594,0.40967,1,1
2,GO P38MAPK CASCADE,2.8267e-05,0.3592,0.41471,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00023283,0.35918,0.43261,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00019306,0.35886,0.38149,1,1
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.00024771,0.35868,0.40215,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00021879,0.35814,0.36487,1,1
2,GO RESPONSE TO MINERALOCORTICOID,0.0003797,0.35798,0.32801,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00024771,0.35782,0.40323,1,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00081392,0.35656,0.39377,1,1
2,GO SEQUESTERING OF METAL ION,0.00091199,0.35591,0.35187,1,1
2,GO INTERACTION WITH SYMBIONT,1.9888e-05,0.35537,0.36391,1,1
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0024341,0.35509,0.39363,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0076456,0.35429,0.36359,1,1
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00023283,0.35396,0.42023,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00035748,0.35368,0.33222,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00012367,0.35338,0.41413,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00035748,0.35338,0.40861,1,1
2,GO RESPONSE TO MANGANESE ION,5.6086e-05,0.35314,0.36867,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021879,0.35231,0.3692,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.00010866,0.35225,0.3632,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,4.5779e-05,0.35187,0.39557,1,1
2,GO COPPER ION TRANSPORT,0.00064645,0.35173,0.32378,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,7.3279e-05,0.3516,0.37977,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0018673,0.35143,0.29114,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0010798,0.35131,0.39909,1,1
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0042727,0.35098,0.33182,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0027019,0.35014,0.49176,1,1
2,GO CALCIUM MEDIATED SIGNALING,0.00028019,0.35008,0.34381,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00017019,0.34978,0.36298,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,6.4139e-05,0.34954,0.39305,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00011593,0.34947,0.35725,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0016767,0.34831,0.38237,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,0.00048214,0.34829,0.35318,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00015974,0.34822,0.34632,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00010181,0.34804,0.40706,1,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,3.9936e-05,0.34769,0.36839,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0025648,0.34766,0.33798,1,1
2,GO SALIVA SECRETION,0.0040644,0.34744,0.3199,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.00035748,0.34742,0.33843,1,1
2,GO RESPONSE TO THYROID HORMONE,0.0014241,0.3469,0.30554,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021879,0.34653,0.36244,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,6.4139e-05,0.34641,0.39855,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012367,0.34616,0.43436,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00026348,0.34557,0.35427,1,1
2,GO BONE REMODELING,0.00042807,0.34539,0.38279,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0010798,0.34534,0.33918,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,6.8565e-05,0.34487,0.3815,1,1
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00048214,0.3447,0.341,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0010209,0.34457,0.37838,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0096484,0.34455,0.29828,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0028457,0.34434,0.32957,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0023095,0.34434,0.32668,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.00012367,0.34423,0.34914,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.3279e-05,0.34277,0.38336,1,1
2,GO MYELOID CELL DEVELOPMENT,0.00014989,0.34276,0.38404,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00021879,0.34255,0.35329,1,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,6.8565e-05,0.34224,0.35108,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00081392,0.34216,0.39525,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00014989,0.34178,0.29604,1,1
2,GO RESPONSE TO VITAMIN D,0.0028457,0.34165,0.31425,1,1
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0025648,0.34152,0.4363,1,1
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00086166,0.34151,0.3433,1,1
2,GO VASCULAR WOUND HEALING,0.0010209,0.34141,0.42804,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00068502,0.34095,0.34551,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0014241,0.34017,0.39846,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.011063,0.33962,0.34777,1,1
2,GO RETINAL METABOLIC PROCESS,0.00015974,0.33901,0.45358,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,8.9327e-05,0.33764,0.39082,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00051151,0.33693,0.38143,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0057394,0.33587,0.31458,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,3.7287e-05,0.33482,0.39076,1,1
2,GO TISSUE REMODELING,0.0003797,0.33472,0.39661,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00029789,0.33446,0.32731,1,1
2,GO DECIDUALIZATION,0.00076864,0.33415,0.38602,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,2.4576e-05,0.33321,0.31905,1,1
2,GO REGULATION OF LYSOSOMAL LUMEN PH,8.3641e-05,0.33285,0.36073,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00031664,0.33274,0.43134,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00015974,0.33224,0.3847,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00015974,0.33212,0.41229,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0023095,0.33201,0.35066,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.3279e-05,0.3311,0.35411,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0027019,0.33097,0.33335,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00033648,0.33083,0.38633,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.012106,0.33079,0.30795,1,1
2,GO STEROID ESTERIFICATION,0.00014989,0.33046,0.33691,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00054254,0.32904,0.30583,1,1
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00081392,0.32774,0.40142,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00018128,0.32681,0.34202,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,8.9327e-05,0.32642,0.33927,1,1
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.00023283,0.32589,0.37416,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.9327e-05,0.32585,0.34736,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.00026348,0.32567,0.34592,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00068502,0.32525,0.34974,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00020554,0.32481,0.33204,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0012758,0.32455,0.32618,1,1
2,GO PULMONARY VALVE DEVELOPMENT,0.0027019,0.32452,0.3879,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,5.2428e-05,0.32376,0.36363,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00054254,0.32331,0.3214,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00057531,0.3232,0.30106,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040321,0.32278,0.31314,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0063209,0.32244,0.36253,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,6.4139e-05,0.32227,0.34609,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00068502,0.32225,0.30215,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.007293,0.32214,0.30677,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00045436,0.32199,0.33569,1,1
2,GO RETINOIC ACID METABOLIC PROCESS,0.00026348,0.32191,0.35998,1,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.0038653,0.32181,0.33426,1,1
2,GO REGULATION OF LIPID STORAGE,0.00045436,0.32139,0.33468,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0060238,0.32138,0.28644,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0034935,0.32107,0.28569,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.00024771,0.31984,0.32507,1,1
2,GO PROSTAGLANDIN TRANSPORT,0.00051151,0.3198,0.38018,1,1
2,GO CHOLESTEROL EFFLUX,0.00086166,0.31977,0.31795,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.5377e-05,0.31973,0.41545,1,1
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.00042807,0.31933,0.39416,1,1
2,GO RESPONSE TO DEXAMETHASONE,0.00019306,0.31923,0.27978,1,1
2,GO REGULATION OF CALCIUM ION IMPORT,0.00033648,0.31882,0.36333,1,1
2,GO RESPONSE TO CORTICOSTERONE,0.0080134,0.31828,0.29046,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015776,0.3181,0.26165,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.013834,0.31775,0.26777,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00028019,0.3177,0.38497,1,1
2,GO CELLULAR RESPONSE TO DSRNA,0.0013481,0.31751,0.3412,1,1
2,GO MEMBRANE PROTEIN PROTEOLYSIS,8.3641e-05,0.31742,0.39717,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00019306,0.31718,0.41492,1,1
2,GO NECROTIC CELL DEATH,0.00010181,0.31713,0.33335,1,1
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00076864,0.31712,0.32963,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00029789,0.31707,0.37237,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00029789,0.31699,0.36615,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00068502,0.3168,0.37181,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00019306,0.3168,0.3138,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0044907,0.31661,0.31755,1,1
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00014989,0.31633,0.29927,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0010209,0.31631,0.36959,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00054254,0.31562,0.35688,1,1
2,GO RESPONSE TO NITRIC OXIDE,0.0024341,0.31519,0.26118,1,1
2,GO EPOXYGENASE P450 PATHWAY,0.0010209,0.31515,0.30715,1,1
2,GO REGULATION OF ISOTYPE SWITCHING,0.00060992,0.31514,0.3622,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00060992,0.31505,0.37721,1,1
2,GO GLIAL CELL PROLIFERATION,0.00057531,0.31398,0.34606,1,1
2,GO B CELL APOPTOTIC PROCESS,0.00035748,0.31392,0.33664,1,1
2,GO SEQUESTERING OF CALCIUM ION,0.00057531,0.31391,0.33313,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.013235,0.3135,0.25459,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00072571,0.31261,0.41799,1,1
2,GO REGULATION OF WOUND HEALING,0.0003797,0.31244,0.37007,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00010866,0.31215,0.36017,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00096503,0.31208,0.37191,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0012071,0.31113,0.35355,1,1
2,GO RESPONSE TO DSRNA,0.00048214,0.31096,0.30062,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00028019,0.31092,0.35146,1,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0013481,0.30952,0.34087,1,1
2,GO RESPONSE TO AMYLOID BETA,0.0012758,0.30943,0.34479,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.4805e-05,0.30933,0.36089,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0018673,0.30881,0.38997,1,1
2,GO REGULATION OF PROTEIN MATURATION,6.8565e-05,0.30872,0.35365,1,1
2,GO BLOOD VESSEL REMODELING,0.0028457,0.3081,0.39557,1,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00096503,0.3078,0.29354,1,1
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00086166,0.30754,0.37264,1,1
2,GO HYALURONAN METABOLIC PROCESS,0.0012758,0.3075,0.36196,1,1
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.0029965,0.30734,0.38477,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00013188,0.30718,0.33875,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8298e-05,0.3063,0.32992,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,6.4139e-05,0.30629,0.34347,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0027019,0.30559,0.33705,1,1
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0019699,0.30546,0.34373,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0028457,0.30531,0.31674,1,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0027019,0.30523,0.30543,1,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00033648,0.30504,0.33556,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0011418,0.30436,0.31717,1,1
2,GO CELL CELL RECOGNITION,9.5377e-05,0.30341,0.2954,1,1
2,GO POSITIVE CHEMOTAXIS,0.00064645,0.30327,0.36632,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0040644,0.30306,0.25819,1,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.060677,0.30252,0.17882,1,1
2,GO OVULATION,0.00015974,0.30218,0.39424,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00045436,0.302,0.29135,1,1
2,GO CERAMIDE TRANSPORT,0.0023095,0.30195,0.29471,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.2428e-05,0.30188,0.33367,1,1
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0003797,0.30154,0.40975,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00017019,0.30145,0.42172,1,1
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00091199,0.30116,0.41697,1,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.013834,0.30115,0.27261,1,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.0020776,0.30041,0.36147,1,1
2,GO TRABECULA MORPHOGENESIS,0.01266,0.30016,0.28333,1,1
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0029965,0.29987,0.32616,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00031664,0.29982,0.30423,1,1
2,GO LYMPH VESSEL DEVELOPMENT,0.0044907,0.29967,0.38999,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.00072571,0.29965,0.26446,1,1
2,GO POSITIVE REGULATION OF JNK CASCADE,0.00064645,0.29887,0.32513,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0076456,0.29885,0.28434,1,1
2,GO REGULATION OF BONE MINERALIZATION,0.0016767,0.29827,0.33865,1,1
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00020554,0.29815,0.3846,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0036751,0.29812,0.34367,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.00054254,0.29802,0.36199,1,1
2,GO NUCLEOSIDE CATABOLIC PROCESS,9.5377e-05,0.29787,0.31804,1,1
2,GO RESPONSE TO PROGESTERONE,0.0016767,0.29776,0.31174,1,1
2,GO REGULATION OF PINOCYTOSIS,0.008797,0.29755,0.26637,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0015041,0.2972,0.36669,1,1
2,GO HOMOTYPIC CELL CELL ADHESION,0.0024341,0.29716,0.32162,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00033648,0.29702,0.32378,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0017696,0.29701,0.24231,1,1
2,GO MATERNAL PLACENTA DEVELOPMENT,0.0010209,0.29673,0.31552,1,1
2,GO ARGININE METABOLIC PROCESS,0.00011593,0.29657,0.32805,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00060992,0.29618,0.36109,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.01266,0.29612,0.25752,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00020554,0.2961,0.29673,1,1
2,GO PROSTATE GLAND GROWTH,0.0017696,0.29567,0.3016,1,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00015974,0.29551,0.36797,1,1
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0012071,0.29535,0.3934,1,1
2,GO ICOSANOID METABOLIC PROCESS,9.5377e-05,0.2951,0.35286,1,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0023095,0.29506,0.37215,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00031664,0.29484,0.30447,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00072571,0.29469,0.27864,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0010798,0.29425,0.31584,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0076456,0.29421,0.35001,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00054254,0.29418,0.2656,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00042807,0.29405,0.26231,1,1
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0020776,0.29389,0.29381,1,1
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0015882,0.29363,0.30682,1,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0027019,0.29354,0.33521,1,1
2,GO HYPOTONIC RESPONSE,0.0036751,0.29323,0.32765,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00028019,0.29316,0.34527,1,1
2,GO LYMPHANGIOGENESIS,0.0025648,0.29308,0.4061,1,1
2,GO INTERACTION WITH HOST,0.00013188,0.29302,0.2985,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00091199,0.29267,0.36507,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.00045436,0.29261,0.35874,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0027019,0.2926,0.2205,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00068502,0.29253,0.28056,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00029789,0.29243,0.31916,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0010798,0.29196,0.32967,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0015041,0.29186,0.31242,1,1
2,GO REGULATION OF BIOMINERALIZATION,0.0034935,0.29179,0.30098,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0019699,0.29177,0.3135,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0013481,0.29145,0.32777,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.00096503,0.29136,0.30937,1,1
2,GO PEPTIDE CATABOLIC PROCESS,0.0003797,0.2913,0.36344,1,1
2,GO THYROID HORMONE METABOLIC PROCESS,0.0042727,0.29124,0.26869,1,1
2,GO RESPONSE TO INACTIVITY,0.010572,0.29121,0.24556,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.00014062,0.29081,0.33417,1,1
2,GO STEROID CATABOLIC PROCESS,0.0054671,0.29052,0.26218,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0016767,0.29046,0.28704,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0015041,0.29045,0.2841,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00068502,0.28949,0.27185,1,1
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.0010798,0.28932,0.28379,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00051151,0.28919,0.29501,1,1
2,GO COAGULATION,0.00086166,0.28837,0.32334,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.007293,0.28826,0.20911,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0054671,0.28816,0.28421,1,1
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00051151,0.288,0.29387,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.00042807,0.28735,0.28503,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00060992,0.28721,0.34023,1,1
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00033648,0.28682,0.31574,1,1
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0040644,0.28673,0.29977,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.00026348,0.2867,0.34834,1,1
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.026142,0.28608,0.30199,1,1
2,GO KERATINOCYTE MIGRATION,0.0047188,0.28576,0.28854,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00040321,0.28568,0.34036,1,1
2,GO POSITIVE REGULATION OF MYELINATION,0.0054671,0.28548,0.29481,1,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0052065,0.28481,0.26053,1,1
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00023283,0.28475,0.34862,1,1
2,GO HEAT GENERATION,0.0010209,0.28408,0.30233,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0060238,0.28364,0.2585,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0092139,0.28362,0.27846,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017019,0.28285,0.2971,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0024341,0.28283,0.29935,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,5.9985e-05,0.28266,0.36275,1,1
2,GO URETER DEVELOPMENT,0.033245,0.28225,0.20758,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00024771,0.28205,0.30091,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0021907,0.28202,0.28139,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0010798,0.28191,0.33978,1,1
2,GO PROSTAGLANDIN SECRETION,0.0023095,0.28151,0.34211,1,1
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00081392,0.28116,0.36849,1,1
2,GO RUFFLE ORGANIZATION,0.00031664,0.28096,0.32532,1,1
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.015104,0.28091,0.31071,1,1
2,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.0036751,0.28072,0.26844,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00033648,0.28057,0.32876,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,8.9327e-05,0.28031,0.33727,1,1
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.012106,0.28001,0.24676,1,1
2,GO TISSUE MIGRATION,0.00072571,0.27993,0.32108,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0040644,0.27981,0.26246,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00060992,0.27968,0.32624,1,1
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.007293,0.27946,0.30294,1,1
2,GO RESPONSE TO STEROL,0.0013481,0.27939,0.29642,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.0027019,0.27912,0.25019,1,1
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00048214,0.27891,0.34403,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.00054254,0.27885,0.34672,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0016767,0.2788,0.29792,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00076864,0.27832,0.33066,1,1
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00332,0.27822,0.3152,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.010572,0.27822,0.24227,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0003797,0.27808,0.39107,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00028019,0.27797,0.37756,1,1
2,GO KERATINOCYTE PROLIFERATION,0.0040644,0.2778,0.28537,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.031957,0.27739,0.2071,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.018736,0.27738,0.24685,1,1
2,GO PULMONARY VALVE MORPHOGENESIS,0.010572,0.27738,0.34932,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00054254,0.27732,0.29589,1,1
2,GO TERPENOID METABOLIC PROCESS,0.00011593,0.27719,0.27369,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00010866,0.27712,0.31903,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00029789,0.27674,0.30919,1,1
2,GO CELL SUBSTRATE ADHESION,0.0038653,0.27672,0.32786,1,1
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.8565e-05,0.27664,0.32019,1,1
2,GO ENAMEL MINERALIZATION,0.00026348,0.27637,0.4056,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.0018673,0.27634,0.28602,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.019548,0.27599,0.24552,1,1
2,GO RESPONSE TO ATP,0.00011593,0.27584,0.32838,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0021907,0.27582,0.3417,1,1
2,GO REGULATION OF AMYLOID BETA FORMATION,0.00068502,0.27488,0.30409,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00081392,0.27479,0.2841,1,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.0076456,0.27474,0.3211,1,1
2,GO MUSCLE CELL PROLIFERATION,0.00026348,0.27419,0.33218,1,1
2,GO GLOMERULUS DEVELOPMENT,0.0063209,0.27405,0.34345,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0028457,0.27358,0.28097,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0028457,0.27329,0.39053,1,1
2,GO GLIAL CELL MIGRATION,0.0057394,0.27273,0.2767,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.0021907,0.27273,0.30296,1,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.0014241,0.2726,0.27157,1,1
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0021907,0.27259,0.32682,1,1
2,GO CELL MATRIX ADHESION,0.0044907,0.2725,0.31866,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.00096503,0.27236,0.31329,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,3.4805e-05,0.27207,0.31596,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.019548,0.272,0.3245,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040321,0.27191,0.30775,1,1
2,GO IRON ION HOMEOSTASIS,0.00045436,0.27188,0.2749,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0018673,0.27176,0.3232,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.012106,0.27162,0.25334,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.00064645,0.27137,0.31394,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00076864,0.27085,0.27065,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00076864,0.27077,0.39679,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00010866,0.26983,0.37194,1,1
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0057394,0.26975,0.26847,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00072571,0.26945,0.30701,1,1
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.031957,0.26914,0.21025,1,1
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.00033648,0.26831,0.31276,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.011574,0.26826,0.25817,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.00023283,0.2677,0.2848,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0036751,0.26751,0.28679,1,1
2,GO VIRAL GENOME REPLICATION,0.0014241,0.26695,0.28298,1,1
2,GO AORTIC VALVE DEVELOPMENT,0.0054671,0.26689,0.37204,1,1
2,GO WOUND HEALING,0.0011418,0.26682,0.31405,1,1
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0019699,0.26647,0.31382,1,1
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0042727,0.26629,0.23556,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00010181,0.26623,0.32688,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00021879,0.26599,0.29834,1,1
2,GO RIG I SIGNALING PATHWAY,0.00081392,0.26592,0.27596,1,1
2,GO PROTEIN KINASE B SIGNALING,0.00024771,0.26587,0.31727,1,1
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020776,0.26564,0.25186,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00031664,0.2654,0.26777,1,1
2,GO RESPONSE TO CORTICOSTEROID,0.00051151,0.26532,0.28705,1,1
2,GO SULFATION,0.0083971,0.26492,0.27034,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00076864,0.26492,0.34475,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.006955,0.26487,0.25314,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0044907,0.2645,0.36226,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0020776,0.26429,0.26623,1,1
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0019699,0.26395,0.30473,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0031545,0.26394,0.30151,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00013188,0.2637,0.27899,1,1
2,GO RESPONSE TO LIPID,0.00031664,0.26366,0.27459,1,1
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00042807,0.26351,0.30267,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,4.8997e-05,0.26333,0.36175,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00064645,0.26286,0.2926,1,1
2,GO REGULATION OF CELL SHAPE,0.00048214,0.26202,0.31994,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00033648,0.26173,0.31778,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00091199,0.26173,0.32914,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0028457,0.26169,0.26986,1,1
2,GO MYOTUBE DIFFERENTIATION,0.0014241,0.26136,0.27377,1,1
2,GO SEQUESTERING OF TRIGLYCERIDE,0.0047188,0.26126,0.2779,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.0015882,0.2612,0.30415,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.00081392,0.26106,0.30253,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00045436,0.26083,0.28699,1,1
2,GO PROTEIN NITROSYLATION,0.00064645,0.26065,0.31931,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.0021907,0.26034,0.34044,1,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0052065,0.26005,0.27928,1,1
2,GO POSITIVE REGULATION OF OSSIFICATION,0.011574,0.25995,0.26094,1,1
2,GO PANCREATIC JUICE SECRETION,0.014457,0.25993,0.25762,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.010101,0.25985,0.24846,1,1
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00332,0.25938,0.3645,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,3.248e-05,0.25935,0.29131,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00015974,0.25903,0.28359,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0012758,0.25883,0.27953,1,1
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00011593,0.25843,0.29421,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0023095,0.25792,0.24145,1,1
2,GO EXOCYTOSIS,0.00072571,0.25751,0.26235,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.00051151,0.2574,0.27905,1,1
2,GO CELLULAR RESPONSE TO NUTRIENT,0.035953,0.25694,0.21534,1,1
2,GO REGULATION OF TRANSPOSITION,0.025096,0.25693,0.19572,1,1
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.052482,0.25661,0.29346,1,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.0054671,0.25631,0.30059,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.00086166,0.25619,0.26158,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.0023095,0.25617,0.32139,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0025648,0.25603,0.24003,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.013834,0.25592,0.22714,1,1
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.021265,0.25551,0.29315,1,1
2,GO VIRAL LIFE CYCLE,0.00031664,0.25543,0.28042,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.011063,0.25534,0.24548,1,1
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.016475,0.25519,0.23622,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0083971,0.25485,0.26944,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0012758,0.25477,0.2318,1,1
2,GO BONE MATURATION,0.0096484,0.25452,0.2696,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0034935,0.25422,0.2984,1,1
2,GO ARTERY MORPHOGENESIS,0.0021907,0.25402,0.32724,1,1
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.018736,0.25399,0.31195,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0014241,0.2539,0.26475,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00033648,0.25326,0.3063,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0031545,0.25296,0.27001,1,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0023095,0.25265,0.30934,1,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0034935,0.2523,0.27527,1,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.0044907,0.25223,0.2903,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0012758,0.25222,0.32372,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.046961,0.2522,0.23999,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.00081392,0.25191,0.27472,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.0003797,0.2519,0.30685,1,1
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00091199,0.2515,0.23036,1,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0010209,0.25109,0.28292,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0042727,0.25078,0.30081,1,1
2,GO PHAGOLYSOSOME ASSEMBLY,0.026142,0.25041,0.235,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0025648,0.25039,0.22183,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00057531,0.25028,0.32456,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0013481,0.25027,0.32033,1,1
2,GO ARTERY DEVELOPMENT,0.0038653,0.25021,0.3164,1,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0010209,0.24982,0.29034,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.2763e-05,0.24944,0.2729,1,1
2,GO CORNIFICATION,0.060677,0.24928,0.17093,1,1
2,GO BRONCHUS DEVELOPMENT,0.012106,0.24894,0.32423,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0036751,0.24811,0.25941,1,1
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,5.6086e-05,0.24809,0.27756,1,1
2,GO EMBRYO IMPLANTATION,0.00081392,0.24809,0.31883,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.00012367,0.24773,0.2372,1,1
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0024341,0.24728,0.27412,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028457,0.24694,0.23343,1,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00060992,0.24658,0.30235,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00021879,0.24655,0.25183,1,1
2,GO TISSUE REGENERATION,0.00072571,0.24637,0.24679,1,1
2,GO REPLACEMENT OSSIFICATION,0.0063209,0.24622,0.29878,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00023283,0.24557,0.28475,1,1
2,GO MANGANESE ION TRANSPORT,0.0057394,0.24556,0.2283,1,1
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.026142,0.24549,0.27679,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00051151,0.24522,0.26557,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.008797,0.2451,0.2664,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0034935,0.24477,0.27445,1,1
2,GO RESPONSE TO VITAMIN,0.0044907,0.24452,0.23186,1,1
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.018736,0.24438,0.261,1,1
2,GO HEART VALVE DEVELOPMENT,0.0066311,0.24433,0.31772,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045436,0.24422,0.28756,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00020554,0.24399,0.25631,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.00024771,0.24381,0.24815,1,1
2,GO RESPONSE TO HYPEROXIA,0.00081392,0.24298,0.30201,1,1
2,GO FIBROBLAST ACTIVATION,0.0054671,0.24284,0.27957,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0080134,0.24283,0.26913,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00072571,0.24264,0.25588,1,1
2,GO SECRETION BY TISSUE,0.00091199,0.24205,0.251,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0012071,0.24203,0.24003,1,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0020776,0.24191,0.28484,1,1
2,GO RESPONSE TO GROWTH HORMONE,0.00048214,0.24182,0.26862,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.016475,0.24148,0.23259,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00042807,0.24116,0.24613,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.013834,0.24109,0.2148,1,1
2,GO LUNG MORPHOGENESIS,0.0057394,0.24104,0.28881,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.0020776,0.24102,0.2567,1,1
2,GO RESPONSE TO RETINOIC ACID,0.0016767,0.24101,0.26534,1,1
2,GO BIOMINERALIZATION,0.0038653,0.24098,0.25479,1,1
2,GO TAXIS,0.0017696,0.24081,0.26859,1,1
2,GO BONE DEVELOPMENT,0.0016767,0.24072,0.2848,1,1
2,GO RESPONSE TO FATTY ACID,0.00060992,0.23988,0.25358,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0066311,0.23937,0.33092,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.013235,0.23917,0.29556,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0028457,0.23823,0.2478,1,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.0076456,0.23781,0.20977,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.007293,0.23778,0.28126,1,1
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0018673,0.23719,0.25357,1,1
2,GO RESPONSE TO WOUNDING,0.0018673,0.23688,0.28097,1,1
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.043559,0.23655,0.26193,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00042807,0.23649,0.27202,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0044907,0.23634,0.24985,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.23614,0.28814,1,1
2,GO PLASMA MEMBRANE FUSION,0.0042727,0.23613,0.28137,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00054254,0.23608,0.25555,1,1
2,GO RESPONSE TO ISCHEMIA,0.0012758,0.23601,0.29126,1,1
2,GO ENGULFMENT OF APOPTOTIC CELL,0.013235,0.23582,0.25388,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00060992,0.23565,0.25155,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00019306,0.23564,0.27268,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.027226,0.23535,0.30662,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0044907,0.23513,0.24334,1,1
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0080134,0.23507,0.26233,1,1
2,GO AMINOGLYCAN METABOLIC PROCESS,0.0029965,0.2349,0.27362,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.026142,0.23459,0.21304,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0063209,0.23447,0.22055,1,1
2,GO TRANSPOSITION,0.034576,0.23429,0.17236,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.0028457,0.23404,0.25775,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00031664,0.23398,0.26658,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023283,0.23383,0.25636,1,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0021907,0.23378,0.24619,1,1
2,GO RESPONSE TO ESTROGEN,0.0015041,0.23364,0.2643,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.00023283,0.23362,0.25156,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.014457,0.23343,0.2944,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.006955,0.23292,0.26901,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0019699,0.23281,0.28428,1,1
2,GO CELL CELL ADHESION,0.00096503,0.23278,0.2875,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0014241,0.23258,0.30319,1,1
2,GO MEGAKARYOCYTE DEVELOPMENT,0.0060238,0.23252,0.26171,1,1
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00064645,0.23251,0.25609,1,1
2,GO ODONTOGENESIS,0.0031545,0.2325,0.25694,1,1
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0018673,0.23236,0.2586,1,1
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.050584,0.23231,0.18445,1,1
2,GO DRUG METABOLIC PROCESS,0.0020776,0.2323,0.27827,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.016475,0.23168,0.23567,1,1
2,GO COPPER ION HOMEOSTASIS,0.0010209,0.23166,0.232,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.040368,0.23123,0.20467,1,1
2,GO DETOXIFICATION,0.00011593,0.23119,0.24179,1,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.046961,0.23105,0.18464,1,1
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.022172,0.23105,0.27442,1,1
2,GO STEROL TRANSPORT,0.00054254,0.23077,0.28312,1,1
2,GO LYMPH VESSEL MORPHOGENESIS,0.011574,0.23063,0.34537,1,1
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0027019,0.23063,0.25974,1,1
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0057394,0.23056,0.26782,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00072571,0.23053,0.24965,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0047188,0.22942,0.26175,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0038653,0.2292,0.2408,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.01266,0.2292,0.2996,1,1
2,GO AMYLOID BETA FORMATION,0.0013481,0.22913,0.25967,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0057394,0.22843,0.26093,1,1
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0010209,0.22834,0.28426,1,1
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0036751,0.22816,0.25999,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.018736,0.22804,0.19545,1,1
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.016475,0.22791,0.24218,1,1
2,GO BROWN FAT CELL DIFFERENTIATION,0.0027019,0.22759,0.23499,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00081392,0.2271,0.2601,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.007293,0.22698,0.2419,1,1
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0020776,0.22687,0.23905,1,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.0014241,0.22666,0.24661,1,1
2,GO ENDOCARDIAL CUSHION FORMATION,0.040368,0.22666,0.27338,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0044907,0.22654,0.24697,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00081392,0.22608,0.28529,1,1
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0021907,0.22607,0.20785,1,1
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0013481,0.22583,0.3094,1,1
2,GO FACE DEVELOPMENT,0.035953,0.22561,0.23418,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.00045436,0.22498,0.241,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,3.4805e-05,0.22478,0.25642,1,1
2,GO MRNA TRANSCRIPTION,0.011063,0.22473,0.26167,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0083971,0.22468,0.28929,1,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.01266,0.22455,0.29252,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.031957,0.22451,0.22314,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00045436,0.22431,0.25306,1,1
2,GO EPIBOLY,0.0028457,0.22383,0.29942,1,1
2,GO LIPID STORAGE,0.00076864,0.22378,0.27083,1,1
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.00019306,0.22362,0.25813,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.00072571,0.22361,0.26314,1,1
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0027019,0.22348,0.23706,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0063209,0.22336,0.32088,1,1
2,GO REGULATION OF OSSIFICATION,0.006955,0.22332,0.25383,1,1
2,GO FATTY ACID TRANSPORT,0.00017019,0.22311,0.27545,1,1
2,GO BONE MINERALIZATION,0.008797,0.22224,0.2653,1,1
2,GO LIPID HOMEOSTASIS,0.00031664,0.22219,0.25917,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00045436,0.22209,0.24362,1,1
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0012758,0.22168,0.25462,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.040368,0.22153,0.28033,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014062,0.2215,0.25658,1,1
2,GO BIOLOGICAL ADHESION,0.0015882,0.22108,0.28469,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.0017696,0.22101,0.24034,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.0012071,0.22071,0.24299,1,1
2,GO AMELOGENESIS,0.00096503,0.22042,0.31601,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0019699,0.22027,0.23875,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0076456,0.21988,0.23615,1,1
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0011418,0.2195,0.21929,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00064645,0.2195,0.24704,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00096503,0.21872,0.29102,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0063209,0.21845,0.28551,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.022172,0.21814,0.22855,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0013481,0.21781,0.25332,1,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00048214,0.21762,0.29284,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0021907,0.21725,0.21504,1,1
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00081392,0.21716,0.33714,1,1
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0024341,0.21681,0.27776,1,1
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0036751,0.21652,0.2601,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0012758,0.21622,0.26454,1,1
2,GO TRACHEA MORPHOGENESIS,0.033245,0.2161,0.30768,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0049572,0.21599,0.23402,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0012758,0.21595,0.3085,1,1
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.020391,0.21581,0.23793,1,1
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0016767,0.2158,0.25501,1,1
2,GO REGULATION OF MAPK CASCADE,0.00086166,0.21569,0.26657,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.016475,0.21537,0.29124,1,1
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.0003797,0.21534,0.2784,1,1
2,GO INTESTINAL ABSORPTION,0.0172,0.21531,0.26531,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00096503,0.21526,0.2711,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0023095,0.21517,0.28311,1,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0018673,0.21499,0.29173,1,1
2,GO NEPHRON TUBULE FORMATION,0.0083971,0.21384,0.24798,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0017696,0.21365,0.2049,1,1
2,GO BILE ACID METABOLIC PROCESS,0.00086166,0.21358,0.21879,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00031664,0.21354,0.2406,1,1
2,GO AORTA DEVELOPMENT,0.0047188,0.21344,0.2957,1,1
2,GO HEPARIN METABOLIC PROCESS,0.015776,0.21292,0.26666,1,1
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0012071,0.21292,0.27104,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.050584,0.2123,0.22272,1,1
2,GO ANIMAL ORGAN REGENERATION,0.00029789,0.21203,0.24756,1,1
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0172,0.21199,0.23122,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0031545,0.21197,0.24184,1,1
2,GO PROTEIN AUTOPROCESSING,0.015104,0.21191,0.19025,1,1
2,GO BICARBONATE TRANSPORT,0.037377,0.21173,0.18123,1,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.0024341,0.21164,0.23053,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0027019,0.21138,0.22482,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0054671,0.21131,0.24625,1,1
2,GO ACTIVATION OF MAPK ACTIVITY,0.0025648,0.21109,0.22604,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.0010798,0.21108,0.25699,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.008797,0.21065,0.20894,1,1
2,GO RESPONSE TO NUTRIENT,0.0019699,0.2105,0.22512,1,1
2,GO PRIMARY MIRNA PROCESSING,0.01266,0.21029,0.26462,1,1
2,GO TISSUE HOMEOSTASIS,0.00054254,0.21011,0.25297,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.025096,0.21002,0.20394,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0172,0.2098,0.1899,1,1
2,GO METAL ION HOMEOSTASIS,0.0031545,0.20977,0.22939,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0016767,0.20971,0.24646,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0019699,0.2091,0.31626,1,1
2,GO RESPONSE TO SALT STRESS,0.030713,0.20906,0.20227,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0024341,0.20878,0.24626,1,1
2,GO ERBB SIGNALING PATHWAY,0.0017696,0.20877,0.23921,1,1
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0020776,0.2085,0.24588,1,1
2,GO ETHER METABOLIC PROCESS,0.0014241,0.20833,0.22429,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0080134,0.20832,0.29422,1,1
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0083971,0.20828,0.20336,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014989,0.20827,0.26128,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.00060992,0.20803,0.24909,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.018736,0.20801,0.22195,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066311,0.20789,0.21745,1,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0036751,0.20766,0.23843,1,1
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.008797,0.20693,0.23526,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.007293,0.20684,0.25432,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.0054671,0.20675,0.20745,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.011063,0.20668,0.20603,1,1
2,GO PROGESTERONE METABOLIC PROCESS,0.013834,0.20664,0.28608,1,1
2,GO FAT CELL DIFFERENTIATION,0.00332,0.20651,0.23882,1,1
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0010798,0.20635,0.20929,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.00060992,0.20622,0.23695,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.0015041,0.20584,0.24966,1,1
2,GO PLATELET MORPHOGENESIS,0.0034935,0.20573,0.28931,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0016767,0.20541,0.24312,1,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0016767,0.2053,0.22311,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00057531,0.2051,0.34747,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0049572,0.20501,0.26142,1,1
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0063209,0.20479,0.28398,1,1
2,GO CELLULAR RESPONSE TO CAMP,0.00081392,0.20464,0.24316,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.041938,0.20462,0.23663,1,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.00096503,0.20456,0.27517,1,1
2,GO CELL MOTILITY,0.0028457,0.20445,0.2398,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00081392,0.20438,0.22801,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.011063,0.2043,0.32159,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0016767,0.20424,0.22119,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0021907,0.20414,0.24185,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0047188,0.20337,0.2078,1,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.0012071,0.20272,0.23877,1,1
2,GO CELLULAR RESPONSE TO ATP,0.0025648,0.20268,0.26105,1,1
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0020776,0.20258,0.27722,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.012106,0.20232,0.19129,1,1
2,GO CELLULAR ION HOMEOSTASIS,0.0038653,0.20197,0.21215,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0012758,0.20173,0.25992,1,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.00024771,0.20171,0.25072,1,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.008797,0.20168,0.24574,1,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025648,0.20161,0.23664,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0038653,0.20103,0.2348,1,1
2,GO RESPONSE TO CAMP,0.0016767,0.20059,0.26263,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.006955,0.20022,0.23724,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0010209,0.19912,0.24119,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.0044907,0.19902,0.19242,1,1
2,GO CELLULAR RESPONSE TO STEROL,0.038848,0.19897,0.19983,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0015882,0.19894,0.23299,1,1
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0018673,0.19883,0.23778,1,1
2,GO PHOSPHATE ION TRANSPORT,0.0044907,0.1988,0.28249,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0038653,0.19871,0.22247,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0096484,0.19829,0.22705,1,1
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.045233,0.19799,0.18601,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.037377,0.19785,0.24066,1,1
2,GO PROTEIN PROCESSING,0.00060992,0.19772,0.26149,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0060238,0.19755,0.2318,1,1
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0057394,0.19688,0.22109,1,1
2,GO XENOBIOTIC TRANSPORT,0.060677,0.19673,0.18217,1,1
2,GO LIPID CATABOLIC PROCESS,0.00057531,0.19667,0.21502,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0063209,0.19656,0.22864,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00086166,0.19651,0.23304,1,1
2,GO PERICARDIUM DEVELOPMENT,0.0038653,0.19624,0.29346,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.007293,0.19612,0.22203,1,1
2,GO RESPONSE TO KETONE,0.0016767,0.19608,0.2255,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.015776,0.19599,0.22469,1,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00091199,0.19597,0.25638,1,1
2,GO ANIMAL ORGAN MATURATION,0.0172,0.19596,0.23317,1,1
2,GO OSTEOBLAST PROLIFERATION,0.028348,0.19497,0.23738,1,1
2,GO PHOSPHOLIPID TRANSPORT,0.013235,0.19493,0.20896,1,1
2,GO RNA DECAPPING,0.0096484,0.19462,0.21173,1,1
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0054671,0.19449,0.21279,1,1
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0012758,0.19378,0.24599,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.027226,0.19363,0.14794,1,1
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.021265,0.19361,0.19107,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00096503,0.19321,0.24951,1,1
2,GO EPITHELIAL CELL PROLIFERATION,0.011063,0.19321,0.21832,1,1
2,GO REGULATION OF PROTEOLYSIS,0.00064645,0.19294,0.21982,1,1
2,GO NUCLEOTIDE SALVAGE,0.0057394,0.19288,0.20091,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0027019,0.19232,0.23127,1,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0011418,0.19209,0.2308,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0003797,0.19187,0.23161,1,1
2,GO REGULATION OF MAP KINASE ACTIVITY,0.0060238,0.19179,0.21348,1,1
2,GO MYOBLAST PROLIFERATION,0.0060238,0.19163,0.2893,1,1
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0024341,0.1916,0.22109,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.031957,0.19141,0.20434,1,1
2,GO RESPONSE TO MECHANICAL STIMULUS,0.016475,0.19129,0.20382,1,1
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0092139,0.19112,0.2287,1,1
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0029965,0.19094,0.2038,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0031545,0.1906,0.18304,1,1
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0054671,0.19032,0.24166,1,1
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0044907,0.19011,0.25678,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.02951,0.18994,0.19157,1,1
2,GO MAINTENANCE OF LOCATION,0.0016767,0.18982,0.22096,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.0040644,0.18982,0.22377,1,1
2,GO CELLULAR RESPONSE TO FATTY ACID,0.0076456,0.18963,0.20069,1,1
2,GO ZINC ION HOMEOSTASIS,0.019548,0.18956,0.21552,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.013235,0.18946,0.18978,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00096503,0.18941,0.19204,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.0031545,0.18936,0.17994,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.015104,0.18902,0.25425,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0010209,0.18892,0.23973,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00064645,0.18889,0.23644,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.00028019,0.18841,0.2215,1,1
2,GO ION HOMEOSTASIS,0.0031545,0.18809,0.20936,1,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.0003797,0.18799,0.21216,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0010798,0.18781,0.18158,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0014241,0.18773,0.2144,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0010798,0.18741,0.21572,1,1
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.015104,0.18716,0.21094,1,1
2,GO LIPID LOCALIZATION,0.0028457,0.18709,0.2239,1,1
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.048745,0.18681,0.21198,1,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0020776,0.18639,0.22357,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025648,0.18607,0.22625,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0096484,0.18584,0.20779,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.017954,0.18541,0.17372,1,1
2,GO REGULATION OF HEAT GENERATION,0.0096484,0.18536,0.25061,1,1
2,GO PROTEIN HOMOTETRAMERIZATION,0.0036751,0.18496,0.21822,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.0025648,0.18492,0.22817,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.011063,0.18482,0.20856,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0015882,0.18473,0.26509,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.015104,0.18456,0.24497,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.00064645,0.18433,0.20811,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0044907,0.18402,0.18167,1,1
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0040644,0.18367,0.23551,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.030713,0.1836,0.16699,1,1
2,GO JNK CASCADE,0.0036751,0.18319,0.2265,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.018736,0.18305,0.14488,1,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0029965,0.18304,0.18583,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.021265,0.18296,0.18923,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.017954,0.18262,0.17684,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.018736,0.18261,0.20523,1,1
2,GO AUTOPHAGOSOME MATURATION,0.0057394,0.18165,0.17464,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.050584,0.18137,0.18234,1,1
2,GO SECRETION,0.0044907,0.18136,0.20594,1,1
2,GO DIGESTION,0.013235,0.18122,0.18015,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.011574,0.18116,0.21221,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0057394,0.18115,0.20203,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00040321,0.18112,0.20204,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.00014062,0.18085,0.23544,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.0014241,0.18055,0.21658,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.00076864,0.18046,0.23429,1,1
2,GO PLACENTA DEVELOPMENT,0.0083971,0.18006,0.19899,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.013235,0.17987,0.19886,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0021907,0.17952,0.20955,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0066311,0.17929,0.27593,1,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0015882,0.17927,0.21445,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0025648,0.1792,0.22742,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00091199,0.17894,0.20947,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0092139,0.17866,0.1662,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00045436,0.17863,0.23766,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0017696,0.1784,0.27442,1,1
2,GO RESPONSE TO UV B,0.0063209,0.17801,0.21168,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0063209,0.17746,0.19929,1,1
2,GO ENDOCYTOSIS,0.0052065,0.17716,0.22264,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0016767,0.17706,0.22756,1,1
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0040644,0.17694,0.26611,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.034576,0.17682,0.24013,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0031545,0.17675,0.23227,1,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.021265,0.17669,0.21212,1,1
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.023112,0.17646,0.17721,1,1
2,GO CELLULAR RESPONSE TO KETONE,0.0076456,0.17644,0.18478,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0020776,0.17616,0.21891,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00068502,0.17576,0.21269,1,1
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.060677,0.17574,0.16397,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0003797,0.17561,0.22352,1,1
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.017954,0.17553,0.21043,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.031957,0.17525,0.10757,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.0012071,0.17524,0.1877,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0096484,0.1749,0.18754,1,1
2,GO STEROL METABOLIC PROCESS,0.0016767,0.17451,0.20963,1,1
2,GO LIPID OXIDATION,0.013834,0.17438,0.14819,1,1
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.010101,0.17435,0.24586,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0021907,0.17428,0.20652,1,1
2,GO RESPONSE TO ALCOHOL,0.00332,0.17424,0.20627,1,1
2,GO HEME METABOLIC PROCESS,0.00045436,0.17395,0.20355,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0057394,0.17349,0.19002,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0010798,0.17347,0.20514,1,1
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.031957,0.17202,0.17598,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0036751,0.17164,0.19676,1,1
2,GO GENITALIA MORPHOGENESIS,0.043559,0.17151,0.23448,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.017954,0.17139,0.21222,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.015104,0.17071,0.17909,1,1
2,GO VITAMIN METABOLIC PROCESS,0.00029789,0.17055,0.20616,1,1
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.040368,0.17043,0.20496,1,1
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.030713,0.16985,0.25386,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0083971,0.1697,0.21419,1,1
2,GO STEROID METABOLIC PROCESS,0.0012758,0.16949,0.18661,1,1
2,GO REGULATION OF JUN KINASE ACTIVITY,0.016475,0.16949,0.21129,1,1
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.006955,0.16915,0.18632,1,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.034576,0.16878,0.22973,1,1
2,GO SKIN DEVELOPMENT,0.035953,0.16855,0.15132,1,1
2,GO POSITIVE REGULATION OF SIGNALING,0.0076456,0.16819,0.18121,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.0080134,0.16815,0.2104,1,1
2,GO RESPONSE TO MUSCLE STRETCH,0.052482,0.16813,0.22936,1,1
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.013235,0.168,0.18096,1,1
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0049572,0.16757,0.21672,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0066311,0.16706,0.21318,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034935,0.16703,0.19826,1,1
2,GO RUFFLE ASSEMBLY,0.0054671,0.16699,0.21498,1,1
2,GO CELL RECOGNITION,0.008797,0.16668,0.19679,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013834,0.16654,0.19114,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0025648,0.16601,0.22942,1,1
2,GO LIVER REGENERATION,0.00096503,0.16595,0.23025,1,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0066311,0.16523,0.20186,1,1
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.026142,0.16463,0.17692,1,1
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.021265,0.16446,0.18228,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.016475,0.16432,0.18718,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.00096503,0.1642,0.23737,1,1
2,GO REGENERATION,0.0029965,0.1639,0.20035,1,1
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0038653,0.16363,0.19517,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.034576,0.16348,0.20927,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.028348,0.16338,0.14458,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.016475,0.16333,0.16257,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.026142,0.1631,0.15925,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0017696,0.1631,0.21741,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.011063,0.16307,0.17935,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.041938,0.16299,0.20889,1,1
2,GO ACTIVATION OF MAPKK ACTIVITY,0.060677,0.16299,0.1737,1,1
2,GO LIPID EXPORT FROM CELL,0.015104,0.16298,0.20696,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0042727,0.16258,0.18342,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.031957,0.16246,0.1594,1,1
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.043559,0.1623,0.19603,1,1
2,GO SYMBIOTIC PROCESS,0.0015882,0.16208,0.17607,1,1
2,GO EMBRYONIC HEMOPOIESIS,0.013235,0.16206,0.24727,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.021265,0.16177,0.21864,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.025096,0.16154,0.22142,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.008797,0.16115,0.24584,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.0010798,0.16111,0.20169,1,1
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.01266,0.16099,0.23758,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0016767,0.1609,0.21662,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.011574,0.16026,0.19314,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0016767,0.16015,0.19598,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.0014241,0.15997,0.21235,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0047188,0.15987,0.18884,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0012071,0.15952,0.19792,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0063209,0.15936,0.18928,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0040644,0.15903,0.21218,1,1
2,GO REGULATION OF CELL DEATH,0.0012071,0.15894,0.19895,1,1
2,GO GDP METABOLIC PROCESS,0.021265,0.15878,0.21218,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.01266,0.15822,0.17297,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.018736,0.15795,0.18417,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0023095,0.15788,0.23289,1,1
2,GO VACUOLAR ACIDIFICATION,0.0031545,0.15787,0.20136,1,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.008797,0.15768,0.18313,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00068502,0.15766,0.22667,1,1
2,GO RNA DESTABILIZATION,0.058535,0.15739,0.19834,1,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.010101,0.15736,0.17654,1,1
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.058535,0.15695,0.1368,1,1
2,GO PROTEIN MATURATION,0.0015041,0.1566,0.20201,1,1
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0049572,0.15651,0.22523,1,1
2,GO LIPID IMPORT INTO CELL,0.045233,0.15632,0.17001,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.046961,0.1563,0.16238,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049572,0.15598,0.19441,1,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038653,0.15576,0.19572,1,1
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.043559,0.15548,0.16026,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.013834,0.15515,0.19399,1,1
2,GO BLASTODERM SEGMENTATION,0.0028457,0.15502,0.23719,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.010101,0.15474,0.1696,1,1
2,GO LYTIC VACUOLE ORGANIZATION,0.033245,0.15459,0.1645,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.01266,0.15434,0.20851,1,1
2,GO REGULATION OF CELLULAR PH,0.041938,0.1543,0.13649,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00018128,0.15395,0.20271,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.010572,0.15373,0.17563,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0076456,0.15367,0.15757,1,1
2,GO ESTROGEN METABOLIC PROCESS,0.0060238,0.15367,0.16515,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0047188,0.15322,0.17004,1,1
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0028457,0.15288,0.2018,1,1
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.012106,0.15272,0.15655,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.02951,0.15221,0.22781,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0083971,0.15171,0.19989,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0021907,0.15168,0.16611,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0014241,0.15131,0.22407,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.011574,0.1509,0.16571,1,1
2,GO LIPID METABOLIC PROCESS,0.0024341,0.15051,0.17737,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.006955,0.15034,0.19027,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00064645,0.15021,0.20972,1,1
2,GO EPIDERMIS DEVELOPMENT,0.045233,0.14989,0.14595,1,1
2,GO DNA DEMETHYLATION,0.060677,0.14983,0.15102,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,0.013834,0.14959,0.14929,1,1
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0042727,0.14933,0.19037,1,1
2,GO VITAMIN TRANSPORT,0.0092139,0.14924,0.19893,1,1
2,GO BODY FLUID SECRETION,0.030713,0.14922,0.14711,1,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.010572,0.14919,0.19488,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.041938,0.14908,0.1515,1,1
2,GO APOPTOTIC SIGNALING PATHWAY,0.0018673,0.14848,0.18686,1,1
2,GO ANION HOMEOSTASIS,0.0049572,0.14835,0.21925,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.022172,0.14832,0.18155,1,1
2,GO IRON ION TRANSPORT,0.0076456,0.14832,0.17846,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.0092139,0.1483,0.16137,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.027226,0.14788,0.18316,1,1
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.037377,0.14773,0.14525,1,1
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.027226,0.14747,0.19142,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.011063,0.14704,0.22153,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0049572,0.14627,0.20597,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.010101,0.14611,0.29829,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0049572,0.14583,0.16445,1,1
2,GO NEGATIVE REGULATION OF SECRETION,0.0057394,0.14559,0.19636,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0096484,0.14536,0.14494,1,1
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.0049572,0.1452,0.19107,1,1
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.023112,0.14503,0.17643,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0013481,0.14496,0.17461,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.007293,0.14358,0.16298,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010101,0.1435,0.17784,1,1
2,GO REGULATION OF PEPTIDE SECRETION,0.038848,0.14324,0.15808,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.025096,0.14299,0.13627,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.034576,0.14292,0.1737,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.027226,0.14289,0.20394,1,1
2,GO CHEMICAL HOMEOSTASIS,0.010572,0.14273,0.17977,1,1
2,GO RESPONSE TO HORMONE,0.011574,0.14272,0.17318,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.012106,0.14263,0.1864,1,1
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0023095,0.14255,0.19243,1,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0080134,0.14233,0.18604,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0027019,0.14205,0.155,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.019548,0.14182,0.19328,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.0060238,0.14173,0.18287,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0014241,0.14164,0.23145,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012758,0.14161,0.15522,1,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0092139,0.14155,0.19801,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0012758,0.14146,0.16547,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.040368,0.14135,0.14975,1,1
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.025096,0.14085,0.15806,1,1
2,GO SLEEP,0.013235,0.14078,0.16598,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0019699,0.14019,0.1924,1,1
2,GO NADP METABOLIC PROCESS,0.019548,0.13978,0.15327,1,1
2,GO MUSCLE ADAPTATION,0.021265,0.13932,0.18609,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.024086,0.13919,0.19457,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,0.015776,0.13915,0.16352,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.013834,0.13889,0.17017,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.016475,0.13883,0.19253,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.007293,0.13877,0.16864,1,1
2,GO REGULATION OF PHOSPHORYLATION,0.010101,0.13853,0.16999,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.007293,0.13846,0.18417,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.019548,0.13803,0.15023,1,1
2,GO APOPTOTIC PROCESS,0.0029965,0.13709,0.17587,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0023095,0.13703,0.14863,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.023112,0.13679,0.16692,1,1
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.040368,0.13667,0.16503,1,1
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.015776,0.13648,0.16491,1,1
2,GO ADAPTIVE THERMOGENESIS,0.050584,0.13641,0.14585,1,1
2,GO REGULATION OF METAL ION TRANSPORT,0.007293,0.136,0.18578,1,1
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.030713,0.13584,0.20174,1,1
2,GO NEGATIVE REGULATION OF TRANSPORT,0.0092139,0.13572,0.17151,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.033245,0.13532,0.193,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0076456,0.1353,0.16074,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.0036751,0.13528,0.1921,1,1
2,GO CELLULAR HOMEOSTASIS,0.0066311,0.1351,0.16891,1,1
2,GO VESICLE CARGO LOADING,0.038848,0.13506,0.14853,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.014457,0.134,0.20231,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0096484,0.13399,0.17121,1,1
2,GO TEMPERATURE HOMEOSTASIS,0.024086,0.1338,0.16178,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0076456,0.13296,0.23313,1,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0034935,0.13286,0.17054,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.037377,0.13278,0.1346,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036751,0.1327,0.16046,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0047188,0.13239,0.15648,1,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.037377,0.13203,0.14797,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.050584,0.13202,0.14119,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0028457,0.13177,0.19269,1,1
2,GO BLASTOCYST FORMATION,0.0049572,0.13167,0.15671,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0044907,0.13154,0.17804,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.033245,0.13122,0.17589,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0029965,0.13052,0.20732,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0036751,0.1304,0.15694,1,1
2,GO GTP METABOLIC PROCESS,0.0049572,0.13002,0.16085,1,1
2,GO HOMEOSTATIC PROCESS,0.0076456,0.12997,0.16994,1,1
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.027226,0.12902,0.16251,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.007293,0.12892,0.15402,1,1
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0066311,0.12888,0.21114,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.048745,0.12871,0.15236,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.013834,0.12851,0.15296,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.020391,0.1285,0.16382,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.024086,0.1284,0.15907,1,1
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.010572,0.1269,0.16845,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.040368,0.12683,0.1292,1,1
2,GO REGULATION OF ENDOCYTOSIS,0.041938,0.12681,0.15975,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.0049572,0.1267,0.13856,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0031545,0.12649,0.15778,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.045233,0.1263,0.12161,1,1
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.02951,0.12613,0.18184,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.054439,0.12589,0.15581,1,1
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0038653,0.12581,0.19369,1,1
2,GO GALACTOSE METABOLIC PROCESS,0.058535,0.12525,0.17716,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.045233,0.12517,0.14448,1,1
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.018736,0.12494,0.14215,1,1
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.046961,0.12476,0.15389,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.048745,0.12459,0.11576,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.020391,0.12443,0.17422,1,1
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.020391,0.12355,0.15415,1,1
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.040368,0.12317,0.14028,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0047188,0.12312,0.17789,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.015104,0.12289,0.1716,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.019548,0.12261,0.14918,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.023112,0.12215,0.15931,1,1
2,GO RESPONSE TO PEPTIDE,0.016475,0.12209,0.1642,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.019548,0.12203,0.14226,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00054254,0.12189,0.18677,1,1
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00332,0.12187,0.13905,1,1
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023095,0.12036,0.17556,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.013834,0.12006,0.15902,1,1
2,GO NEGATIVE REGULATION OF SIGNALING,0.030713,0.12,0.15028,1,1
2,GO PROTEIN TETRAMERIZATION,0.014457,0.11985,0.16726,1,1
2,GO REGULATION OF MUSCLE ADAPTATION,0.046961,0.11848,0.16358,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.0066311,0.11793,0.16155,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.008797,0.11773,0.16526,1,1
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.016475,0.11772,0.15845,1,1
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.024086,0.11699,0.15576,1,1
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.040368,0.11691,0.14727,1,1
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.040368,0.11679,0.19309,1,1
2,GO REGULATION OF PH,0.056456,0.11634,0.12065,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.037377,0.11633,0.14174,1,1
2,GO ACTIN NUCLEATION,0.008797,0.11631,0.1665,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE,0.041938,0.11622,0.15417,1,1
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.040368,0.1158,0.1903,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0096484,0.1156,0.16357,1,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.025096,0.11498,0.15848,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.012106,0.11441,0.17008,1,1
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.016475,0.11427,0.1532,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.043559,0.11382,0.16907,1,1
2,GO AMP METABOLIC PROCESS,0.031957,0.11323,0.14036,1,1
2,GO COPII COATED VESICLE BUDDING,0.045233,0.11321,0.13396,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0063209,0.11263,0.16026,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.054439,0.11249,0.1393,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.11145,0.18523,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0076456,0.11137,0.14967,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.0052065,0.11121,0.1398,1,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.040368,0.11118,0.13985,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020391,0.11108,0.13341,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.006955,0.10961,0.16748,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0023095,0.1091,0.16023,1,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.020391,0.10868,0.15832,1,1
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.033245,0.10832,0.15388,1,1
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.041938,0.1082,0.14964,1,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.052482,0.10817,0.12793,1,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.060677,0.108,0.14003,1,1
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.025096,0.10768,0.14239,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.046961,0.10748,0.14394,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.045233,0.10745,0.15314,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.011063,0.10715,0.18851,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.023112,0.10661,0.16078,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.030713,0.1058,0.11251,1,1
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.034576,0.10577,0.1595,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0042727,0.10528,0.17317,1,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.015776,0.10512,0.15628,1,1
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.048745,0.10417,0.15712,1,1
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.043559,0.10409,0.14708,1,1
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.017954,0.10406,0.15425,1,1
2,GO RESPONSE TO OXYGEN LEVELS,0.0092139,0.10337,0.14854,1,1
2,GO AGING,0.013235,0.10326,0.16689,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0044907,0.10245,0.16865,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.052482,0.10205,0.11893,1,1
2,GO RESPONSE TO DRUG,0.021265,0.10196,0.15452,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.052482,0.10157,0.12552,1,1
2,GO GOLGI VESICLE BUDDING,0.045233,0.10131,0.13343,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0036751,0.10059,0.13939,1,1
2,GO PROTEOLYSIS,0.017954,0.099867,0.14489,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.02951,0.099651,0.15568,1,1
2,GO ANDROGEN METABOLIC PROCESS,0.033245,0.09963,0.12366,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.097961,0.10889,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0096484,0.097728,0.14244,1,1
2,GO REGULATION OF LIGASE ACTIVITY,0.038848,0.097268,0.12944,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.030713,0.096838,0.16911,1,1
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.027226,0.096266,0.1481,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.010101,0.096158,0.1299,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.030713,0.095326,0.11028,1,1
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.02951,0.094703,0.16224,1,1
2,GO PROTEIN DESTABILIZATION,0.022172,0.094451,0.15496,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.026142,0.092702,0.13864,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.037377,0.091185,0.12504,1,1
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.022172,0.090526,0.15532,1,1
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.056456,0.089673,0.13851,1,1
2,GO REGULATION OF ERAD PATHWAY,0.048745,0.089587,0.15544,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.010101,0.089322,0.13575,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.034576,0.089208,0.12162,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.035953,0.08771,0.12959,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0092139,0.087023,0.13624,1,1
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.050584,0.082346,0.1422,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.026142,0.081596,0.16617,1,1
2,GO RESPONSE TO NITROGEN COMPOUND,0.054439,0.080045,0.13147,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.023112,0.079362,0.13129,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.050584,0.076029,0.13864,1,1
2,GO RESPONSE TO ACID CHEMICAL,0.052482,0.075897,0.12982,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00011593,0.66771,0.66494,1,1
3,GO COMMISSURAL NEURON AXON GUIDANCE,3.4805e-05,0.65709,0.5884,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0066311,0.65483,0.48233,1,1
3,GO RESPONSE TO POTASSIUM ION,0.00081392,0.64682,0.47754,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.0023095,0.63923,0.51753,1,1
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0015041,0.63061,0.48695,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00072571,0.61198,0.51373,1,1
3,GO SYNAPTIC MEMBRANE ADHESION,0.00023283,0.60825,0.54678,1,1
3,GO REGULATION OF SYNAPSE MATURATION,0.00024771,0.60697,0.57369,1,1
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00051151,0.59893,0.51692,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.4947e-05,0.59795,0.67878,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00031664,0.58419,0.47663,1,1
3,GO PREPULSE INHIBITION,0.00010181,0.57503,0.57284,1,1
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00048214,0.55783,0.45449,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00096503,0.55217,0.43922,1,1
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00031664,0.53498,0.48049,1,1
3,GO CENTRIOLE CENTRIOLE COHESION,2.4576e-05,0.53217,0.54824,1,1
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0018673,0.52575,0.48088,1,1
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0013481,0.5227,0.43851,1,1
3,GO MEIOTIC CHROMOSOME SEPARATION,0.00024771,0.51632,0.46043,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00026348,0.50494,0.48753,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00332,0.50008,0.47835,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00014989,0.49886,0.57002,1,1
3,GO DISTAL TUBULE DEVELOPMENT,0.0063209,0.49814,0.42514,1,1
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0011418,0.49626,0.43254,1,1
3,GO POSTSYNAPSE ASSEMBLY,0.00033648,0.49027,0.47313,1,1
3,GO MICROTUBULE DEPOLYMERIZATION,0.00018128,0.47855,0.44339,1,1
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.0063209,0.47279,0.44135,1,1
3,GO SYNAPSE MATURATION,0.00064645,0.46501,0.49857,1,1
3,GO REGULATION OF NEURON MIGRATION,0.00019306,0.45598,0.49733,1,1
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00033648,0.45544,0.39666,1,1
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.00072571,0.45436,0.42975,1,1
3,GO FOREBRAIN REGIONALIZATION,0.00019306,0.45136,0.50593,1,1
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0040644,0.44818,0.40388,1,1
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.026142,0.44699,0.3961,1,1
3,GO DENDRITIC TRANSPORT,0.0011418,0.44437,0.44479,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.00068502,0.44268,0.44515,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0017696,0.4401,0.37002,1,1
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00035748,0.43943,0.41621,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.0015882,0.43512,0.39532,1,1
3,GO HISTONE H3 K36 METHYLATION,0.00033648,0.42971,0.44396,1,1
3,GO SPINAL CORD PATTERNING,0.0012758,0.42597,0.44615,1,1
3,GO DENTATE GYRUS DEVELOPMENT,0.00033648,0.42533,0.51043,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.0057394,0.41946,0.32448,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00072571,0.41781,0.38256,1,1
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0020776,0.4164,0.35161,1,1
3,GO KINETOCHORE ORGANIZATION,0.00033648,0.41565,0.4183,1,1
3,GO SYNAPTIC VESICLE CLUSTERING,0.00096503,0.41548,0.44561,1,1
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.00057531,0.41375,0.45555,1,1
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00028019,0.41273,0.38043,1,1
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.0025648,0.40982,0.37726,1,1
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00060992,0.40885,0.40134,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.00013188,0.40693,0.41871,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00045436,0.40543,0.38458,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00072571,0.40495,0.35811,1,1
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0040644,0.39872,0.34086,1,1
3,GO REPLICATION FORK PROCESSING,0.00064645,0.39861,0.40228,1,1
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00021879,0.39842,0.42227,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.0013481,0.3972,0.4014,1,1
3,GO NEURONAL ION CHANNEL CLUSTERING,0.00026348,0.3959,0.44236,1,1
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0015882,0.39374,0.34409,1,1
3,GO HISTONE H3 K9 METHYLATION,0.00028019,0.39349,0.39548,1,1
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0011418,0.39278,0.39023,1,1
3,GO GROWTH HORMONE SECRETION,0.00035748,0.39209,0.42689,1,1
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00031664,0.392,0.3778,1,1
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00054254,0.39089,0.39745,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.00011593,0.38898,0.36659,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0028457,0.38759,0.34284,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0023095,0.38679,0.31593,1,1
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00081392,0.38619,0.35083,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0016767,0.38615,0.3247,1,1
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00076864,0.38596,0.41259,1,1
3,GO MRNA SPLICE SITE SELECTION,0.00010866,0.38582,0.4212,1,1
3,GO KINETOCHORE ASSEMBLY,0.0015041,0.38506,0.36876,1,1
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,8.9327e-05,0.38113,0.49063,1,1
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00057531,0.37459,0.38124,1,1
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00057531,0.37284,0.38557,1,1
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.00028019,0.37117,0.51755,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00076864,0.36962,0.3765,1,1
3,GO REGULATION OF COLLATERAL SPROUTING,0.006955,0.36818,0.3033,1,1
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0019699,0.36817,0.3205,1,1
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00035748,0.36793,0.34146,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00011593,0.36607,0.44716,1,1
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0012758,0.36508,0.34201,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00011593,0.36459,0.3747,1,1
3,GO STARTLE RESPONSE,0.00021879,0.36335,0.4142,1,1
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00072571,0.36284,0.37002,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0012071,0.36238,0.43152,1,1
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00024771,0.36006,0.37565,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0031545,0.35895,0.32791,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00042807,0.35773,0.36346,1,1
3,GO CENTRIOLE ASSEMBLY,0.0003797,0.35663,0.35357,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00017019,0.35638,0.42923,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0012758,0.35599,0.32576,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.01266,0.35568,0.29645,1,1
3,GO DENSE CORE GRANULE TRANSPORT,0.0044907,0.35542,0.40703,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0028457,0.35423,0.34115,1,1
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.00064645,0.35349,0.27504,1,1
3,GO METENCEPHALON DEVELOPMENT,8.9327e-05,0.35324,0.34532,1,1
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.014457,0.35222,0.29615,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0060238,0.35114,0.32543,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00040321,0.35062,0.331,1,1
3,GO RESPONSE TO COCAINE,0.00019306,0.34764,0.36926,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.00031664,0.34752,0.3485,1,1
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00019306,0.34625,0.36058,1,1
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0080134,0.34623,0.27991,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00072571,0.34583,0.38934,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0012758,0.34509,0.28804,1,1
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00013188,0.34434,0.36193,1,1
3,GO RESPONSE TO L GLUTAMATE,0.00023283,0.3439,0.34031,1,1
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.00096503,0.34373,0.41151,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00033648,0.34331,0.33764,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0042727,0.34172,0.29584,1,1
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00028019,0.34001,0.3359,1,1
3,GO EPITHELIAL CELL MATURATION,0.011063,0.337,0.26149,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0015882,0.33477,0.31678,1,1
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00064645,0.33471,0.32842,1,1
3,GO PROTEIN POLYGLUTAMYLATION,0.00332,0.33441,0.33054,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.0054671,0.33336,0.32903,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00081392,0.33316,0.30277,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.015776,0.33266,0.37581,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0034935,0.33202,0.30443,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0021907,0.33131,0.32884,1,1
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00068502,0.33078,0.32455,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.016475,0.33064,0.27062,1,1
3,GO CEREBELLAR CORTEX FORMATION,0.00054254,0.33043,0.35005,1,1
3,GO MITOTIC SISTER CHROMATID COHESION,0.00020554,0.32849,0.34655,1,1
3,GO AXONAL FASCICULATION,0.0034935,0.32773,0.31403,1,1
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.0014241,0.32734,0.31344,1,1
3,GO HOMOLOGOUS RECOMBINATION,0.00051151,0.32669,0.32497,1,1
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0044907,0.3265,0.42983,1,1
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.00086166,0.32638,0.28829,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00096503,0.32637,0.44989,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0021907,0.32612,0.33137,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.00042807,0.32566,0.32271,1,1
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0015882,0.32472,0.31158,1,1
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00023283,0.32451,0.32601,1,1
3,GO REGULATION OF FEEDING BEHAVIOR,0.00017019,0.32395,0.29018,1,1
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00091199,0.32289,0.32434,1,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.013235,0.32287,0.28782,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.011063,0.32221,0.25969,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00028019,0.32195,0.33196,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.048745,0.32191,0.26184,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0016767,0.32128,0.30414,1,1
3,GO DENDRITE MORPHOGENESIS,0.00072571,0.32096,0.31387,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.0040644,0.32075,0.28897,1,1
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0021907,0.31946,0.36857,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0038653,0.3184,0.33378,1,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.0012071,0.31752,0.31855,1,1
3,GO FOREBRAIN NEURON DEVELOPMENT,0.0034935,0.31663,0.29678,1,1
3,GO HISTONE H3 K9 MODIFICATION,0.00064645,0.31612,0.33348,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.01266,0.31543,0.2613,1,1
3,GO RESPONSE TO INSECTICIDE,0.0076456,0.31469,0.28282,1,1
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0083971,0.31427,0.26155,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,0.00096503,0.31418,0.31153,1,1
3,GO CATECHOLAMINE UPTAKE,0.0010798,0.31404,0.35752,1,1
3,GO REGULATION OF SISTER CHROMATID COHESION,0.00026348,0.31391,0.36528,1,1
3,GO SECRETORY GRANULE LOCALIZATION,0.0023095,0.31377,0.35306,1,1
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0020776,0.31361,0.32658,1,1
3,GO CENTROMERE COMPLEX ASSEMBLY,0.00051151,0.31238,0.35987,1,1
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00060992,0.31058,0.32091,1,1
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0017696,0.31029,0.30146,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0028457,0.31026,0.36679,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0017696,0.30967,0.37064,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.027226,0.30934,0.30156,1,1
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.00042807,0.30817,0.33606,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00020554,0.30602,0.36447,1,1
3,GO CHROMATIN SILENCING AT TELOMERE,0.00015974,0.30584,0.3265,1,1
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0019699,0.30538,0.30174,1,1
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0042727,0.30511,0.35568,1,1
3,GO SPINAL CORD DEVELOPMENT,0.00014989,0.30481,0.38724,1,1
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0016767,0.30471,0.29438,1,1
3,GO HISTONE EXCHANGE,0.0003797,0.30445,0.31065,1,1
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00011593,0.30418,0.34698,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00026348,0.30409,0.34049,1,1
3,GO CARNITINE SHUTTLE,0.00091199,0.3034,0.30249,1,1
3,GO ADULT BEHAVIOR,0.00045436,0.3022,0.3121,1,1
3,GO UTERUS DEVELOPMENT,0.0036751,0.29975,0.35534,1,1
3,GO G0 TO G1 TRANSITION,0.00048214,0.29974,0.32932,1,1
3,GO NEURON FATE SPECIFICATION,0.0024341,0.299,0.39055,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0011418,0.29879,0.29252,1,1
3,GO REGULATION OF CHROMOSOME SEGREGATION,7.3279e-05,0.29798,0.3231,1,1
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.00054254,0.29796,0.31102,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0011418,0.29774,0.29936,1,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.007293,0.29744,0.28756,1,1
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00051151,0.29727,0.32248,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.00091199,0.29658,0.31644,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0016767,0.2959,0.2713,1,1
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00064645,0.29496,0.34732,1,1
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.0060238,0.29496,0.31181,1,1
3,GO RESPONSE TO ACETYLCHOLINE,0.00096503,0.29479,0.36183,1,1
3,GO NEUROTRANSMITTER SECRETION,0.0010798,0.29435,0.30328,1,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0060238,0.29388,0.2856,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0016767,0.29384,0.27746,1,1
3,GO MITOTIC RECOMBINATION,0.0018673,0.29366,0.29876,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.027226,0.29291,0.23604,1,1
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.010572,0.29217,0.2946,1,1
3,GO REGULATION OF CHROMATIN BINDING,0.00076864,0.2916,0.3304,1,1
3,GO NEURON MIGRATION,0.00013188,0.29136,0.36993,1,1
3,GO ANTEROGRADE AXONAL TRANSPORT,0.0013481,0.29122,0.2857,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,8.9327e-05,0.29014,0.35661,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.0042727,0.2891,0.31153,1,1
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.00040321,0.28896,0.29685,1,1
3,GO P BODY ASSEMBLY,0.0023095,0.2889,0.31919,1,1
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.008797,0.28884,0.28639,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0020776,0.2878,0.31925,1,1
3,GO CHROMOSOME SEPARATION,0.00018128,0.28778,0.33085,1,1
3,GO GOLGI RIBBON FORMATION,0.00091199,0.28761,0.34267,1,1
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0092139,0.28759,0.25689,1,1
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00057531,0.28756,0.31329,1,1
3,GO REGULATION OF MICROTUBULE BINDING,0.0015882,0.28744,0.34764,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00033648,0.28693,0.3334,1,1
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.00332,0.28678,0.27202,1,1
3,GO HISTONE H3 K4 TRIMETHYLATION,0.011063,0.28642,0.3187,1,1
3,GO GLIAL CELL FATE COMMITMENT,0.0052065,0.28602,0.30384,1,1
3,GO STRESS GRANULE ASSEMBLY,0.00028019,0.2853,0.31205,1,1
3,GO DENDRITE DEVELOPMENT,0.00081392,0.28488,0.29366,1,1
3,GO CHROMATIN REMODELING AT CENTROMERE,0.00081392,0.28427,0.35219,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0010209,0.28406,0.30325,1,1
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0011418,0.28406,0.28435,1,1
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,7.3279e-05,0.28339,0.31914,1,1
3,GO THALAMUS DEVELOPMENT,0.011063,0.28279,0.26197,1,1
3,GO NUCLEAR MIGRATION,0.0013481,0.2826,0.3914,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00091199,0.28216,0.34805,1,1
3,GO PEPTIDYL LYSINE METHYLATION,0.00051151,0.28139,0.32248,1,1
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0021907,0.28126,0.28663,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0092139,0.28069,0.30029,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0015041,0.28047,0.32038,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00028019,0.27997,0.31495,1,1
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.00012367,0.2796,0.32925,1,1
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,7.8298e-05,0.27934,0.31953,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.0021907,0.27902,0.29187,1,1
3,GO RESPONSE TO NICOTINE,0.0021907,0.27875,0.27849,1,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0028457,0.27829,0.30246,1,1
3,GO RECOMBINATIONAL REPAIR,0.00054254,0.27811,0.29992,1,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00035748,0.27774,0.28845,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0012758,0.27747,0.28448,1,1
3,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.0052065,0.27744,0.27899,1,1
3,GO RESPONSE TO HYDROXYUREA,0.0025648,0.27706,0.27102,1,1
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.038848,0.27665,0.21657,1,1
3,GO HISTONE H2A UBIQUITINATION,0.0020776,0.27659,0.27126,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.00051151,0.27547,0.29323,1,1
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.0080134,0.27523,0.27804,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0018673,0.27518,0.31367,1,1
3,GO MEIOSIS I CELL CYCLE PROCESS,0.00040321,0.27494,0.28482,1,1
3,GO HISTONE METHYLATION,0.00045436,0.27464,0.31801,1,1
3,GO MISMATCH REPAIR,0.00014989,0.27366,0.29031,1,1
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0040644,0.27362,0.25859,1,1
3,GO LEARNING,0.00068502,0.27227,0.28858,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0011418,0.27197,0.31691,1,1
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0024341,0.27177,0.29238,1,1
3,GO POSTSYNAPSE ORGANIZATION,0.0010209,0.27167,0.28356,1,1
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00010181,0.27077,0.35146,1,1
3,GO PROTEIN METHYLATION,0.0003797,0.27071,0.2995,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0011418,0.27059,0.29661,1,1
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.00091199,0.2702,0.31276,1,1
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.00045436,0.27016,0.282,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,0.00072571,0.2697,0.29537,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.0042727,0.26959,0.25679,1,1
3,GO SYNAPTIC VESICLE LOCALIZATION,0.0060238,0.26934,0.254,1,1
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.017954,0.26838,0.2964,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00068502,0.26782,0.29093,1,1
3,GO NEUROBLAST PROLIFERATION,0.0013481,0.2671,0.29694,1,1
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.015776,0.26692,0.24362,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0044907,0.26685,0.2865,1,1
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0028457,0.26624,0.33072,1,1
3,GO SMOOTHENED SIGNALING PATHWAY,0.00064645,0.26621,0.27409,1,1
3,GO MICROTUBULE BASED PROCESS,0.00045436,0.26614,0.26843,1,1
3,GO CHROMOSOME SEGREGATION,0.00064645,0.2658,0.27877,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0017696,0.2643,0.30178,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.021265,0.26413,0.2739,1,1
3,GO SISTER CHROMATID COHESION,0.00045436,0.26353,0.3185,1,1
3,GO DNA GEOMETRIC CHANGE,0.00086166,0.26259,0.28273,1,1
3,GO GENITALIA MORPHOGENESIS,0.030713,0.26242,0.26073,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,0.0017696,0.26152,0.33538,1,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0028457,0.26024,0.26208,1,1
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0038653,0.25994,0.29086,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00051151,0.25947,0.25756,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.015776,0.25832,0.20467,1,1
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00040321,0.25832,0.29879,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.025096,0.25814,0.196,1,1
3,GO REGULATION OF AXONOGENESIS,0.00332,0.25814,0.29078,1,1
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0031545,0.25783,0.24676,1,1
3,GO SINGLE STRAND BREAK REPAIR,0.0025648,0.25747,0.26372,1,1
3,GO MICROTUBULE NUCLEATION,0.0038653,0.25715,0.30377,1,1
3,GO REGULATION OF CHROMOSOME SEPARATION,7.3279e-05,0.2562,0.30263,1,1
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.0013481,0.25576,0.25823,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.010572,0.2557,0.28935,1,1
3,GO RESPONSE TO LEUCINE,0.0042727,0.25533,0.31002,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.00017019,0.25512,0.29057,1,1
3,GO NEUROTRANSMITTER TRANSPORT,0.0015041,0.25466,0.2782,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0016767,0.25395,0.27864,1,1
3,GO DNA DEPENDENT DNA REPLICATION,0.00081392,0.2537,0.28542,1,1
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00076864,0.25317,0.34712,1,1
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.00045436,0.25308,0.24195,1,1
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0017696,0.25307,0.25866,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00024771,0.25264,0.29023,1,1
3,GO FEEDING BEHAVIOR,0.006955,0.2525,0.20778,1,1
3,GO SYNAPTIC SIGNALING,0.0017696,0.25238,0.24737,1,1
3,GO HISTONE H4 K16 ACETYLATION,0.0012758,0.25209,0.28824,1,1
3,GO AXONAL TRANSPORT,0.0015041,0.25176,0.28836,1,1
3,GO MITOTIC SPINDLE ASSEMBLY,0.0011418,0.25101,0.26836,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00019306,0.25045,0.27059,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0021907,0.2503,0.28079,1,1
3,GO RESPONSE TO FOOD,0.0017696,0.24986,0.27212,1,1
3,GO HISTONE H3 K4 METHYLATION,0.00051151,0.2498,0.29901,1,1
3,GO HISTONE H3 K9 TRIMETHYLATION,0.0012758,0.24917,0.30892,1,1
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,9.5377e-05,0.24869,0.29854,1,1
3,GO CHROMATIN REMODELING,0.00048214,0.24849,0.28388,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00035748,0.24836,0.30298,1,1
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00026348,0.24814,0.27471,1,1
3,GO DNA RECOMBINATION,0.0038653,0.24783,0.22274,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0017696,0.24762,0.2634,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0013481,0.24724,0.30397,1,1
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,9.5377e-05,0.24669,0.30855,1,1
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0031545,0.24662,0.27568,1,1
3,GO HINDBRAIN MORPHOGENESIS,0.00068502,0.24598,0.27634,1,1
3,GO HINDBRAIN DEVELOPMENT,0.00048214,0.24539,0.27107,1,1
3,GO PEPTIDYL METHIONINE MODIFICATION,0.031957,0.24459,0.1746,1,1
3,GO SISTER CHROMATID SEGREGATION,0.0003797,0.24445,0.28425,1,1
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0014241,0.24408,0.36138,1,1
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.013834,0.24343,0.30326,1,1
3,GO METHIONINE METABOLIC PROCESS,0.020391,0.24323,0.20539,1,1
3,GO APICAL PROTEIN LOCALIZATION,0.011574,0.24313,0.27084,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00033648,0.24262,0.27848,1,1
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0083971,0.24156,0.36615,1,1
3,GO REGULATION OF CYTOKINESIS,0.0014241,0.24095,0.26557,1,1
3,GO ECTODERM DEVELOPMENT,0.00332,0.2389,0.23661,1,1
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.018736,0.23881,0.2102,1,1
3,GO NEUROTRANSMITTER REUPTAKE,0.0047188,0.23863,0.24847,1,1
3,GO HIPPO SIGNALING,0.013834,0.23826,0.25346,1,1
3,GO HISTONE H4 DEACETYLATION,0.0066311,0.23774,0.20177,1,1
3,GO NUCLEOSOME ORGANIZATION,0.00060992,0.2366,0.27492,1,1
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.017954,0.23602,0.2305,1,1
3,GO NON RECOMBINATIONAL REPAIR,0.0012758,0.23583,0.23662,1,1
3,GO CELL CYCLE DNA REPLICATION,0.0013481,0.2354,0.29628,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,0.00072571,0.23536,0.25608,1,1
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00086166,0.23475,0.26257,1,1
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.010101,0.23464,0.286,1,1
3,GO REGULATION OF HISTONE METHYLATION,0.00048214,0.23423,0.31172,1,1
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.0019699,0.23404,0.23445,1,1
3,GO DNA REPLICATION,0.00051151,0.23364,0.28281,1,1
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0027019,0.23339,0.31036,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0040644,0.23274,0.23018,1,1
3,GO SIALYLATION,0.006955,0.23269,0.26879,1,1
3,GO LOCOMOTORY BEHAVIOR,0.0015041,0.23226,0.26933,1,1
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0057394,0.2321,0.26686,1,1
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00096503,0.23193,0.28117,1,1
3,GO SPINDLE LOCALIZATION,0.0028457,0.23181,0.25157,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.010101,0.23145,0.22069,1,1
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0017696,0.23061,0.25551,1,1
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.00048214,0.23021,0.27874,1,1
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.00081392,0.23009,0.25966,1,1
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0054671,0.22998,0.28372,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0027019,0.22952,0.26056,1,1
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0042727,0.22909,0.29126,1,1
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0029965,0.22831,0.2395,1,1
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0024341,0.22821,0.2807,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.00057531,0.2281,0.27389,1,1
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00035748,0.22762,0.26977,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0083971,0.22748,0.29221,1,1
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.012106,0.22748,0.20665,1,1
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0044907,0.22703,0.25708,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0027019,0.2264,0.25074,1,1
3,GO PANCREAS DEVELOPMENT,0.0027019,0.22567,0.28631,1,1
3,GO MRNA 3 END PROCESSING,0.0013481,0.22543,0.2331,1,1
3,GO DNA CONFORMATION CHANGE,0.00072571,0.2254,0.28844,1,1
3,GO HISTONE UBIQUITINATION,0.0025648,0.22528,0.24662,1,1
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.031957,0.22488,0.21682,1,1
3,GO RNA POLYADENYLATION,0.0029965,0.22427,0.23186,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.00091199,0.22324,0.25206,1,1
3,GO DNA REPLICATION INITIATION,0.0047188,0.22304,0.24613,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.0076456,0.22287,0.27248,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.0017696,0.22274,0.23846,1,1
3,GO MRNA METHYLATION,0.0031545,0.22273,0.26552,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00086166,0.2222,0.22311,1,1
3,GO REGULATION OF NEURON DIFFERENTIATION,0.0019699,0.22125,0.25132,1,1
3,GO REGULATION OF MRNA 3 END PROCESSING,0.0025648,0.22009,0.23403,1,1
3,GO HISTONE MONOUBIQUITINATION,0.0057394,0.21953,0.24411,1,1
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0031545,0.21945,0.24419,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0020776,0.21936,0.28386,1,1
3,GO NUCLEOSOME ASSEMBLY,0.0012071,0.21929,0.29292,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0028457,0.21911,0.28156,1,1
3,GO REGULATION OF EXIT FROM MITOSIS,0.0029965,0.21842,0.29166,1,1
3,GO PALLIUM DEVELOPMENT,0.00072571,0.21792,0.25722,1,1
3,GO ACTIVATION OF JNKK ACTIVITY,0.054439,0.21726,0.20486,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0057394,0.21621,0.27361,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0052065,0.21615,0.29622,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00076864,0.21583,0.22593,1,1
3,GO POSITIVE REGULATION OF DNA REPAIR,0.0012758,0.21561,0.23808,1,1
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.008797,0.21555,0.22469,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0060238,0.21527,0.26704,1,1
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0024341,0.21518,0.28386,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.0012071,0.21326,0.23228,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,0.007293,0.21232,0.22315,1,1
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0036751,0.21185,0.26014,1,1
3,GO DNA PACKAGING,0.00051151,0.21178,0.29906,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.011574,0.21086,0.1948,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.006955,0.21083,0.2483,1,1
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.013834,0.21059,0.24614,1,1
3,GO MALE MEIOSIS I,0.0052065,0.21054,0.26788,1,1
3,GO METANEPHROS MORPHOGENESIS,0.02951,0.21034,0.21882,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.0031545,0.21019,0.23279,1,1
3,GO TORC1 SIGNALING,0.0023095,0.20995,0.26766,1,1
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00091199,0.20985,0.27084,1,1
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.006955,0.20958,0.22409,1,1
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00060992,0.20954,0.23421,1,1
3,GO RRNA CATABOLIC PROCESS,0.030713,0.20844,0.16046,1,1
3,GO MEMBRANE DOCKING,0.00332,0.20784,0.22494,1,1
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.0054671,0.20747,0.22811,1,1
3,GO DOUBLE STRAND BREAK REPAIR,0.0010798,0.2069,0.26544,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0066311,0.20624,0.19419,1,1
3,GO RNA INTERFERENCE,0.0044907,0.20441,0.22248,1,1
3,GO DNA INTEGRITY CHECKPOINT,0.0024341,0.2036,0.26577,1,1
3,GO RNA EXPORT FROM NUCLEUS,0.0019699,0.20351,0.21993,1,1
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00086166,0.20293,0.21376,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.0025648,0.20284,0.20867,1,1
3,GO HISTONE H2A ACETYLATION,0.0016767,0.20256,0.22774,1,1
3,GO ASSOCIATIVE LEARNING,0.0010209,0.20046,0.23583,1,1
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0010209,0.20029,0.1832,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00081392,0.19995,0.23373,1,1
3,GO METHYLATION,0.00081392,0.19933,0.21449,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.008797,0.19678,0.2474,1,1
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.027226,0.19668,0.1957,1,1
3,GO CELL CYCLE CHECKPOINT,0.0019699,0.19656,0.26668,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.010572,0.19629,0.23685,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0024341,0.19629,0.21929,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.058535,0.19623,0.19976,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.033245,0.19622,0.20216,1,1
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0017696,0.19494,0.24932,1,1
3,GO REGULATION OF DNA REPLICATION,0.0010209,0.19444,0.24692,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.052482,0.19394,0.13203,1,1
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0040644,0.19354,0.20992,1,1
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00332,0.19285,0.22751,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.0021907,0.19259,0.27385,1,1
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0038653,0.19251,0.25747,1,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.052482,0.1909,0.28154,1,1
3,GO FOREBRAIN DEVELOPMENT,0.00076864,0.18971,0.25174,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0044907,0.18912,0.17838,1,1
3,GO REGULATION OF BEHAVIOR,0.007293,0.18852,0.19594,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00086166,0.18818,0.31308,1,1
3,GO PROTEIN MONOUBIQUITINATION,0.00332,0.18808,0.235,1,1
3,GO RNA METHYLATION,0.0096484,0.18799,0.16775,1,1
3,GO RESPONSE TO VITAMIN A,0.052482,0.18753,0.1429,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0013481,0.18742,0.23158,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.010101,0.18702,0.21858,1,1
3,GO TRNA TRANSPORT,0.0038653,0.18624,0.21212,1,1
3,GO INCLUSION BODY ASSEMBLY,0.0096484,0.18536,0.24321,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0010798,0.18529,0.24601,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0042727,0.18396,0.23158,1,1
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.0042727,0.18391,0.24483,1,1
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0012071,0.1836,0.1876,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0027019,0.18359,0.22908,1,1
3,GO PRIMARY MIRNA PROCESSING,0.011063,0.18312,0.21312,1,1
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.0057394,0.18305,0.18644,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.006955,0.18279,0.20218,1,1
3,GO ATP TRANSPORT,0.026142,0.18275,0.17209,1,1
3,GO NEGATIVE REGULATION OF CELL AGING,0.0038653,0.18248,0.2377,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0083971,0.18219,0.20312,1,1
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.0010798,0.18179,0.20596,1,1
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0057394,0.18173,0.21696,1,1
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0027019,0.1812,0.22084,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0025648,0.18058,0.17625,1,1
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.016475,0.18054,0.25633,1,1
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0029965,0.18051,0.24163,1,1
3,GO DNA METABOLIC PROCESS,0.0031545,0.17884,0.18687,1,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00332,0.17664,0.16222,1,1
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.008797,0.17643,0.2193,1,1
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0028457,0.17443,0.20994,1,1
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0023095,0.1743,0.21513,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0034935,0.17386,0.21688,1,1
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0054671,0.17374,0.20533,1,1
3,GO SYNAPTIC VESICLE RECYCLING,0.0096484,0.17369,0.20547,1,1
3,GO REGULATION OF DNA RECOMBINATION,0.02951,0.17356,0.17384,1,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0063209,0.1731,0.20087,1,1
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0011418,0.17283,0.23783,1,1
3,GO NCRNA TRANSCRIPTION,0.0019699,0.17273,0.18456,1,1
3,GO NUCLEAR BODY ORGANIZATION,0.0047188,0.17159,0.19374,1,1
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0054671,0.17156,0.17983,1,1
3,GO MOTOR NEURON AXON GUIDANCE,0.030713,0.17102,0.22988,1,1
3,GO REGULATION OF CELL CYCLE PROCESS,0.00096503,0.17014,0.216,1,1
3,GO TELOMERE ORGANIZATION,0.0028457,0.16975,0.19895,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0096484,0.16955,0.15627,1,1
3,GO TRNA METHYLATION,0.010572,0.16873,0.16442,1,1
3,GO CARTILAGE MORPHOGENESIS,0.048745,0.16853,0.24361,1,1
3,GO NUCLEAR EXPORT,0.0021907,0.16788,0.20242,1,1
3,GO ORGANELLE LOCALIZATION,0.011063,0.16726,0.17504,1,1
3,GO DETECTION OF VISIBLE LIGHT,0.0017696,0.16678,0.15586,1,1
3,GO RNA SURVEILLANCE,0.0057394,0.16629,0.13955,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.050584,0.16466,0.13277,1,1
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0029965,0.16403,0.20645,1,1
3,GO RNA DESTABILIZATION,0.023112,0.16399,0.20591,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00051151,0.16365,0.16367,1,1
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0052065,0.16358,0.18107,1,1
3,GO PROTEIN SUMOYLATION,0.0038653,0.16312,0.20896,1,1
3,GO DEMETHYLATION,0.0040644,0.16218,0.21576,1,1
3,GO RRNA TRANSCRIPTION,0.0040644,0.16213,0.17589,1,1
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.027226,0.1616,0.17639,1,1
3,GO SNRNA TRANSCRIPTION,0.0034935,0.16158,0.17606,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.0076456,0.16089,0.26086,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.017954,0.16062,0.18601,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.017954,0.16019,0.15264,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.00051151,0.15788,0.23211,1,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.034576,0.15781,0.16656,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.021265,0.15777,0.21078,1,1
3,GO MRNA CLEAVAGE,0.013235,0.15715,0.21346,1,1
3,GO RNA STABILIZATION,0.0047188,0.15677,0.2062,1,1
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.035953,0.15588,0.21736,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.0080134,0.15528,0.16754,1,1
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.023112,0.1552,0.17103,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0080134,0.15474,0.13721,1,1
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0016767,0.15328,0.19623,1,1
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.038848,0.15322,0.20207,1,1
3,GO NUCLEAR TRANSPORT,0.0040644,0.15174,0.17717,1,1
3,GO DNA METHYLATION,0.008797,0.15149,0.17709,1,1
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0027019,0.15145,0.22411,1,1
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0038653,0.15042,0.15891,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.045233,0.1502,0.20681,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.048745,0.14852,0.20585,1,1
3,GO DETECTION OF LIGHT STIMULUS,0.0083971,0.14815,0.11569,1,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.040368,0.14812,0.15144,1,1
3,GO REGULATION OF SENSORY PERCEPTION,0.019548,0.14764,0.18413,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.007293,0.14683,0.15415,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.058535,0.14677,0.15095,1,1
3,GO RNA LOCALIZATION,0.0049572,0.14633,0.1699,1,1
3,GO RNA MODIFICATION,0.025096,0.14619,0.11543,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,0.0083971,0.14588,0.21572,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0080134,0.1456,0.1537,1,1
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0017696,0.14488,0.16039,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0044907,0.14428,0.19468,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0096484,0.14418,0.1649,1,1
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.024086,0.14351,0.10288,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.033245,0.14259,0.17685,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.023112,0.14244,0.15834,1,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.0034935,0.14229,0.19549,1,1
3,GO MRNA METABOLIC PROCESS,0.0014241,0.141,0.1686,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0060238,0.13895,0.22262,1,1
3,GO PROTEIN REFOLDING,0.038848,0.1382,0.16872,1,1
3,GO SENSORY PERCEPTION OF SMELL,0.006955,0.13798,0.12678,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.026142,0.13759,0.27582,1,1
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.01266,0.13735,0.24283,1,1
3,GO IMPORT INTO NUCLEUS,0.018736,0.13589,0.14896,1,1
3,GO MAINTENANCE OF CELL NUMBER,0.01266,0.13571,0.17406,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.0040644,0.13571,0.17469,1,1
3,GO INTRACELLULAR MRNA LOCALIZATION,0.012106,0.13484,0.19204,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.007293,0.13388,0.12455,1,1
3,GO RESPONSE TO AMINO ACID STARVATION,0.0096484,0.13326,0.18551,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.010572,0.13318,0.15188,1,1
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.0060238,0.13311,0.17213,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.0066311,0.1311,0.12726,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0028457,0.13054,0.20466,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.034576,0.12975,0.1309,1,1
3,GO TRNA MODIFICATION,0.023112,0.12844,0.13235,1,1
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.020391,0.12783,0.13715,1,1
3,GO PHOTOTRANSDUCTION,0.014457,0.1277,0.10206,1,1
3,GO MITOCHONDRIAL DNA REPLICATION,0.018736,0.12695,0.15686,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.019548,0.12687,0.16837,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.058535,0.12637,0.19542,1,1
3,GO APOPTOTIC DNA FRAGMENTATION,0.019548,0.12587,0.15922,1,1
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.054439,0.12466,0.11602,1,1
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.015104,0.12343,0.14401,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.037377,0.12342,0.1965,1,1
3,GO MULTI ORGANISM LOCALIZATION,0.019548,0.12252,0.13372,1,1
3,GO SNRNA METABOLIC PROCESS,0.01266,0.12179,0.13065,1,1
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.010572,0.1209,0.17505,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.050584,0.12031,0.12493,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0066311,0.1197,0.12633,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.023112,0.11842,0.13876,1,1
3,GO DNA MODIFICATION,0.018736,0.1181,0.1393,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.030713,0.11735,0.11621,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.028348,0.11717,0.20015,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.026142,0.11703,0.13229,1,1
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0049572,0.11682,0.28201,1,1
3,GO MATURATION OF SSU RRNA,0.043559,0.11522,0.10675,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0060238,0.11414,0.16639,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.024086,0.11345,0.099375,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.027226,0.11331,0.09312,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.038848,0.11322,0.13368,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.030713,0.11241,0.15969,1,1
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.011574,0.11229,0.11894,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.037377,0.11055,0.17886,1,1
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0066311,0.10993,0.20458,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.058535,0.10828,0.10414,1,1
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.034576,0.10717,0.11938,1,1
3,GO NCRNA PROCESSING,0.024086,0.10695,0.10384,1,1
3,GO RRNA METABOLIC PROCESS,0.034576,0.10415,0.095757,1,1
3,GO ESTABLISHMENT OF CELL POLARITY,0.028348,0.10277,0.18762,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.030713,0.10174,0.091875,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.0080134,0.10102,0.13322,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.025096,0.099082,0.13217,1,1
3,GO RHYTHMIC BEHAVIOR,0.048745,0.099042,0.14539,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.060677,0.096103,0.1257,1,1
3,GO NCRNA METABOLIC PROCESS,0.025096,0.093731,0.10247,1,1
3,GO RIBOSOME BIOGENESIS,0.040368,0.093478,0.088074,1,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.024086,0.093436,0.11718,1,1
3,GO RESPONSE TO STARVATION,0.040368,0.091299,0.15271,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.025096,0.088764,0.10758,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.043559,0.075273,0.089819,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.02951,0.073024,0.081987,1,1
3,GO RNA CATABOLIC PROCESS,0.013834,0.067469,0.09184,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.056456,0.066618,0.064114,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.052482,0.056709,0.06305,1,1
4,GO OUTER DYNEIN ARM ASSEMBLY,7.8298e-05,0.74089,0.66843,1,1
4,GO INNER DYNEIN ARM ASSEMBLY,0.00029789,0.64477,0.60731,1,1
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00012367,0.64095,0.58737,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.0011418,0.59833,0.59521,1,1
4,GO LOOP OF HENLE DEVELOPMENT,0.00096503,0.56502,0.49584,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.55906,0.6318,1,1
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00020554,0.55535,0.52814,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,4.8997e-05,0.54079,0.56593,1,1
4,GO DENSE CORE GRANULE TRANSPORT,0.00028019,0.53825,0.60671,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.041938,0.53519,0.33995,1,1
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.007293,0.53035,0.4769,1,1
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.00029789,0.52327,0.46019,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00015974,0.5215,0.52004,1,1
4,GO PONS DEVELOPMENT,0.00019306,0.51956,0.57388,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0031545,0.49926,0.50975,1,1
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00035748,0.49031,0.63092,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00015974,0.48895,0.71166,1,1
4,GO NEURON REMODELING,3.7287e-05,0.48408,0.54782,1,1
4,GO VOCALIZATION BEHAVIOR,0.0003797,0.4826,0.4906,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00031664,0.48173,0.40524,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00033648,0.48159,0.48977,1,1
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0017696,0.47815,0.45996,1,1
4,GO AXONEME ASSEMBLY,0.00011593,0.47527,0.49149,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0172,0.47266,0.34989,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.012106,0.47255,0.45701,1,1
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00028019,0.4678,0.46472,1,1
4,GO DISTAL TUBULE DEVELOPMENT,0.015776,0.46603,0.36091,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.00010866,0.46491,0.38958,1,1
4,GO MICROTUBULE BUNDLE FORMATION,0.00012367,0.46353,0.43278,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,2.2907e-05,0.46347,0.61123,1,1
4,GO EXTRACELLULAR TRANSPORT,0.00026348,0.46198,0.45644,1,1
4,GO DENDRITIC TRANSPORT,0.0054671,0.4608,0.38071,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00096503,0.45915,0.46725,1,1
4,GO SYNAPTIC VESICLE DOCKING,0.0014241,0.45664,0.62294,1,1
4,GO ELASTIC FIBER ASSEMBLY,0.020391,0.45292,0.43337,1,1
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00076864,0.45075,0.44683,1,1
4,GO MOTILE CILIUM ASSEMBLY,0.00051151,0.44903,0.40296,1,1
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00064645,0.44852,0.49467,1,1
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00017019,0.44568,0.52873,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.030713,0.44285,0.31269,1,1
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019548,0.44279,0.38053,1,1
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.011063,0.44273,0.35732,1,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0076456,0.44197,0.41319,1,1
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00014062,0.43807,0.45119,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0066311,0.43502,0.46091,1,1
4,GO RECEPTOR CLUSTERING,0.00035748,0.43125,0.3925,1,1
4,GO INTERLEUKIN 5 PRODUCTION,0.0054671,0.42967,0.39555,1,1
4,GO RESPONSE TO PAIN,4.5779e-05,0.42854,0.451,1,1
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00029789,0.42728,0.46231,1,1
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0012071,0.42592,0.37893,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0092139,0.4247,0.36406,1,1
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00060992,0.4247,0.41802,1,1
4,GO SECRETORY GRANULE LOCALIZATION,0.00033648,0.42463,0.46749,1,1
4,GO ADRENAL GLAND DEVELOPMENT,7.3279e-05,0.42423,0.44035,1,1
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0028457,0.42352,0.44054,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,7.8298e-05,0.42336,0.44818,1,1
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0014241,0.42275,0.44086,1,1
4,GO LUTEINIZATION,0.0010798,0.4222,0.43504,1,1
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00076864,0.42155,0.66127,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,4.8997e-05,0.42105,0.43891,1,1
4,GO IRON COORDINATION ENTITY TRANSPORT,0.00068502,0.41659,0.39648,1,1
4,GO LONG TERM SYNAPTIC DEPRESSION,0.0038653,0.41547,0.34052,1,1
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00332,0.41537,0.56475,1,1
4,GO SYNAPSE MATURATION,0.006955,0.41524,0.36734,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0027019,0.41399,0.37671,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00013188,0.4129,0.40884,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0015041,0.41231,0.39951,1,1
4,GO PARENTAL BEHAVIOR,0.028348,0.41186,0.29041,1,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.00076864,0.41143,0.47254,1,1
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0036751,0.41031,0.34161,1,1
4,GO RESPONSE TO POTASSIUM ION,0.0021907,0.4101,0.43513,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0025648,0.4091,0.38477,1,1
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0034935,0.40892,0.46203,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00031664,0.40816,0.57271,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.007293,0.40751,0.36124,1,1
4,GO COLLECTING DUCT DEVELOPMENT,0.0063209,0.40487,0.37976,1,1
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00057531,0.40341,0.38876,1,1
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00029789,0.40326,0.41446,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0054671,0.40278,0.38971,1,1
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0083971,0.40114,0.36772,1,1
4,GO RESPONSE TO FORSKOLIN,0.00064645,0.40074,0.41279,1,1
4,GO NEURON CELLULAR HOMEOSTASIS,0.022172,0.3993,0.27823,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00068502,0.39898,0.38617,1,1
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00040321,0.39815,0.63061,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00019306,0.39743,0.62283,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0019699,0.3955,0.36674,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.8997e-05,0.39418,0.43335,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0014241,0.39392,0.40837,1,1
4,GO DIVALENT METAL ION EXPORT,0.0092139,0.39309,0.29333,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00028019,0.39265,0.44708,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00042807,0.39164,0.40964,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00028019,0.39089,0.55625,1,1
4,GO INTESTINAL LIPID ABSORPTION,0.0042727,0.39043,0.40269,1,1
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00023283,0.39007,0.38574,1,1
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0016767,0.38769,0.3862,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00045436,0.3876,0.41917,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.8267e-05,0.38743,0.56262,1,1
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.010101,0.38672,0.36864,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0060238,0.38595,0.38647,1,1
4,GO NEURON MATURATION,9.5377e-05,0.38582,0.39117,1,1
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0016767,0.38543,0.37385,1,1
4,GO REFLEX,0.00068502,0.38451,0.43046,1,1
4,GO REGULATION OF NEURON MIGRATION,0.0034935,0.38437,0.38592,1,1
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0036751,0.38403,0.52903,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0018673,0.38194,0.38451,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00072571,0.38004,0.38322,1,1
4,GO LIPOXYGENASE PATHWAY,0.015104,0.37795,0.26384,1,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.00332,0.37771,0.39012,1,1
4,GO MEMBRANE DEPOLARIZATION,8.3641e-05,0.37604,0.41137,1,1
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.021265,0.37577,0.38542,1,1
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0012071,0.37526,0.37718,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.00076864,0.37372,0.47113,1,1
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.025096,0.37311,0.30845,1,1
4,GO COLLATERAL SPROUTING,0.00017019,0.37305,0.44204,1,1
4,GO INSEMINATION,0.0021907,0.37271,0.38655,1,1
4,GO FEAR RESPONSE,0.0036751,0.37214,0.26827,1,1
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00048214,0.37204,0.50935,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.011063,0.37175,0.35629,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00021879,0.37131,0.33001,1,1
4,GO SYNAPTIC MEMBRANE ADHESION,0.0080134,0.37032,0.37265,1,1
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0023095,0.36962,0.39746,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,3.4805e-05,0.3689,0.55708,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0016767,0.36888,0.29507,1,1
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00091199,0.36857,0.4248,1,1
4,GO LYMPH NODE DEVELOPMENT,0.010101,0.36818,0.34607,1,1
4,GO REGULATION OF COLLATERAL SPROUTING,0.00091199,0.36785,0.41976,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.00051151,0.3675,0.36613,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0040644,0.36715,0.35257,1,1
4,GO SYNAPTIC VESICLE BUDDING,0.00045436,0.36625,0.38344,1,1
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0028457,0.36615,0.4426,1,1
4,GO CILIUM MOVEMENT,0.00054254,0.36582,0.37553,1,1
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00072571,0.36543,0.41544,1,1
4,GO RESPONSE TO MAGNESIUM ION,0.0016767,0.36496,0.37451,1,1
4,GO CGMP MEDIATED SIGNALING,0.00029789,0.36494,0.38969,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.0052065,0.36434,0.35412,1,1
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.012106,0.36427,0.35647,1,1
4,GO MEMBRANE HYPERPOLARIZATION,0.0010798,0.3641,0.33009,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,0.0023095,0.36296,0.32523,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00033648,0.36141,0.52927,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00033648,0.36132,0.42924,1,1
4,GO PANCREATIC JUICE SECRETION,0.0014241,0.36028,0.32745,1,1
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0034935,0.36,0.32901,1,1
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.00086166,0.35915,0.48935,1,1
4,GO REGULATION OF SYNAPSE MATURATION,0.0092139,0.3587,0.3629,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.00048214,0.35787,0.38058,1,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00028019,0.35757,0.48299,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00026348,0.35734,0.53205,1,1
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0036751,0.35676,0.40901,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00031664,0.35647,0.3493,1,1
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0019699,0.35618,0.34912,1,1
4,GO PREPULSE INHIBITION,0.0172,0.35598,0.34503,1,1
4,GO CHEMOSENSORY BEHAVIOR,0.00051151,0.35492,0.39004,1,1
4,GO LIPID DIGESTION,0.0076456,0.35473,0.34204,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0012758,0.35469,0.34,1,1
4,GO SYNAPTIC VESICLE PRIMING,0.00086166,0.3538,0.51576,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00076864,0.3533,0.33794,1,1
4,GO RESPONSE TO DIETARY EXCESS,8.3641e-05,0.35324,0.38986,1,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.0019699,0.35234,0.32077,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0019699,0.35234,0.41948,1,1
4,GO NEURON CELL CELL ADHESION,0.00076864,0.35142,0.52666,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,4.2763e-05,0.35084,0.36426,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00042807,0.35075,0.42215,1,1
4,GO LATERAL VENTRICLE DEVELOPMENT,0.0025648,0.35075,0.35973,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.00057531,0.35068,0.37585,1,1
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.006955,0.35041,0.36443,1,1
4,GO LIPID TRANSLOCATION,0.00035748,0.34966,0.36417,1,1
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0016767,0.34777,0.57511,1,1
4,GO LOCALIZATION WITHIN MEMBRANE,0.00096503,0.34758,0.32582,1,1
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.00021879,0.34756,0.39938,1,1
4,GO LEARNING,0.0014241,0.3474,0.31579,1,1
4,GO SYNAPTIC VESICLE LOCALIZATION,0.00033648,0.34668,0.38084,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00010866,0.34651,0.38294,1,1
4,GO ATRIAL SEPTUM DEVELOPMENT,0.0013481,0.34573,0.36075,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00031664,0.3455,0.37126,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.01266,0.34533,0.34972,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0034935,0.34451,0.352,1,1
4,GO POSTSYNAPSE ASSEMBLY,0.0049572,0.34376,0.42516,1,1
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.00017019,0.34228,0.39153,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0042727,0.3413,0.2836,1,1
4,GO SYNAPSE ORGANIZATION,0.00057531,0.34123,0.35052,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.01266,0.34084,0.294,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0010798,0.34039,0.39408,1,1
4,GO CARDIAC CHAMBER FORMATION,0.056456,0.34006,0.21338,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.021265,0.3388,0.28294,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00054254,0.33865,0.39906,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0015882,0.33809,0.48087,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.011063,0.33739,0.29155,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0017696,0.33702,0.36109,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0016767,0.33648,0.40977,1,1
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00020554,0.33645,0.36121,1,1
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.019548,0.33555,0.30364,1,1
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0042727,0.3354,0.28523,1,1
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0003797,0.33397,0.36677,1,1
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0015041,0.33362,0.36479,1,1
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0028457,0.33353,0.37796,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.018736,0.33349,0.25124,1,1
4,GO ASSOCIATIVE LEARNING,0.0017696,0.33315,0.32186,1,1
4,GO LONG TERM MEMORY,0.0042727,0.33284,0.32665,1,1
4,GO SENSORY PERCEPTION OF TASTE,8.9327e-05,0.33266,0.33282,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00018128,0.33257,0.43481,1,1
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00060992,0.33251,0.38833,1,1
4,GO EXPLORATION BEHAVIOR,0.0080134,0.33212,0.30966,1,1
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00076864,0.33202,0.3224,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00042807,0.33188,0.36877,1,1
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0010798,0.33157,0.3457,1,1
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00081392,0.33143,0.37624,1,1
4,GO DOPAMINE TRANSPORT,0.00011593,0.3312,0.43143,1,1
4,GO CELL AGGREGATION,0.0040644,0.33114,0.32318,1,1
4,GO ASTROCYTE ACTIVATION,0.052482,0.33108,0.27485,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.011063,0.33099,0.29014,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00026348,0.33093,0.33323,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0011418,0.33068,0.3278,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0021907,0.33042,0.30899,1,1
4,GO MYOTUBE CELL DEVELOPMENT,0.0010798,0.33029,0.27375,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00033648,0.33016,0.38654,1,1
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0038653,0.32905,0.32545,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.00060992,0.32892,0.39957,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.00045436,0.32891,0.34058,1,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0017696,0.32877,0.37132,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0049572,0.32852,0.30184,1,1
4,GO MEMORY,0.00048214,0.32851,0.33122,1,1
4,GO SYNAPSE ASSEMBLY,0.00051151,0.32837,0.39524,1,1
4,GO POSTSYNAPSE ORGANIZATION,0.0014241,0.32826,0.30227,1,1
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00060992,0.3277,0.3996,1,1
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00091199,0.32714,0.38289,1,1
4,GO CARDIOBLAST DIFFERENTIATION,0.0034935,0.32699,0.30353,1,1
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.011063,0.32696,0.29693,1,1
4,GO NEUROMUSCULAR PROCESS,0.0018673,0.32627,0.3058,1,1
4,GO CHOLESTEROL EFFLUX,0.0028457,0.32593,0.2803,1,1
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0016767,0.32588,0.33711,1,1
4,GO PROTEIN POLYGLUTAMYLATION,0.00086166,0.32588,0.34795,1,1
4,GO MECHANOSENSORY BEHAVIOR,0.0024341,0.32585,0.37337,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00076864,0.32494,0.39861,1,1
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0049572,0.32457,0.28297,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0014241,0.32422,0.31504,1,1
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00048214,0.32328,0.36111,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00024771,0.32266,0.39098,1,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.00068502,0.32193,0.37194,1,1
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0011418,0.32147,0.30495,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00072571,0.32134,0.33781,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00081392,0.32122,0.31289,1,1
4,GO DIOL METABOLIC PROCESS,0.00018128,0.32108,0.31774,1,1
4,GO NEURONAL ACTION POTENTIAL,0.00048214,0.32103,0.42556,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,6.4139e-05,0.32081,0.37504,1,1
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00048214,0.32017,0.39357,1,1
4,GO COLLAGEN CATABOLIC PROCESS,0.011063,0.32001,0.35388,1,1
4,GO LONG TERM SYNAPTIC POTENTIATION,0.00040321,0.31953,0.36411,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.00024771,0.31945,0.36617,1,1
4,GO SYNAPTIC VESICLE CLUSTERING,0.0016767,0.3182,0.48396,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,3.9936e-05,0.3182,0.35216,1,1
4,GO SECONDARY PALATE DEVELOPMENT,0.00064645,0.31812,0.41314,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00021879,0.31782,0.39785,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00021879,0.31779,0.35707,1,1
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0054671,0.31724,0.30842,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.024086,0.31716,0.2651,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00023283,0.31699,0.35298,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0044907,0.31691,0.293,1,1
4,GO REGULATION OF MICROTUBULE BINDING,0.00035748,0.3161,0.37525,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0018673,0.31544,0.40321,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.054439,0.31536,0.2578,1,1
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.00076864,0.31508,0.38317,1,1
4,GO MUSCLE FIBER DEVELOPMENT,0.00031664,0.31504,0.30518,1,1
4,GO SYNAPTIC VESICLE MATURATION,0.00076864,0.31454,0.49508,1,1
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.022172,0.31447,0.27865,1,1
4,GO SYNAPTIC SIGNALING,0.00042807,0.31434,0.34399,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.0031545,0.31421,0.30568,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.014457,0.31391,0.40088,1,1
4,GO RETINA LAYER FORMATION,0.007293,0.31345,0.38702,1,1
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0066311,0.31336,0.37654,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.016475,0.31326,0.26898,1,1
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0020776,0.31265,0.32202,1,1
4,GO SYNAPTIC VESICLE TRANSPORT,0.00019306,0.31257,0.35837,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00076864,0.31247,0.39171,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.023112,0.31236,0.26802,1,1
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0076456,0.31195,0.30122,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0096484,0.31183,0.26348,1,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0013481,0.31183,0.42862,1,1
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0010209,0.31167,0.28569,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.5779e-05,0.31118,0.37935,1,1
4,GO CELL JUNCTION MAINTENANCE,0.0023095,0.31073,0.33234,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,2.4576e-05,0.31071,0.35772,1,1
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00064645,0.3104,0.33717,1,1
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00051151,0.31036,0.35302,1,1
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0015882,0.31029,0.39085,1,1
4,GO ALANINE TRANSPORT,0.0052065,0.30983,0.3289,1,1
4,GO STARTLE RESPONSE,0.007293,0.30964,0.3114,1,1
4,GO TRANSCYTOSIS,0.0044907,0.30944,0.31521,1,1
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00042807,0.30941,0.38249,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.0010798,0.30925,0.38714,1,1
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00081392,0.3092,0.42288,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.0063209,0.30895,0.31079,1,1
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.00054254,0.30882,0.3453,1,1
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0029965,0.30843,0.32393,1,1
4,GO ENDODERMAL CELL DIFFERENTIATION,0.007293,0.30839,0.38461,1,1
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0060238,0.30823,0.38318,1,1
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.015776,0.30785,0.25255,1,1
4,GO REGULATION OF VESICLE FUSION,0.00045436,0.30779,0.38634,1,1
4,GO AXON EXTENSION,0.0012758,0.30772,0.33107,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00015974,0.30742,0.41541,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0017696,0.30658,0.36401,1,1
4,GO NEURONAL ION CHANNEL CLUSTERING,0.0034935,0.30635,0.37996,1,1
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00014989,0.30631,0.31607,1,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.00060992,0.30629,0.37909,1,1
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.00076864,0.30625,0.34354,1,1
4,GO WATER HOMEOSTASIS,0.0018673,0.30613,0.27878,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00017019,0.30611,0.38838,1,1
4,GO NEURON PROJECTION GUIDANCE,0.0015041,0.30594,0.31079,1,1
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.013834,0.30573,0.25096,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0034935,0.30547,0.50284,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.015104,0.30537,0.29273,1,1
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0080134,0.30531,0.25506,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0020776,0.30526,0.28639,1,1
4,GO SKELETAL MUSCLE ADAPTATION,0.0003797,0.30488,0.36444,1,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0012758,0.3043,0.30668,1,1
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.015104,0.30409,0.37352,1,1
4,GO SEX DETERMINATION,0.0052065,0.30393,0.28241,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0015882,0.3037,0.28194,1,1
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.052482,0.30366,0.30161,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,4.5779e-05,0.30322,0.3621,1,1
4,GO POSITIVE REGULATION OF MYELINATION,0.0049572,0.30266,0.33128,1,1
4,GO REGULATION OF CILIUM ASSEMBLY,0.0049572,0.30256,0.27799,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0012758,0.3025,0.39704,1,1
4,GO O GLYCAN PROCESSING,0.0049572,0.30213,0.26941,1,1
4,GO SPINAL CORD PATTERNING,0.031957,0.30194,0.28064,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00072571,0.30152,0.34995,1,1
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00091199,0.30111,0.4258,1,1
4,GO KERATINOCYTE DEVELOPMENT,0.010572,0.30099,0.29465,1,1
4,GO BLOOD VESSEL REMODELING,0.0023095,0.30091,0.35042,1,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00057531,0.30088,0.34031,1,1
4,GO LYMPH VESSEL DEVELOPMENT,0.015104,0.30016,0.32239,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0031545,0.30014,0.28295,1,1
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0083971,0.2993,0.3572,1,1
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0020776,0.29918,0.35697,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00028019,0.29914,0.4262,1,1
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0014241,0.29887,0.33622,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00060992,0.29877,0.31914,1,1
4,GO NEUROTRANSMITTER TRANSPORT,0.00060992,0.29877,0.37018,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.00014062,0.29852,0.37139,1,1
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0040644,0.29789,0.33058,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.025096,0.29787,0.26258,1,1
4,GO CARDIAC ATRIUM DEVELOPMENT,0.0027019,0.29781,0.31718,1,1
4,GO REGULATION OF PINOCYTOSIS,0.0066311,0.29772,0.30802,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0027019,0.2976,0.30562,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00081392,0.29736,0.29788,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,7.3279e-05,0.2972,0.34402,1,1
4,GO BEHAVIOR,0.00096503,0.29702,0.27858,1,1
4,GO REGULATION OF AXON GUIDANCE,0.0080134,0.29671,0.33147,1,1
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00076864,0.29659,0.38836,1,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0015041,0.29653,0.32735,1,1
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.00057531,0.2963,0.31495,1,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00028019,0.2958,0.32113,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00332,0.2957,0.27129,1,1
4,GO RESPONSE TO GLUCAGON,0.0044907,0.29564,0.24933,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00014989,0.29537,0.32638,1,1
4,GO REGULATION OF AXONOGENESIS,0.0012758,0.29516,0.32923,1,1
4,GO MICROTUBULE BASED MOVEMENT,0.0015041,0.29491,0.28102,1,1
4,GO REGULATION OF STEM CELL DIVISION,0.021265,0.29487,0.30099,1,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00014989,0.29478,0.34138,1,1
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00076864,0.29458,0.28382,1,1
4,GO MICROTUBULE SEVERING,0.0083971,0.29453,0.26612,1,1
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.017954,0.29425,0.23747,1,1
4,GO COPULATION,0.020391,0.29415,0.24276,1,1
4,GO NEURON PROJECTION EXTENSION,0.00057531,0.29411,0.33978,1,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0040644,0.29321,0.52376,1,1
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.013235,0.293,0.22833,1,1
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0019699,0.2929,0.26301,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.00013188,0.29272,0.30249,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00045436,0.29264,0.33709,1,1
4,GO PROTEIN ACTIVATION CASCADE,0.027226,0.29254,0.25454,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0023095,0.29173,0.23389,1,1
4,GO NEUROTRANSMITTER SECRETION,0.00096503,0.29171,0.39112,1,1
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00081392,0.29127,0.3384,1,1
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.013235,0.29124,0.29057,1,1
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.0060238,0.29122,0.3065,1,1
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0044907,0.2912,0.28977,1,1
4,GO SPECIFICATION OF SYMMETRY,0.00045436,0.29118,0.29699,1,1
4,GO NEURON PROJECTION ARBORIZATION,0.0024341,0.29084,0.32759,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,3.7287e-05,0.29083,0.35923,1,1
4,GO CELL PART MORPHOGENESIS,0.00076864,0.29081,0.29315,1,1
4,GO DETECTION OF CALCIUM ION,0.0063209,0.29046,0.34269,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0019699,0.29045,0.34684,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0034935,0.29007,0.25673,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00033648,0.28993,0.32349,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0036751,0.28986,0.30251,1,1
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.0014241,0.28986,0.3315,1,1
4,GO NEURAL RETINA DEVELOPMENT,0.0083971,0.2898,0.23064,1,1
4,GO DIET INDUCED THERMOGENESIS,0.0066311,0.28944,0.27887,1,1
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.056456,0.28939,0.38007,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00057531,0.28915,0.30652,1,1
4,GO ADULT BEHAVIOR,0.0021907,0.28891,0.29809,1,1
4,GO AXO DENDRITIC TRANSPORT,0.0012071,0.28878,0.30726,1,1
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.024086,0.28862,0.23734,1,1
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.00060992,0.28852,0.2909,1,1
4,GO INTRACILIARY TRANSPORT,0.015104,0.28834,0.235,1,1
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00048214,0.28817,0.38922,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.0083971,0.28801,0.26486,1,1
4,GO CELL JUNCTION ORGANIZATION,0.00048214,0.28709,0.31699,1,1
4,GO ANTEROGRADE AXONAL TRANSPORT,0.0029965,0.28674,0.2969,1,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.006955,0.28664,0.25852,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0040644,0.28641,0.26774,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0060238,0.28624,0.3121,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045436,0.28594,0.31372,1,1
4,GO SPERM MOTILITY,0.0021907,0.28534,0.28733,1,1
4,GO RESPONSE TO EPINEPHRINE,0.0017696,0.28512,0.35439,1,1
4,GO AXON DEVELOPMENT,0.00086166,0.28462,0.29016,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.0021907,0.28443,0.33588,1,1
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.0172,0.28417,0.27936,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00057531,0.28413,0.28737,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0024341,0.28392,0.32176,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0047188,0.28385,0.2629,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00054254,0.28382,0.32268,1,1
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.008797,0.28381,0.32239,1,1
4,GO GLUTAMATE SECRETION,0.0021907,0.28349,0.32963,1,1
4,GO REGULATION OF MITOPHAGY,8.3641e-05,0.2834,0.40713,1,1
4,GO RETROGRADE AXONAL TRANSPORT,0.013235,0.2834,0.31828,1,1
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.00332,0.28308,0.3744,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0021907,0.28293,0.41424,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.00023283,0.28291,0.46241,1,1
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0013481,0.28287,0.44715,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.008797,0.28275,0.29184,1,1
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0018673,0.28274,0.37253,1,1
4,GO LOCOMOTOR RHYTHM,0.00054254,0.2827,0.40088,1,1
4,GO NEGATIVE CHEMOTAXIS,0.0023095,0.28264,0.35393,1,1
4,GO DEVELOPMENTAL CELL GROWTH,0.00029789,0.28254,0.32879,1,1
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0080134,0.28245,0.29283,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.01266,0.28242,0.27063,1,1
4,GO POTASSIUM ION TRANSPORT,0.00045436,0.28238,0.31615,1,1
4,GO WALKING BEHAVIOR,0.00081392,0.28226,0.30981,1,1
4,GO NEURON RECOGNITION,0.0096484,0.28197,0.30001,1,1
4,GO AZOLE TRANSMEMBRANE TRANSPORT,0.023112,0.28189,0.259,1,1
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00068502,0.28185,0.30768,1,1
4,GO MICROTUBULE POLYMERIZATION,0.0036751,0.28176,0.27743,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.00086166,0.28167,0.33269,1,1
4,GO CAMP METABOLIC PROCESS,0.0019699,0.28143,0.33605,1,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.00051151,0.28131,0.35003,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.0018673,0.2813,0.27146,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00017019,0.28086,0.31976,1,1
4,GO PEPTIDE HORMONE SECRETION,0.00010866,0.28062,0.30627,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0031545,0.28059,0.26934,1,1
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0015041,0.28038,0.2954,1,1
4,GO DENDRITE SELF AVOIDANCE,0.045233,0.28027,0.2523,1,1
4,GO GLOMERULUS DEVELOPMENT,0.011574,0.28024,0.31769,1,1
4,GO COGNITION,0.0017696,0.27983,0.27465,1,1
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0013481,0.27965,0.26913,1,1
4,GO MICROTUBULE BASED TRANSPORT,0.00091199,0.27948,0.2792,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0017696,0.27948,0.27844,1,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00086166,0.2792,0.32581,1,1
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0023095,0.27868,0.31225,1,1
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0014241,0.27863,0.37071,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.00054254,0.27863,0.32081,1,1
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0023095,0.27862,0.26641,1,1
4,GO SYNAPTIC VESICLE RECYCLING,9.5377e-05,0.27842,0.39943,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00081392,0.27822,0.32254,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0012758,0.27795,0.27961,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.027226,0.2778,0.24454,1,1
4,GO MONOAMINE TRANSPORT,0.00021879,0.27778,0.36307,1,1
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0060238,0.27759,0.3367,1,1
4,GO DEVELOPMENTAL MATURATION,0.00011593,0.27732,0.2986,1,1
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0060238,0.27723,0.37361,1,1
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0012758,0.2772,0.35979,1,1
4,GO AORTIC VALVE DEVELOPMENT,0.0096484,0.27717,0.29953,1,1
4,GO CELL JUNCTION ASSEMBLY,0.00031664,0.27715,0.3163,1,1
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0020776,0.27673,0.40212,1,1
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0012071,0.27665,0.33493,1,1
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00014989,0.27665,0.45764,1,1
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0054671,0.27634,0.23171,1,1
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.019548,0.27621,0.238,1,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00068502,0.27616,0.30519,1,1
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0066311,0.27586,0.31564,1,1
4,GO MACROPHAGE PROLIFERATION,0.054439,0.27543,0.33419,1,1
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00076864,0.27538,0.35269,1,1
4,GO THYROID HORMONE METABOLIC PROCESS,0.0060238,0.27496,0.26769,1,1
4,GO REGULATION OF EXOCYTOSIS,0.00019306,0.27491,0.32661,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.011063,0.27456,0.25023,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.019548,0.27441,0.27605,1,1
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00045436,0.27437,0.36912,1,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0052065,0.27428,0.28656,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.0010798,0.27419,0.26214,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.052482,0.27408,0.23688,1,1
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.00060992,0.27382,0.29118,1,1
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0083971,0.27369,0.35751,1,1
4,GO BASEMENT MEMBRANE ASSEMBLY,0.0016767,0.2733,0.43582,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00024771,0.27323,0.32094,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.0013481,0.27316,0.28196,1,1
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0024341,0.27314,0.28785,1,1
4,GO ACTIN CROSSLINK FORMATION,0.0063209,0.27311,0.28455,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00010866,0.27306,0.30841,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.060677,0.27306,0.21188,1,1
4,GO ADHERENS JUNCTION ASSEMBLY,0.00031664,0.273,0.36507,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00051151,0.27284,0.33156,1,1
4,GO REPRODUCTIVE BEHAVIOR,0.010101,0.27279,0.25201,1,1
4,GO CILIUM ORGANIZATION,0.0042727,0.27248,0.26676,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00096503,0.27248,0.37263,1,1
4,GO REGULATION OF MEMBRANE POTENTIAL,0.00035748,0.27219,0.32564,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.045233,0.272,0.26899,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0024341,0.27188,0.25615,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00042807,0.27156,0.30558,1,1
4,GO RESPONSE TO AMYLOID BETA,0.0092139,0.2714,0.29202,1,1
4,GO PLATELET MORPHOGENESIS,0.00031664,0.27125,0.3451,1,1
4,GO FUCOSYLATION,0.00028019,0.27113,0.33452,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00072571,0.271,0.32594,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00028019,0.2707,0.29248,1,1
4,GO CELL VOLUME HOMEOSTASIS,0.0017696,0.27023,0.28249,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.017954,0.27015,0.29582,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00096503,0.27003,0.31666,1,1
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0060238,0.26992,0.27085,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.01266,0.26977,0.28003,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.0083971,0.26976,0.25953,1,1
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.021265,0.26966,0.28011,1,1
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.018736,0.26958,0.29465,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0015882,0.26957,0.28972,1,1
4,GO NEURON DEVELOPMENT,0.00076864,0.2694,0.28715,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.00014989,0.26905,0.39135,1,1
4,GO PROTEIN KINASE C SIGNALING,0.00060992,0.26892,0.37341,1,1
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.02951,0.26884,0.32625,1,1
4,GO NERVOUS SYSTEM PROCESS,0.00040321,0.26861,0.26553,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00332,0.26861,0.37504,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.054439,0.26851,0.22429,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0028457,0.26842,0.33048,1,1
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00332,0.26825,0.32768,1,1
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0076456,0.26825,0.33363,1,1
4,GO DENDRITE DEVELOPMENT,0.0017696,0.2682,0.28312,1,1
4,GO RESPONSE TO AMPHETAMINE,0.0019699,0.26796,0.23801,1,1
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0015882,0.26795,0.28834,1,1
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.012106,0.26775,0.27522,1,1
4,GO INSULIN SECRETION,7.8298e-05,0.2675,0.31047,1,1
4,GO RESPONSE TO ISCHEMIA,0.00081392,0.26737,0.297,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0012071,0.26731,0.25758,1,1
4,GO OSTEOCLAST DEVELOPMENT,0.014457,0.26718,0.30766,1,1
4,GO LYSOSOME LOCALIZATION,0.0052065,0.26697,0.26379,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.00048214,0.26696,0.30299,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0003797,0.26694,0.26744,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0020776,0.26659,0.30135,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00054254,0.26655,0.27532,1,1
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0060238,0.26654,0.33613,1,1
4,GO NEURON PROJECTION ORGANIZATION,0.0014241,0.26637,0.31345,1,1
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.00068502,0.26617,0.28892,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.050584,0.26593,0.26649,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0015882,0.26567,0.32808,1,1
4,GO SIGNAL RELEASE,0.00031664,0.26525,0.28347,1,1
4,GO ENDOCYTIC RECYCLING,0.00024771,0.26517,0.31998,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.035953,0.26507,0.32155,1,1
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00081392,0.26502,0.25802,1,1
4,GO DENDRITE MORPHOGENESIS,0.0028457,0.26501,0.30218,1,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0003797,0.26497,0.3038,1,1
4,GO AXONAL TRANSPORT,0.0024341,0.26463,0.29186,1,1
4,GO IMPORT INTO CELL,0.00060992,0.26456,0.27147,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0019699,0.26448,0.28707,1,1
4,GO INOSITOL METABOLIC PROCESS,0.019548,0.26433,0.235,1,1
4,GO COLLAGEN METABOLIC PROCESS,0.0172,0.26431,0.33229,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.020391,0.2642,0.22966,1,1
4,GO REGULATION OF HORMONE SECRETION,0.00023283,0.26416,0.27515,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0020776,0.26416,0.32129,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0027019,0.26402,0.27392,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0019699,0.26402,0.25089,1,1
4,GO PHOSPHOLIPID TRANSPORT,0.0025648,0.26371,0.24446,1,1
4,GO REGULATION OF BONE REMODELING,0.025096,0.26349,0.2667,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,1.6059e-05,0.26343,0.35438,1,1
4,GO LIPID GLYCOSYLATION,0.00086166,0.26342,0.33875,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0063209,0.26337,0.31843,1,1
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00064645,0.26316,0.2888,1,1
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0083971,0.26291,0.32014,1,1
4,GO TRANSPORT ALONG MICROTUBULE,0.0028457,0.26289,0.247,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.00011593,0.26285,0.44191,1,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.00064645,0.26264,0.32014,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0028457,0.26255,0.26701,1,1
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0172,0.26241,0.26998,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.00040321,0.26239,0.27565,1,1
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00091199,0.26238,0.28596,1,1
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0012071,0.26236,0.30834,1,1
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.015776,0.26235,0.27973,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.025096,0.2623,0.22562,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.00033648,0.26228,0.31592,1,1
4,GO REGULATION OF CELL SIZE,0.00076864,0.26227,0.30291,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.006955,0.26222,0.23564,1,1
4,GO HORMONE TRANSPORT,0.00019306,0.26159,0.27784,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.028348,0.26154,0.24481,1,1
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.037377,0.26141,0.21266,1,1
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00096503,0.26136,0.29727,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00054254,0.26123,0.2865,1,1
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.034576,0.26119,0.23369,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,6.4139e-05,0.26117,0.3483,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00019306,0.2611,0.3029,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.016475,0.261,0.25998,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00060992,0.2609,0.29032,1,1
4,GO DENDRITIC SPINE MORPHOGENESIS,0.00332,0.26086,0.3234,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00017019,0.26064,0.30429,1,1
4,GO CALCIUM ION IMPORT,0.0024341,0.26055,0.30989,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0027019,0.26029,0.37667,1,1
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00081392,0.26028,0.29442,1,1
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.030713,0.26017,0.25842,1,1
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0063209,0.25998,0.30525,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.018736,0.25998,0.27956,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00026348,0.25967,0.37262,1,1
4,GO PROTEIN LOCALIZATION TO CILIUM,0.011574,0.25939,0.25736,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.00031664,0.25935,0.27749,1,1
4,GO CELL MIGRATION IN HINDBRAIN,0.0036751,0.25921,0.31834,1,1
4,GO NODAL SIGNALING PATHWAY,0.00035748,0.25915,0.30828,1,1
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.056456,0.25904,0.23018,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.00096503,0.25897,0.37416,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.0044907,0.25893,0.2267,1,1
4,GO ACROSOME REACTION,0.00031664,0.25888,0.27029,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0076456,0.25883,0.25522,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0034935,0.25862,0.28506,1,1
4,GO RESPONSE TO REDOX STATE,0.00045436,0.25831,0.35994,1,1
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0024341,0.25827,0.28986,1,1
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.017954,0.25799,0.22191,1,1
4,GO REGULATION OF NEURON DIFFERENTIATION,0.0011418,0.25778,0.26851,1,1
4,GO PROTEIN KINASE A SIGNALING,0.0028457,0.25771,0.24515,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0029965,0.25758,0.30617,1,1
4,GO MYOTUBE DIFFERENTIATION,0.0024341,0.25727,0.26658,1,1
4,GO CERAMIDE TRANSPORT,0.0031545,0.25727,0.34453,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00023283,0.25718,0.30636,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00014062,0.25715,0.3123,1,1
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.011063,0.25704,0.29158,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00021879,0.25697,0.29839,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00020554,0.25693,0.30909,1,1
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00021879,0.25689,0.36174,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.00023283,0.2567,0.33522,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00045436,0.25666,0.2598,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.031957,0.25665,0.25914,1,1
4,GO CELL PROJECTION ORGANIZATION,0.00091199,0.25665,0.27123,1,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.010572,0.25635,0.24481,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0042727,0.25594,0.3172,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0049572,0.25578,0.27435,1,1
4,GO FOREGUT MORPHOGENESIS,0.012106,0.25575,0.24652,1,1
4,GO CELL CELL SIGNALING,0.00045436,0.25571,0.26487,1,1
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00051151,0.2557,0.29021,1,1
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0012758,0.25568,0.29723,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,8.3641e-05,0.25567,0.33283,1,1
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.015776,0.25564,0.25077,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00051151,0.25558,0.28342,1,1
4,GO LEFT RIGHT PATTERN FORMATION,0.0063209,0.25523,0.26359,1,1
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0010209,0.25498,0.32424,1,1
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0020776,0.25471,0.37051,1,1
4,GO SECRETORY GRANULE ORGANIZATION,0.00024771,0.2547,0.30324,1,1
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0014241,0.2547,0.44497,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.020391,0.25466,0.22635,1,1
4,GO NEUROGENESIS,0.00072571,0.25457,0.2614,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0010209,0.25456,0.27894,1,1
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.008797,0.25448,0.27258,1,1
4,GO PLATELET ACTIVATION,0.014457,0.2544,0.2769,1,1
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.00019306,0.25429,0.26709,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0049572,0.25398,0.34364,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.013834,0.25396,0.2371,1,1
4,GO REGULATION OF ION TRANSPORT,0.00054254,0.25386,0.28514,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0057394,0.25376,0.2339,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00033648,0.25352,0.26863,1,1
4,GO NEURON DIFFERENTIATION,0.00091199,0.25325,0.2691,1,1
4,GO CELL MORPHOGENESIS,0.00076864,0.25308,0.27866,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00021879,0.25293,0.318,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.0014241,0.25292,0.34417,1,1
4,GO CELLULAR RESPONSE TO ATP,0.016475,0.25292,0.20688,1,1
4,GO ACIDIC AMINO ACID TRANSPORT,0.0018673,0.2529,0.29169,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0083971,0.2525,0.21581,1,1
4,GO THALAMUS DEVELOPMENT,0.008797,0.25237,0.27533,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0049572,0.25223,0.36405,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0063209,0.25204,0.25954,1,1
4,GO MYELOID CELL DEVELOPMENT,0.0057394,0.25203,0.25749,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0013481,0.25181,0.30796,1,1
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.035953,0.25181,0.26572,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00051151,0.2518,0.32413,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.020391,0.25168,0.21715,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0057394,0.25142,0.24165,1,1
4,GO PHOSPHATE ION TRANSPORT,0.0021907,0.25132,0.27388,1,1
4,GO LOCOMOTORY BEHAVIOR,0.0023095,0.25122,0.2973,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,0.0017696,0.25113,0.25008,1,1
4,GO BONE RESORPTION,0.031957,0.2509,0.25537,1,1
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.012106,0.25087,0.42089,1,1
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.025096,0.25068,0.32515,1,1
4,GO BONE MATURATION,0.0066311,0.2504,0.26422,1,1
4,GO REGULATION OF INSULIN SECRETION,0.00014062,0.25014,0.30244,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.010101,0.25012,0.26373,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0015882,0.25004,0.27292,1,1
4,GO TORC1 SIGNALING,0.00076864,0.24963,0.3186,1,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0029965,0.24957,0.30218,1,1
4,GO REGULATION OF LYASE ACTIVITY,0.019548,0.24944,0.19736,1,1
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.0092139,0.24941,0.29295,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00064645,0.24911,0.27068,1,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0010209,0.24907,0.29447,1,1
4,GO PRESYNAPSE ORGANIZATION,0.0025648,0.24884,0.3451,1,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.0044907,0.24873,0.33531,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0063209,0.24871,0.28104,1,1
4,GO BONE CELL DEVELOPMENT,0.0021907,0.24843,0.30941,1,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008797,0.2484,0.3543,1,1
4,GO PANCREAS DEVELOPMENT,0.00064645,0.24812,0.28785,1,1
4,GO BODY MORPHOGENESIS,0.0031545,0.24799,0.29658,1,1
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00054254,0.2478,0.27633,1,1
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.0015041,0.24768,0.28388,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0020776,0.24751,0.27275,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.01266,0.24733,0.30861,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028457,0.24729,0.24475,1,1
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0010798,0.2472,0.28633,1,1
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042727,0.24718,0.32666,1,1
4,GO ENDODERM DEVELOPMENT,0.0034935,0.24715,0.30905,1,1
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.0031545,0.2471,0.26282,1,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.025096,0.24705,0.208,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.013834,0.24704,0.24328,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0021907,0.24686,0.30213,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0012758,0.24664,0.27004,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0018673,0.24663,0.32203,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.00081392,0.24659,0.25089,1,1
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.017954,0.24633,0.26523,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.013235,0.24628,0.23219,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.00332,0.24618,0.21957,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.02951,0.24617,0.26082,1,1
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0092139,0.24605,0.31402,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0036751,0.24603,0.28636,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0018673,0.24602,0.27668,1,1
4,GO FIBROBLAST ACTIVATION,0.0083971,0.246,0.2343,1,1
4,GO DENDRITE EXTENSION,0.00018128,0.24584,0.4149,1,1
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.006955,0.24554,0.31063,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00014989,0.24553,0.29346,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0063209,0.24549,0.25583,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.043559,0.24537,0.18929,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.011574,0.24532,0.26734,1,1
4,GO THYROID GLAND DEVELOPMENT,0.0024341,0.24528,0.25944,1,1
4,GO REGULATION OF TELOMERE CAPPING,0.012106,0.24523,0.23289,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.00017019,0.24519,0.51076,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.011574,0.24505,0.2249,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0044907,0.24503,0.25125,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.0052065,0.245,0.32905,1,1
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0096484,0.24493,0.25359,1,1
4,GO REGULATION OF HORMONE LEVELS,0.00019306,0.24483,0.25016,1,1
4,GO REGULATION OF TUBE SIZE,0.0013481,0.2448,0.24324,1,1
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0060238,0.24473,0.24311,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0049572,0.24464,0.26678,1,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.014457,0.24447,0.23604,1,1
4,GO SKELETAL MUSCLE CONTRACTION,0.00081392,0.2444,0.33123,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00035748,0.24438,0.36612,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00072571,0.24424,0.26381,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.00054254,0.24414,0.31081,1,1
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0021907,0.24382,0.28533,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0060238,0.24372,0.29033,1,1
4,GO MEMBRANE BIOGENESIS,0.00015974,0.24363,0.36397,1,1
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.006955,0.24345,0.24079,1,1
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00072571,0.24336,0.32449,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0015882,0.24335,0.24727,1,1
4,GO ORGANIC CATION TRANSPORT,0.0060238,0.24318,0.23737,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0027019,0.24309,0.23509,1,1
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0015041,0.24309,0.25761,1,1
4,GO OLFACTORY LOBE DEVELOPMENT,0.0054671,0.24309,0.28043,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0023095,0.24295,0.29521,1,1
4,GO RESPONSE TO NICOTINE,0.048745,0.24295,0.17547,1,1
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.0020776,0.24279,0.25486,1,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0031545,0.24241,0.3358,1,1
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0015041,0.24225,0.35345,1,1
4,GO PINOCYTOSIS,0.028348,0.24211,0.23674,1,1
4,GO KERATINOCYTE MIGRATION,0.0052065,0.24202,0.27343,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.0023095,0.24182,0.23728,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.040368,0.24165,0.22318,1,1
4,GO CATECHOLAMINE SECRETION,0.00018128,0.24152,0.39571,1,1
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0060238,0.24147,0.23644,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.008797,0.24135,0.26854,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0024341,0.24131,0.23791,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00014062,0.2413,0.31094,1,1
4,GO SCHWANN CELL DEVELOPMENT,0.0011418,0.24129,0.30905,1,1
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.008797,0.24119,0.22128,1,1
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.008797,0.24099,0.29504,1,1
4,GO NUCLEUS LOCALIZATION,0.0034935,0.24079,0.37537,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00023283,0.24078,0.30587,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.0038653,0.24075,0.23627,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.023112,0.24073,0.26756,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.0076456,0.24058,0.27029,1,1
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.021265,0.24054,0.26561,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0027019,0.2405,0.30359,1,1
4,GO MITOPHAGY,0.00026348,0.24049,0.31338,1,1
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0042727,0.24048,0.26903,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00017019,0.24021,0.33782,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0010798,0.23982,0.24746,1,1
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.00033648,0.23972,0.27711,1,1
4,GO REGULATION OF TISSUE REMODELING,0.017954,0.2397,0.26488,1,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0015041,0.23968,0.26302,1,1
4,GO HEAD MORPHOGENESIS,0.007293,0.23968,0.31014,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.017954,0.2396,0.25448,1,1
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0092139,0.2396,0.21286,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0027019,0.23935,0.23426,1,1
4,GO SENSORY PERCEPTION,0.00064645,0.23923,0.22678,1,1
4,GO AORTA MORPHOGENESIS,0.0044907,0.23918,0.33241,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0027019,0.23916,0.2311,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00060992,0.23912,0.26009,1,1
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.019548,0.23896,0.27905,1,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0029965,0.23894,0.29224,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.014457,0.23894,0.2357,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0060238,0.23892,0.26871,1,1
4,GO RESPONSE TO INACTIVITY,0.020391,0.2387,0.23082,1,1
4,GO CALCINEURIN MEDIATED SIGNALING,0.0019699,0.23862,0.25975,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00018128,0.23862,0.27359,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0040644,0.2386,0.31217,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.010101,0.23859,0.27303,1,1
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00076864,0.23857,0.31437,1,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.0027019,0.23856,0.22942,1,1
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0016767,0.23854,0.30131,1,1
4,GO REGULATION OF GONAD DEVELOPMENT,0.022172,0.23848,0.20764,1,1
4,GO CHONDROCYTE PROLIFERATION,0.014457,0.23847,0.30014,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.045233,0.23832,0.26991,1,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.00019306,0.2383,0.30416,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.0011418,0.23823,0.26991,1,1
4,GO REGULATION OF TORC1 SIGNALING,0.0012071,0.23818,0.28699,1,1
4,GO AORTA DEVELOPMENT,0.0049572,0.23787,0.30084,1,1
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00332,0.2378,0.23065,1,1
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0052065,0.23772,0.29148,1,1
4,GO TISSUE MIGRATION,0.015776,0.23757,0.23666,1,1
4,GO ACTIN FILAMENT BASED PROCESS,0.0012758,0.23747,0.25589,1,1
4,GO BONE GROWTH,0.010101,0.2374,0.27432,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,9.5377e-05,0.23736,0.39314,1,1
4,GO CATION TRANSPORT,0.00031664,0.23735,0.26324,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.007293,0.23721,0.23176,1,1
4,GO GENETIC IMPRINTING,0.00072571,0.23708,0.32121,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.043559,0.23703,0.19587,1,1
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0021907,0.23687,0.30442,1,1
4,GO TRANSFERRIN TRANSPORT,6.8565e-05,0.23666,0.28704,1,1
4,GO SENSORY SYSTEM DEVELOPMENT,0.00081392,0.23652,0.25605,1,1
4,GO METAL ION TRANSPORT,0.00060992,0.23651,0.26721,1,1
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0017696,0.23635,0.32768,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.00024771,0.23627,0.32802,1,1
4,GO NEURON MIGRATION,0.0083971,0.23625,0.25844,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.00013188,0.23615,0.2831,1,1
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.022172,0.23603,0.22601,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.006955,0.236,0.25662,1,1
4,GO PEPTIDE SECRETION,0.00086166,0.23588,0.25572,1,1
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.040368,0.23573,0.22105,1,1
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.010572,0.23568,0.28274,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0028457,0.23556,0.25351,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.015104,0.23551,0.22624,1,1
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00086166,0.23544,0.39671,1,1
4,GO REGULATION OF TRANSPORT,0.00072571,0.23543,0.24242,1,1
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0060238,0.2354,0.24609,1,1
4,GO PLASMA MEMBRANE TUBULATION,0.0014241,0.23527,0.30088,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0023095,0.23526,0.28175,1,1
4,GO TUBULIN DEACETYLATION,0.0012071,0.23523,0.3629,1,1
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.022172,0.23522,0.26372,1,1
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00064645,0.23515,0.27862,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.00033648,0.23506,0.27104,1,1
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0019699,0.23503,0.26975,1,1
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0024341,0.23498,0.23953,1,1
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0018673,0.23494,0.27425,1,1
4,GO SODIUM ION TRANSPORT,0.00014062,0.23483,0.33025,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0023095,0.23464,0.30131,1,1
4,GO CGMP METABOLIC PROCESS,0.0052065,0.23458,0.32156,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0038653,0.23428,0.27926,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0031545,0.23397,0.25703,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,7.3279e-05,0.2338,0.29425,1,1
4,GO REGULATION OF NEURON MATURATION,0.0011418,0.23373,0.31729,1,1
4,GO MICROTUBULE ANCHORING,0.010101,0.23358,0.31123,1,1
4,GO REGULATION OF CELL MORPHOGENESIS,0.0010798,0.23353,0.27351,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.00054254,0.2335,0.31511,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0021907,0.23349,0.27631,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.008797,0.23345,0.24491,1,1
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0063209,0.23316,0.30683,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0054671,0.23307,0.27494,1,1
4,GO RESPONSE TO INSECTICIDE,0.033245,0.23289,0.22616,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.00020554,0.2328,0.30344,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.050584,0.2327,0.17358,1,1
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00072571,0.23266,0.2282,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00031664,0.23265,0.27728,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.00014989,0.23263,0.30191,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0172,0.23262,0.275,1,1
4,GO BRAIN MORPHOGENESIS,0.0049572,0.23233,0.28016,1,1
4,GO NEURAL NUCLEUS DEVELOPMENT,0.00035748,0.23227,0.27143,1,1
4,GO CELL MATRIX ADHESION,0.00332,0.23222,0.30471,1,1
4,GO CELL SUBSTRATE ADHESION,0.0036751,0.23209,0.29486,1,1
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.00048214,0.23208,0.26638,1,1
4,GO NEURAL TUBE PATTERNING,0.046961,0.23204,0.1932,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.025096,0.23193,0.36164,1,1
4,GO LENS FIBER CELL DIFFERENTIATION,0.011063,0.23173,0.2047,1,1
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0049572,0.23172,0.33794,1,1
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0031545,0.23157,0.28136,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.006955,0.2315,0.34543,1,1
4,GO SCHWANN CELL DIFFERENTIATION,0.0015041,0.23136,0.26471,1,1
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0021907,0.23131,0.33354,1,1
4,GO CHROMATIN DISASSEMBLY,0.018736,0.23126,0.22345,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.034576,0.23124,0.24912,1,1
4,GO METENCEPHALON DEVELOPMENT,0.0016767,0.2312,0.26219,1,1
4,GO SEGMENT SPECIFICATION,0.015104,0.23115,0.29459,1,1
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.0029965,0.23115,0.31109,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0014241,0.23094,0.31697,1,1
4,GO CELL PROJECTION ASSEMBLY,0.0028457,0.23087,0.24366,1,1
4,GO PROTEIN TRIMERIZATION,0.030713,0.23086,0.24374,1,1
4,GO PARTURITION,0.0015882,0.23084,0.28402,1,1
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.02951,0.23074,0.18488,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0023095,0.23071,0.25908,1,1
4,GO REGULATION OF CYCLASE ACTIVITY,0.020391,0.2307,0.19941,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.010572,0.23049,0.23249,1,1
4,GO RESPONSE TO DOPAMINE,0.00045436,0.23047,0.25296,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.021265,0.23044,0.26489,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0044907,0.23036,0.27147,1,1
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.021265,0.2303,0.21897,1,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.0036751,0.23024,0.28507,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.043559,0.23015,0.23377,1,1
4,GO LYMPH VESSEL MORPHOGENESIS,0.02951,0.23004,0.27186,1,1
4,GO ENERGY HOMEOSTASIS,0.00076864,0.23003,0.29285,1,1
4,GO CARDIAC CONDUCTION,0.0023095,0.23003,0.30619,1,1
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.033245,0.22991,0.20654,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0092139,0.22991,0.30971,1,1
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.0052065,0.2298,0.25845,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0015882,0.22978,0.2359,1,1
4,GO NUCLEAR MIGRATION,0.0036751,0.22977,0.37693,1,1
4,GO REGULATION OF PEPTIDE SECRETION,0.0012071,0.22964,0.24696,1,1
4,GO RESPONSE TO PROGESTERONE,0.013235,0.22964,0.24506,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.00091199,0.22957,0.26461,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0012071,0.22954,0.21414,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.00033648,0.22949,0.25931,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0034935,0.22947,0.23023,1,1
4,GO REGULATION OF CELL DEVELOPMENT,0.0010209,0.22944,0.24596,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.019548,0.22944,0.23448,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0013481,0.2294,0.272,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0047188,0.22925,0.22462,1,1
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.0060238,0.2289,0.23657,1,1
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0010209,0.22882,0.23002,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0015041,0.22862,0.28058,1,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.0036751,0.22852,0.25645,1,1
4,GO ARACHIDONIC ACID SECRETION,0.01266,0.22832,0.18106,1,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0003797,0.22826,0.30144,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,8.9327e-05,0.22822,0.26313,1,1
4,GO REGULATION OF SECRETION,0.00072571,0.22813,0.25417,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.017954,0.22777,0.22695,1,1
4,GO MYOBLAST FUSION,0.018736,0.22739,0.28031,1,1
4,GO TELOMERE CAPPING,0.010101,0.22734,0.22184,1,1
4,GO POSITIVE REGULATION OF GROWTH,0.00029789,0.22727,0.27467,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0080134,0.22717,0.18954,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.006955,0.22709,0.26738,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00014062,0.227,0.31911,1,1
4,GO CARDIAC CHAMBER DEVELOPMENT,0.0023095,0.22696,0.25946,1,1
4,GO ENDODERM FORMATION,0.0092139,0.22687,0.33279,1,1
4,GO METAL ION HOMEOSTASIS,0.0042727,0.22685,0.21896,1,1
4,GO ACTIN FILAMENT SEVERING,0.027226,0.22675,0.26931,1,1
4,GO BIOLOGICAL ADHESION,0.0023095,0.22665,0.2753,1,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0038653,0.22659,0.27561,1,1
4,GO RECEPTOR RECYCLING,0.0028457,0.22654,0.23852,1,1
4,GO ACTION POTENTIAL,0.0012071,0.22646,0.3365,1,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.056456,0.22646,0.25255,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.0040644,0.22646,0.24053,1,1
4,GO ARTERY MORPHOGENESIS,0.0049572,0.22643,0.27969,1,1
4,GO HISTONE H3 K14 ACETYLATION,0.0038653,0.22637,0.30534,1,1
4,GO OVULATION CYCLE PROCESS,0.012106,0.22629,0.25252,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.00024771,0.22629,0.34772,1,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.006955,0.22621,0.23523,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.041938,0.22594,0.18983,1,1
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0034935,0.22592,0.24364,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00028019,0.22585,0.27776,1,1
4,GO SPLEEN DEVELOPMENT,0.0024341,0.22574,0.2478,1,1
4,GO CELLULAR RESPONSE TO PH,0.0017696,0.2254,0.28733,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.00057531,0.22538,0.25027,1,1
4,GO RESPONSE TO IRON ION,0.0054671,0.22522,0.23349,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00051151,0.22494,0.25979,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.00086166,0.22487,0.24917,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.0012758,0.2248,0.2918,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00068502,0.22477,0.28951,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0047188,0.22469,0.30754,1,1
4,GO RESPONSE TO STEROL,0.0049572,0.22456,0.2906,1,1
4,GO MYELIN ASSEMBLY,0.00064645,0.22453,0.34982,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.0028457,0.22447,0.32427,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.0036751,0.22435,0.22966,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0038653,0.22429,0.26018,1,1
4,GO METANEPHROS MORPHOGENESIS,0.0060238,0.22417,0.25738,1,1
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.015104,0.22409,0.21914,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00064645,0.22407,0.28765,1,1
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0021907,0.22389,0.27698,1,1
4,GO CARDIAC SEPTUM DEVELOPMENT,0.0049572,0.22386,0.27165,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0044907,0.2236,0.25251,1,1
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0029965,0.22352,0.2561,1,1
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0060238,0.2235,0.23231,1,1
4,GO MATING,0.006955,0.22316,0.23666,1,1
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.0057394,0.22308,0.24627,1,1
4,GO ION HOMEOSTASIS,0.00332,0.223,0.22111,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007293,0.22245,0.26298,1,1
4,GO SPERM AXONEME ASSEMBLY,0.015104,0.22244,0.22261,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0010209,0.22243,0.26542,1,1
4,GO RESPONSE TO GONADOTROPIN,0.00054254,0.22233,0.26247,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.007293,0.22228,0.21332,1,1
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.010572,0.22226,0.25237,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0031545,0.22222,0.26529,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0024341,0.22208,0.23832,1,1
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00040321,0.22172,0.25927,1,1
4,GO VISUAL BEHAVIOR,0.00031664,0.22157,0.3047,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00091199,0.22147,0.30663,1,1
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00081392,0.22138,0.24698,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,0.008797,0.22131,0.33841,1,1
4,GO REGULATION OF WOUND HEALING,0.011574,0.22129,0.23173,1,1
4,GO ANIMAL ORGAN MATURATION,0.007293,0.22119,0.26656,1,1
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0054671,0.22118,0.28246,1,1
4,GO PHAGOSOME MATURATION,0.00026348,0.22102,0.27218,1,1
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.0047188,0.22081,0.23976,1,1
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.008797,0.22078,0.26006,1,1
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.023112,0.22077,0.28655,1,1
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00031664,0.22066,0.36631,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0044907,0.22053,0.20313,1,1
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0076456,0.2204,0.29314,1,1
4,GO SENSORY ORGAN MORPHOGENESIS,0.0040644,0.22039,0.22203,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,0.027226,0.22034,0.25779,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.007293,0.22009,0.25039,1,1
4,GO COAGULATION,0.011063,0.22001,0.24022,1,1
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0018673,0.21981,0.21975,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.025096,0.21972,0.19792,1,1
4,GO LUNG CELL DIFFERENTIATION,0.035953,0.21962,0.24717,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.0052065,0.21959,0.24176,1,1
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0018673,0.21943,0.30576,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0060238,0.2194,0.20177,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,6.4139e-05,0.21928,0.27221,1,1
4,GO DEVELOPMENTAL GROWTH,0.00076864,0.21921,0.25479,1,1
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0016767,0.21918,0.2928,1,1
4,GO CORNIFICATION,0.054439,0.21909,0.14961,1,1
4,GO PEPTIDYL ARGININE METHYLATION,0.0020776,0.219,0.25555,1,1
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.031957,0.21895,0.1927,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.0017696,0.21883,0.24501,1,1
4,GO PLATELET DEGRANULATION,0.020391,0.21869,0.25924,1,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0027019,0.21863,0.26892,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.019548,0.21856,0.27045,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.007293,0.21851,0.2214,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0010798,0.21849,0.27432,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0020776,0.21824,0.24017,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.054439,0.21807,0.20861,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.0020776,0.21795,0.22053,1,1
4,GO EYE MORPHOGENESIS,0.0017696,0.21782,0.26822,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0017696,0.2178,0.20505,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0034935,0.21767,0.27947,1,1
4,GO AMINE TRANSPORT,0.00051151,0.21716,0.31718,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.050584,0.2171,0.23807,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0027019,0.21704,0.31086,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.010572,0.21701,0.2509,1,1
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00076864,0.21682,0.2636,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.013834,0.21661,0.21868,1,1
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.019548,0.2166,0.24631,1,1
4,GO NEUROTRANSMITTER REUPTAKE,0.0028457,0.21659,0.28977,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0012758,0.21639,0.31144,1,1
4,GO GLIAL CELL FATE COMMITMENT,0.043559,0.21635,0.24435,1,1
4,GO ENDOCYTOSIS,0.0015882,0.21635,0.26038,1,1
4,GO ARTERY DEVELOPMENT,0.0060238,0.21633,0.27682,1,1
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0012071,0.21625,0.31137,1,1
4,GO RESPONSE TO ATP,0.027226,0.21624,0.19454,1,1
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.011063,0.21624,0.26417,1,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0054671,0.21614,0.24303,1,1
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0057394,0.21592,0.23231,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.016475,0.21588,0.23572,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0025648,0.21576,0.23067,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0012071,0.21558,0.34183,1,1
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0063209,0.21527,0.29208,1,1
4,GO RESPONSE TO AXON INJURY,0.00035748,0.2151,0.26009,1,1
4,GO EPIBOLY,0.008797,0.21508,0.26455,1,1
4,GO MULTICELLULAR ORGANISM GROWTH,0.00064645,0.21504,0.27281,1,1
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.01266,0.21501,0.20678,1,1
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00072571,0.215,0.28382,1,1
4,GO HEART PROCESS,0.0029965,0.21496,0.25518,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.024086,0.21493,0.28747,1,1
4,GO MESENCHYME DEVELOPMENT,0.0031545,0.21489,0.2403,1,1
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.012106,0.21473,0.21912,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.060677,0.21472,0.20699,1,1
4,GO HINDBRAIN DEVELOPMENT,0.0019699,0.21457,0.24486,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0024341,0.21447,0.23478,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.0172,0.21436,0.21235,1,1
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0052065,0.21422,0.24439,1,1
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.00018128,0.21409,0.27063,1,1
4,GO DIGESTION,0.0024341,0.21406,0.2142,1,1
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0036751,0.21387,0.24963,1,1
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0092139,0.21377,0.26605,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.006955,0.21375,0.23648,1,1
4,GO SOMITE DEVELOPMENT,0.0038653,0.21351,0.22768,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.00332,0.21343,0.2384,1,1
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.00060992,0.21334,0.26038,1,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00081392,0.21334,0.26794,1,1
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.048745,0.21331,0.18592,1,1
4,GO DENDRITIC SPINE DEVELOPMENT,0.0049572,0.21326,0.27715,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00057531,0.21319,0.26762,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0036751,0.21318,0.29993,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.035953,0.21308,0.22627,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0027019,0.21298,0.30044,1,1
4,GO POSITIVE REGULATION OF ACROSOME REACTION,0.008797,0.21297,0.21092,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0092139,0.21296,0.24098,1,1
4,GO LYMPHANGIOGENESIS,0.050584,0.21289,0.24071,1,1
4,GO CAMERA TYPE EYE DEVELOPMENT,0.0027019,0.21279,0.23754,1,1
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.013834,0.21273,0.22617,1,1
4,GO LYTIC VACUOLE ORGANIZATION,0.00045436,0.21261,0.25948,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0020776,0.2126,0.24276,1,1
4,GO WOUND HEALING,0.008797,0.21235,0.25037,1,1
4,GO PROTEIN AUTOPHOSPHORYLATION,0.0052065,0.21227,0.24681,1,1
4,GO ION TRANSPORT,0.0003797,0.21205,0.25177,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.037377,0.212,0.22818,1,1
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.011574,0.21188,0.24305,1,1
4,GO CHEMICAL HOMEOSTASIS,0.00076864,0.21183,0.22934,1,1
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00091199,0.21178,0.28595,1,1
4,GO LIPID PHOSPHORYLATION,0.0040644,0.21176,0.23314,1,1
4,GO AMINO ACID TRANSPORT,0.00068502,0.21171,0.24969,1,1
4,GO HEART MORPHOGENESIS,0.0040644,0.21165,0.23181,1,1
4,GO RESPONSE TO AMINE,0.0031545,0.21163,0.20794,1,1
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.006955,0.21161,0.29327,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.00026348,0.21151,0.25335,1,1
4,GO SENSORY ORGAN DEVELOPMENT,0.0038653,0.2115,0.21972,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,4.5779e-05,0.21142,0.2759,1,1
4,GO REGULATION OF MYELINATION,0.025096,0.21138,0.20993,1,1
4,GO REGULATION OF METAL ION TRANSPORT,0.0029965,0.21137,0.25638,1,1
4,GO DETECTION OF VISIBLE LIGHT,0.00051151,0.21131,0.20492,1,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.00060992,0.21123,0.24991,1,1
4,GO FOCAL ADHESION ASSEMBLY,0.0076456,0.21116,0.27992,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0057394,0.21109,0.29244,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00086166,0.21101,0.34853,1,1
4,GO REGULATION OF PROTEIN TARGETING,0.00011593,0.21094,0.25718,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0010209,0.21093,0.24595,1,1
4,GO EXOCYTIC PROCESS,0.00017019,0.2109,0.32829,1,1
4,GO NOREPINEPHRINE TRANSPORT,0.054439,0.21084,0.24197,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0066311,0.21084,0.23019,1,1
4,GO FUCOSE METABOLIC PROCESS,0.0036751,0.21082,0.23183,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0019699,0.21065,0.29346,1,1
4,GO LIPID LOCALIZATION,0.0015882,0.2106,0.22766,1,1
4,GO ACTIN FILAMENT ORGANIZATION,0.00096503,0.2105,0.24818,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0172,0.21045,0.23845,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00076864,0.21023,0.2211,1,1
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0015041,0.21014,0.25138,1,1
4,GO HEAD DEVELOPMENT,0.0015041,0.21001,0.24034,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0063209,0.21,0.25971,1,1
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.037377,0.20997,0.2043,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0036751,0.2099,0.29085,1,1
4,GO CELL GROWTH,0.00019306,0.20988,0.26136,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00054254,0.20977,0.26642,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.012106,0.20977,0.24129,1,1
4,GO ENTRY INTO HOST,0.048745,0.20957,0.20196,1,1
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0080134,0.20953,0.29573,1,1
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00060992,0.20937,0.25648,1,1
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0083971,0.20919,0.27328,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.006955,0.20898,0.30931,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.014457,0.20894,0.28274,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0014241,0.20888,0.25874,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0003797,0.20874,0.26165,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0076456,0.20861,0.24821,1,1
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0003797,0.20854,0.33815,1,1
4,GO ACTIVATION OF MAPKK ACTIVITY,0.0044907,0.20834,0.29431,1,1
4,GO RESPONSE TO LEPTIN,0.00014989,0.20816,0.31428,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.0010209,0.20816,0.2194,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,3.7287e-05,0.20814,0.24922,1,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.0018673,0.2081,0.23364,1,1
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0040644,0.20795,0.28881,1,1
4,GO FATTY ACID BETA OXIDATION,0.0010798,0.20791,0.23646,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.037377,0.20766,0.24709,1,1
4,GO NEUROTRANSMITTER UPTAKE,0.0021907,0.20764,0.23593,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0014241,0.20763,0.28736,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0054671,0.20758,0.26832,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00091199,0.20741,0.2562,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.014457,0.20734,0.27429,1,1
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00048214,0.20733,0.25581,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00010181,0.2073,0.27112,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0012071,0.20725,0.26528,1,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.0092139,0.20708,0.28008,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.037377,0.20693,0.20857,1,1
4,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.006955,0.20674,0.30235,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00045436,0.20673,0.29635,1,1
4,GO MICROTUBULE BASED PROCESS,0.01266,0.20672,0.20589,1,1
4,GO HYALURONAN METABOLIC PROCESS,0.0080134,0.20672,0.28645,1,1
4,GO TRANSEPITHELIAL TRANSPORT,0.031957,0.20669,0.20586,1,1
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.017954,0.20668,0.30425,1,1
4,GO JNK CASCADE,0.0021907,0.20651,0.25306,1,1
4,GO GOLGI RIBBON FORMATION,0.023112,0.20649,0.27957,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.00096503,0.20649,0.25526,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0044907,0.20647,0.20178,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0018673,0.20616,0.26683,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.017954,0.2061,0.27161,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00076864,0.20595,0.22362,1,1
4,GO CELL MATURATION,0.00028019,0.20592,0.24749,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0028457,0.20586,0.29712,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0020776,0.20578,0.2348,1,1
4,GO HISTONE H4 K5 ACETYLATION,0.013834,0.2056,0.23661,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0016767,0.20541,0.25117,1,1
4,GO RESPONSE TO ESTROGEN,0.0060238,0.2053,0.22087,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.006955,0.20525,0.2265,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0083971,0.20521,0.32952,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0012071,0.2052,0.25694,1,1
4,GO ERYTHROCYTE MATURATION,0.019548,0.20517,0.26008,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0029965,0.20511,0.26158,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.00068502,0.20502,0.25891,1,1
4,GO MUSCLE CELL FATE COMMITMENT,0.052482,0.20501,0.21027,1,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0047188,0.20499,0.22943,1,1
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.024086,0.20499,0.17977,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0036751,0.20494,0.26311,1,1
4,GO ICOSANOID METABOLIC PROCESS,0.014457,0.20492,0.20647,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.010101,0.20484,0.23214,1,1
4,GO MYOFIBRIL ASSEMBLY,0.00076864,0.20474,0.27351,1,1
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0054671,0.20457,0.27492,1,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.021265,0.20456,0.21296,1,1
4,GO SOMITOGENESIS,0.0066311,0.20454,0.22531,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.0012071,0.20454,0.3794,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0011418,0.20436,0.2519,1,1
4,GO PROTEIN DEMETHYLATION,0.0060238,0.20434,0.32723,1,1
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0060238,0.20415,0.27743,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0096484,0.2041,0.242,1,1
4,GO GLIAL CELL DEVELOPMENT,0.0010798,0.20404,0.24819,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.0010209,0.204,0.23241,1,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0020776,0.20399,0.26,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00033648,0.20373,0.31986,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.018736,0.20366,0.22963,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.056456,0.20343,0.1878,1,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0036751,0.20339,0.2823,1,1
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.00028019,0.20334,0.21308,1,1
4,GO SECRETION,0.0021907,0.20323,0.21904,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.006955,0.20316,0.2126,1,1
4,GO REGULATION OF LIPID STORAGE,0.01266,0.20315,0.23806,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.0054671,0.20308,0.21185,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00035748,0.20294,0.23877,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.00024771,0.2029,0.29233,1,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0054671,0.20286,0.25039,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0024341,0.20283,0.2378,1,1
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0011418,0.20279,0.33956,1,1
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00081392,0.20279,0.25419,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.0025648,0.20276,0.25007,1,1
4,GO MUSCLE CONTRACTION,0.0014241,0.20268,0.25177,1,1
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.013834,0.20263,0.22728,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0010798,0.20262,0.28419,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0024341,0.20248,0.27031,1,1
4,GO FORMATION OF PRIMARY GERM LAYER,0.0049572,0.20231,0.26981,1,1
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.00091199,0.20228,0.26059,1,1
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.010101,0.20226,0.22633,1,1
4,GO PEPTIDE CATABOLIC PROCESS,0.006955,0.20212,0.24895,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.008797,0.202,0.2432,1,1
4,GO RECEPTOR INTERNALIZATION,0.010572,0.20188,0.22198,1,1
4,GO RESPONSE TO MONOSACCHARIDE,4.5779e-05,0.2018,0.26717,1,1
4,GO MIRNA METABOLIC PROCESS,0.00332,0.20175,0.24519,1,1
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0014241,0.2017,0.20375,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00086166,0.20161,0.22963,1,1
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0021907,0.20159,0.28335,1,1
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0012758,0.20153,0.23929,1,1
4,GO ADAPTIVE THERMOGENESIS,0.0016767,0.20148,0.21367,1,1
4,GO CELLULAR RESPONSE TO SALT STRESS,0.011574,0.20147,0.22445,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0034935,0.20132,0.22906,1,1
4,GO EMBRYO IMPLANTATION,0.012106,0.2013,0.26129,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0044907,0.20128,0.20248,1,1
4,GO OOGENESIS,0.008797,0.20125,0.1845,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00051151,0.20114,0.29797,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00332,0.20108,0.27417,1,1
4,GO MUSCLE CELL DIFFERENTIATION,0.00081392,0.20083,0.24923,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0010798,0.20074,0.25505,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.031957,0.20066,0.21175,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0066311,0.20057,0.22066,1,1
4,GO ADAPTATION OF SIGNALING PATHWAY,0.041938,0.20044,0.26209,1,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.0025648,0.20034,0.27901,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.0023095,0.20029,0.23696,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0057394,0.20026,0.20658,1,1
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.048745,0.20022,0.17106,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.0060238,0.20004,0.19735,1,1
4,GO RESPONSE TO HORMONE,0.0027019,0.2,0.20776,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0019699,0.19986,0.21606,1,1
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0023095,0.19978,0.21724,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.006955,0.19967,0.26299,1,1
4,GO INTESTINAL ABSORPTION,0.043559,0.19966,0.23333,1,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.014457,0.19961,0.27657,1,1
4,GO EXOCYTOSIS,0.0080134,0.19956,0.21362,1,1
4,GO REGULATION OF GTPASE ACTIVITY,0.0040644,0.19947,0.24942,1,1
4,GO MAINTENANCE OF LOCATION,0.0047188,0.19944,0.21396,1,1
4,GO OVULATION CYCLE,0.016475,0.19939,0.24873,1,1
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0015041,0.19937,0.28154,1,1
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0060238,0.19933,0.22949,1,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0049572,0.19931,0.27449,1,1
4,GO DICARBOXYLIC ACID TRANSPORT,0.00081392,0.1993,0.25857,1,1
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.021265,0.19919,0.2039,1,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00064645,0.19914,0.27303,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00010181,0.19908,0.29882,1,1
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0019699,0.19899,0.23579,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.01266,0.19895,0.22394,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.040368,0.19893,0.20581,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.038848,0.19888,0.19699,1,1
4,GO RESPONSE TO WOUNDING,0.0080134,0.19885,0.24305,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00057531,0.19862,0.24572,1,1
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0027019,0.19842,0.27218,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.0063209,0.19833,0.25875,1,1
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.013235,0.19832,0.23083,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.014457,0.19831,0.22624,1,1
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.007293,0.19822,0.23347,1,1
4,GO RESPONSE TO CARBOHYDRATE,6.4139e-05,0.19819,0.25292,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0024341,0.19816,0.35063,1,1
4,GO HISTONE H4 DEACETYLATION,0.0172,0.19809,0.17866,1,1
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.0025648,0.19808,0.27768,1,1
4,GO MEMBRANE DOCKING,0.0042727,0.19802,0.22649,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.013834,0.19764,0.26012,1,1
4,GO FACE DEVELOPMENT,0.0063209,0.19746,0.28597,1,1
4,GO KERATINIZATION,0.021265,0.19738,0.17104,1,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.0011418,0.19722,0.22767,1,1
4,GO RESPONSE TO CALCIUM ION,0.00048214,0.1972,0.28786,1,1
4,GO MATERNAL PLACENTA DEVELOPMENT,0.025096,0.19711,0.22862,1,1
4,GO STRESS FIBER ASSEMBLY,0.0011418,0.19708,0.27148,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0025648,0.19691,0.33462,1,1
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0080134,0.19687,0.27151,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0021907,0.19675,0.28808,1,1
4,GO NEURAL CREST CELL DIFFERENTIATION,0.035953,0.19674,0.19478,1,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0052065,0.19674,0.23363,1,1
4,GO SHORT TERM MEMORY,0.035953,0.19669,0.27604,1,1
4,GO OSTEOBLAST PROLIFERATION,0.058535,0.19667,0.20904,1,1
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.0015882,0.19658,0.23169,1,1
4,GO TISSUE REGENERATION,0.0080134,0.19653,0.21214,1,1
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.0021907,0.19651,0.22481,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0027019,0.19644,0.22245,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0096484,0.19643,0.20582,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00064645,0.19637,0.26265,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.012106,0.1963,0.1929,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.012106,0.19612,0.20477,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.014457,0.19609,0.20627,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0015882,0.19606,0.22587,1,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.015776,0.196,0.26472,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.0057394,0.19591,0.31937,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00064645,0.19583,0.26764,1,1
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.00332,0.19578,0.25799,1,1
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0012071,0.19578,0.26338,1,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.035953,0.19547,0.22019,1,1
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0029965,0.1953,0.26036,1,1
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.011063,0.19524,0.1952,1,1
4,GO REGULATION OF TOR SIGNALING,0.00091199,0.1952,0.23475,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.0020776,0.19511,0.23391,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.01266,0.19509,0.23767,1,1
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0042727,0.19506,0.2585,1,1
4,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0063209,0.19506,0.20845,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0025648,0.19506,0.30374,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.011574,0.19498,0.22438,1,1
4,GO MUSCLE SYSTEM PROCESS,0.0017696,0.19496,0.23964,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0096484,0.19494,0.21121,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0042727,0.19494,0.24258,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00024771,0.19494,0.24887,1,1
4,GO FILOPODIUM ASSEMBLY,0.017954,0.19479,0.21616,1,1
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0029965,0.19477,0.27371,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0014241,0.19469,0.228,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.0010209,0.19462,0.21109,1,1
4,GO CARDIAC MUSCLE CONTRACTION,0.0047188,0.19442,0.26681,1,1
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0096484,0.19435,0.26507,1,1
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.010101,0.19419,0.3156,1,1
4,GO REGULATION OF CELLULAR PH,0.00057531,0.19417,0.22835,1,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0021907,0.19407,0.26643,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.00054254,0.19392,0.26603,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.007293,0.1939,0.25729,1,1
4,GO POST EMBRYONIC DEVELOPMENT,0.00096503,0.19385,0.26541,1,1
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0036751,0.19371,0.21714,1,1
4,GO SPINAL CORD DEVELOPMENT,0.012106,0.19364,0.23907,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.013235,0.19354,0.302,1,1
4,GO LIPID DROPLET ORGANIZATION,0.0010209,0.19344,0.21561,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00057531,0.19341,0.28754,1,1
4,GO NEURON DEATH,0.0019699,0.19341,0.21765,1,1
4,GO GROWTH,0.00057531,0.19306,0.22593,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.033245,0.19292,0.22055,1,1
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.023112,0.19281,0.21774,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0018673,0.19276,0.25028,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0047188,0.19269,0.29266,1,1
4,GO LIPID CATABOLIC PROCESS,0.0019699,0.19265,0.19981,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.0027019,0.19262,0.25488,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0044907,0.19262,0.24857,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.017954,0.19257,0.19298,1,1
4,GO ZYMOGEN ACTIVATION,0.050584,0.19253,0.1987,1,1
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0014241,0.19245,0.22351,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00091199,0.19242,0.26412,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.00096503,0.19209,0.21247,1,1
4,GO HISTONE H3 K9 ACETYLATION,0.010572,0.192,0.21516,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.014457,0.19191,0.2561,1,1
4,GO HEART DEVELOPMENT,0.0020776,0.19184,0.23638,1,1
4,GO REGULATION OF PROTEIN BINDING,0.00045436,0.19167,0.23903,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.035953,0.19155,0.21799,1,1
4,GO NADH METABOLIC PROCESS,0.0014241,0.19147,0.22628,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0015882,0.19142,0.21248,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00072571,0.19138,0.22861,1,1
4,GO DETECTION OF LIGHT STIMULUS,0.00024771,0.1913,0.20635,1,1
4,GO AMYLOID FIBRIL FORMATION,0.056456,0.1912,0.20807,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.0063209,0.19115,0.19504,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00014989,0.19114,0.26563,1,1
4,GO SEGMENTATION,0.014457,0.19092,0.19429,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0057394,0.19091,0.25868,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0031545,0.1908,0.24713,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0047188,0.19073,0.23763,1,1
4,GO MIDGUT DEVELOPMENT,0.025096,0.19068,0.29259,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00332,0.19054,0.3025,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0019699,0.19051,0.2472,1,1
4,GO MUSCLE HYPERTROPHY,0.00064645,0.19048,0.25742,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.0172,0.19046,0.17885,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.014457,0.19045,0.21009,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.052482,0.19025,0.17056,1,1
4,GO REGULATION OF CILIUM MOVEMENT,0.025096,0.19022,0.19711,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.011063,0.19012,0.25192,1,1
4,GO FEEDING BEHAVIOR,0.0080134,0.1901,0.20279,1,1
4,GO RESPONSE TO ESTRADIOL,0.0057394,0.19009,0.19947,1,1
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0076456,0.1899,0.26944,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0023095,0.18985,0.23522,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.00035748,0.18983,0.2554,1,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0057394,0.1898,0.25923,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036751,0.1898,0.2088,1,1
4,GO LIPID MODIFICATION,0.0015882,0.18956,0.23425,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.0096484,0.18937,0.1971,1,1
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0012758,0.18931,0.23021,1,1
4,GO MITOCHONDRION LOCALIZATION,0.013235,0.1893,0.23692,1,1
4,GO ORGANIC ACID TRANSPORT,0.00081392,0.18927,0.21975,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0015041,0.1889,0.24238,1,1
4,GO PROTEIN PROCESSING,0.0023095,0.18889,0.2176,1,1
4,GO HOMEOSTATIC PROCESS,0.0016767,0.18879,0.20243,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00023283,0.18875,0.29472,1,1
4,GO ACTIN FILAMENT BASED MOVEMENT,0.0040644,0.18874,0.25546,1,1
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0076456,0.1887,0.23918,1,1
4,GO NEURAL CREST CELL MIGRATION,0.019548,0.18849,0.23145,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0024341,0.18848,0.25332,1,1
4,GO REGULATION OF GROWTH,0.00033648,0.18846,0.2259,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0052065,0.18839,0.20428,1,1
4,GO MUSCLE ORGAN MORPHOGENESIS,0.007293,0.18834,0.24359,1,1
4,GO COBALAMIN METABOLIC PROCESS,0.0092139,0.1883,0.2066,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0044907,0.18827,0.28813,1,1
4,GO REGULATION OF PROTEIN FOLDING,0.0054671,0.18822,0.20336,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0076456,0.18817,0.22393,1,1
4,GO CELL MOTILITY,0.0047188,0.18809,0.23377,1,1
4,GO CELLULAR HOMEOSTASIS,0.0024341,0.188,0.20139,1,1
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.043559,0.18787,0.21516,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.0018673,0.18777,0.22155,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0076456,0.18775,0.21121,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.025096,0.18766,0.20358,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00091199,0.18748,0.23539,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00086166,0.18745,0.27101,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00332,0.18738,0.22421,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.00054254,0.18738,0.29775,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0017696,0.18737,0.2549,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0025648,0.18736,0.23258,1,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0034935,0.18734,0.25873,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.0029965,0.18727,0.3174,1,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0042727,0.18727,0.22382,1,1
4,GO MUSCLE ORGAN DEVELOPMENT,0.0040644,0.18709,0.20988,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0049572,0.18701,0.28438,1,1
4,GO MELANOCYTE DIFFERENTIATION,0.02951,0.18697,0.20553,1,1
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.018736,0.18693,0.24412,1,1
4,GO ENSHEATHMENT OF NEURONS,0.0029965,0.1869,0.22206,1,1
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.023112,0.18661,0.19679,1,1
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.035953,0.18642,0.25486,1,1
4,GO RECEPTOR METABOLIC PROCESS,0.0049572,0.1864,0.2184,1,1
4,GO BONE REMODELING,0.025096,0.18632,0.26247,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.041938,0.18629,0.17539,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,8.3641e-05,0.18621,0.23642,1,1
4,GO NEPHRON DEVELOPMENT,0.008797,0.18609,0.24738,1,1
4,GO RESPONSE TO GROWTH FACTOR,0.0010798,0.18609,0.24368,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0172,0.18602,0.23446,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.007293,0.18599,0.18936,1,1
4,GO RESPONSE TO PH,0.0012758,0.18594,0.32915,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.02951,0.18583,0.13694,1,1
4,GO TISSUE REMODELING,0.015104,0.1858,0.27536,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00076864,0.1858,0.26741,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.060677,0.18574,0.21209,1,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00031664,0.18561,0.26854,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.00096503,0.18552,0.21134,1,1
4,GO ENDOCARDIUM DEVELOPMENT,0.023112,0.18546,0.19339,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.00054254,0.18516,0.2667,1,1
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0042727,0.18515,0.25221,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0017696,0.18496,0.22426,1,1
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0034935,0.1849,0.34491,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00091199,0.18487,0.25916,1,1
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.0018673,0.18487,0.26457,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.013834,0.18482,0.28033,1,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00076864,0.18478,0.24117,1,1
4,GO VASCULOGENESIS,0.058535,0.18476,0.20685,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.050584,0.18471,0.21216,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0060238,0.18468,0.23446,1,1
4,GO PROTEIN HETEROOLIGOMERIZATION,0.0054671,0.18467,0.23522,1,1
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0017696,0.18463,0.2545,1,1
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0080134,0.18458,0.24138,1,1
4,GO HISTONE DEUBIQUITINATION,0.027226,0.18456,0.22715,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.054439,0.18455,0.20853,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0010798,0.18453,0.23399,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.014457,0.18434,0.18449,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0029965,0.18421,0.22983,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.027226,0.18406,0.20904,1,1
4,GO CELLULAR RESPONSE TO NUTRIENT,0.021265,0.18404,0.23849,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0083971,0.18393,0.25556,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.026142,0.1839,0.20909,1,1
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.045233,0.18386,0.20965,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0092139,0.18377,0.22819,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.024086,0.18376,0.18048,1,1
4,GO KERATINOCYTE PROLIFERATION,0.024086,0.18376,0.20969,1,1
4,GO REGULATION OF APPETITE,0.030713,0.18372,0.26506,1,1
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.00060992,0.18369,0.24342,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.0012071,0.18364,0.32081,1,1
4,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.027226,0.18363,0.21798,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.048745,0.18362,0.19055,1,1
4,GO CHLORIDE TRANSPORT,0.0031545,0.18351,0.2734,1,1
4,GO CELL CELL ADHESION,0.0063209,0.18347,0.25255,1,1
4,GO NEURON APOPTOTIC PROCESS,0.0021907,0.18344,0.21133,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0028457,0.18327,0.20283,1,1
4,GO LIPOPROTEIN LOCALIZATION,0.046961,0.18324,0.21369,1,1
4,GO ACTIN MEDIATED CELL CONTRACTION,0.006955,0.18322,0.24032,1,1
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.0063209,0.18317,0.28074,1,1
4,GO TAXIS,0.0172,0.18316,0.22608,1,1
4,GO POTASSIUM ION HOMEOSTASIS,0.0044907,0.1831,0.25578,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0011418,0.18301,0.26279,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00045436,0.18297,0.21799,1,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0031545,0.18279,0.22387,1,1
4,GO STEROL TRANSPORT,0.0066311,0.18273,0.23144,1,1
4,GO RESPONSE TO FLUID SHEAR STRESS,0.028348,0.18259,0.23526,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.010572,0.18253,0.20381,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0015041,0.18251,0.20482,1,1
4,GO CRISTAE FORMATION,0.0040644,0.18248,0.20581,1,1
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0054671,0.18242,0.20457,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00014989,0.18235,0.25215,1,1
4,GO REGULATION OF PH,0.00060992,0.18228,0.21975,1,1
4,GO TUBE MORPHOGENESIS,0.016475,0.18227,0.22288,1,1
4,GO RESPONSE TO COLD,0.00091199,0.1821,0.26467,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.00081392,0.18208,0.27528,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.018736,0.18206,0.16971,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0012758,0.18206,0.22859,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0012758,0.18203,0.22346,1,1
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.014457,0.18196,0.25238,1,1
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0038653,0.18195,0.22264,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.012106,0.18194,0.19245,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0038653,0.18192,0.22285,1,1
4,GO OOCYTE DIFFERENTIATION,0.00332,0.18161,0.22389,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.018736,0.18142,0.23445,1,1
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.008797,0.18138,0.17471,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.0011418,0.18138,0.22994,1,1
4,GO GLIAL CELL DIFFERENTIATION,0.00068502,0.18136,0.23545,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0052065,0.18132,0.21839,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.048745,0.18131,0.19614,1,1
4,GO EAR MORPHOGENESIS,0.021265,0.18125,0.1774,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00010866,0.18124,0.25557,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.013235,0.1811,0.22493,1,1
4,GO EPITHELIAL TUBE FORMATION,0.0066311,0.18105,0.21299,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0025648,0.18095,0.20985,1,1
4,GO SYNCYTIUM FORMATION,0.030713,0.1807,0.2436,1,1
4,GO PROTEIN KINASE B SIGNALING,0.013235,0.18064,0.22436,1,1
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.021265,0.18061,0.20124,1,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0011418,0.18028,0.20517,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0010209,0.18027,0.21753,1,1
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0054671,0.18022,0.22261,1,1
4,GO NEURAL TUBE FORMATION,0.0063209,0.1798,0.22548,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00076864,0.17977,0.24043,1,1
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.045233,0.17975,0.20154,1,1
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0044907,0.17966,0.21098,1,1
4,GO LATERAL MESODERM DEVELOPMENT,0.013834,0.17965,0.22113,1,1
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0028457,0.1796,0.31348,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.017954,0.1795,0.20036,1,1
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0052065,0.17947,0.21871,1,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.00072571,0.17939,0.24172,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00076864,0.17938,0.24283,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.0044907,0.17927,0.22164,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.014457,0.17925,0.18099,1,1
4,GO REGULATION OF LIPASE ACTIVITY,0.056456,0.17916,0.1773,1,1
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.011063,0.17914,0.20011,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,0.0083971,0.17907,0.17635,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.020391,0.1788,0.21224,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.007293,0.17871,0.1908,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00020554,0.17863,0.25293,1,1
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.015776,0.17855,0.26271,1,1
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0040644,0.17848,0.22717,1,1
4,GO CARBOHYDRATE PHOSPHORYLATION,0.0010798,0.17846,0.25064,1,1
4,GO RESPONSE TO PEPTIDE,0.0015882,0.17844,0.21218,1,1
4,GO TISSUE HOMEOSTASIS,0.0044907,0.17841,0.22682,1,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0060238,0.17833,0.23195,1,1
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.027226,0.17829,0.23505,1,1
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.015776,0.17828,0.24446,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0020776,0.1782,0.25222,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.010572,0.17794,0.19911,1,1
4,GO HEART VALVE FORMATION,0.050584,0.17791,0.23396,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.00010181,0.17768,0.30371,1,1
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.018736,0.17768,0.18848,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00072571,0.17762,0.23306,1,1
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.01266,0.17749,0.20054,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0016767,0.17746,0.31117,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0023095,0.17742,0.21784,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0060238,0.17734,0.21362,1,1
4,GO CELL CELL SIGNALING BY WNT,0.00091199,0.1772,0.22116,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00021879,0.17709,0.21519,1,1
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0019699,0.17694,0.35205,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.020391,0.17689,0.21699,1,1
4,GO CYTOSKELETON ORGANIZATION,0.0027019,0.17686,0.22963,1,1
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00076864,0.17675,0.27887,1,1
4,GO HORMONE METABOLIC PROCESS,0.0020776,0.17668,0.19553,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0057394,0.17664,0.18476,1,1
4,GO PHAGOSOME ACIDIFICATION,0.00018128,0.17663,0.23143,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0012758,0.17656,0.23539,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0049572,0.17648,0.21983,1,1
4,GO RESPONSE TO STEROID HORMONE,0.010101,0.17639,0.19523,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.0172,0.17633,0.23238,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0015041,0.17631,0.20495,1,1
4,GO LYSOSOMAL TRANSPORT,0.0017696,0.17625,0.28457,1,1
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0076456,0.17624,0.21035,1,1
4,GO RESPONSE TO ALKALOID,0.0025648,0.17624,0.21253,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0092139,0.1762,0.25234,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00072571,0.17609,0.22809,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00033648,0.17606,0.27677,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.035953,0.17603,0.194,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.0027019,0.17602,0.25456,1,1
4,GO NON MOTILE CILIUM ASSEMBLY,0.030713,0.17584,0.1894,1,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0172,0.17583,0.34335,1,1
4,GO CIRCADIAN RHYTHM,0.0024341,0.17574,0.19776,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0015882,0.17566,0.24686,1,1
4,GO HEPARIN METABOLIC PROCESS,0.043559,0.17566,0.27534,1,1
4,GO DETECTION OF STIMULUS,0.00010866,0.17561,0.20262,1,1
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.052482,0.17557,0.20542,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0057394,0.17554,0.25555,1,1
4,GO PHOTOPERIODISM,0.0010798,0.17537,0.22242,1,1
4,GO VASCULATURE DEVELOPMENT,0.020391,0.17535,0.22777,1,1
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0076456,0.17533,0.20951,1,1
4,GO VITAMIN TRANSPORT,0.0036751,0.17528,0.21143,1,1
4,GO MACROMOLECULE DEACYLATION,0.0013481,0.17509,0.24698,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.043559,0.17505,0.17961,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0092139,0.17501,0.1752,1,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.0038653,0.17496,0.21825,1,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0044907,0.17494,0.24134,1,1
4,GO BLOOD VESSEL MORPHOGENESIS,0.024086,0.17489,0.22493,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,0.0029965,0.17479,0.20567,1,1
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.026142,0.17479,0.1899,1,1
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.031957,0.17477,0.26859,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.018736,0.17459,0.20559,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.0038653,0.17457,0.31316,1,1
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.023112,0.17455,0.21824,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0080134,0.17452,0.22899,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.006955,0.1745,0.21607,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,7.8298e-05,0.17447,0.24752,1,1
4,GO MEMBRANE FUSION,0.00072571,0.17441,0.25107,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.0016767,0.17439,0.27668,1,1
4,GO ORGANELLE LOCALIZATION,0.0029965,0.17439,0.20712,1,1
4,GO AXIS SPECIFICATION,0.0066311,0.17425,0.1852,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00091199,0.17399,0.21573,1,1
4,GO PHOTOTRANSDUCTION,0.00024771,0.17396,0.18242,1,1
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0038653,0.1738,0.22785,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0011418,0.17378,0.20478,1,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.034576,0.17378,0.14123,1,1
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.048745,0.17369,0.17311,1,1
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.020391,0.17363,0.19559,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020776,0.17361,0.26479,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.011063,0.17358,0.22277,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.014457,0.1734,0.23565,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0015882,0.17334,0.2175,1,1
4,GO INORGANIC ANION TRANSPORT,0.0013481,0.17333,0.25109,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0080134,0.17316,0.22754,1,1
4,GO LIPID OXIDATION,0.0027019,0.17299,0.21147,1,1
4,GO CORONARY VASCULATURE DEVELOPMENT,0.006955,0.17298,0.26509,1,1
4,GO RNA DESTABILIZATION,0.013834,0.17294,0.24959,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0018673,0.17286,0.22701,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0044907,0.17284,0.22638,1,1
4,GO LAMELLIPODIUM ASSEMBLY,0.033245,0.17273,0.19141,1,1
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0034935,0.1727,0.27972,1,1
4,GO PROTEIN MATURATION,0.0017696,0.17267,0.18685,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0020776,0.17251,0.2489,1,1
4,GO ECTODERM DEVELOPMENT,0.02951,0.17243,0.17435,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.023112,0.17232,0.202,1,1
4,GO UV DAMAGE EXCISION REPAIR,0.030713,0.17232,0.21417,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00023283,0.17231,0.23786,1,1
4,GO TOR SIGNALING,0.00081392,0.17214,0.22166,1,1
4,GO CELL CELL RECOGNITION,0.040368,0.17184,0.14595,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0017696,0.17183,0.22693,1,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0028457,0.17182,0.25368,1,1
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0057394,0.17173,0.2445,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00091199,0.17145,0.20309,1,1
4,GO MIDBRAIN DEVELOPMENT,0.0015041,0.17138,0.18074,1,1
4,GO CARDIOCYTE DIFFERENTIATION,0.0023095,0.17125,0.23976,1,1
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.0076456,0.17124,0.24362,1,1
4,GO HISTONE DEACETYLATION,0.00332,0.17117,0.2485,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.038848,0.17112,0.19117,1,1
4,GO SELECTIVE AUTOPHAGY,0.0017696,0.17103,0.24772,1,1
4,GO PIGMENT CELL DIFFERENTIATION,0.013834,0.17074,0.21599,1,1
4,GO RESPONSE TO METAL ION,0.00033648,0.1707,0.21755,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.011063,0.17067,0.20287,1,1
4,GO MEMBRANE ORGANIZATION,0.0010209,0.17066,0.2196,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0044907,0.17063,0.27731,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,0.0034935,0.1706,0.26904,1,1
4,GO INNER EAR MORPHOGENESIS,0.025096,0.17043,0.1859,1,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0025648,0.1704,0.22657,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00081392,0.17028,0.23806,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00086166,0.17028,0.22496,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.00064645,0.17013,0.20574,1,1
4,GO GASTRULATION,0.0031545,0.17004,0.24822,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.018736,0.16996,0.17239,1,1
4,GO HISTONE H3 ACETYLATION,0.0172,0.16975,0.18449,1,1
4,GO MUSCLE ADAPTATION,0.0016767,0.16963,0.23636,1,1
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.010572,0.16958,0.2631,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0023095,0.16946,0.19412,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0038653,0.16942,0.2337,1,1
4,GO VACUOLAR TRANSPORT,0.00068502,0.16941,0.26499,1,1
4,GO ALDEHYDE CATABOLIC PROCESS,0.0023095,0.1694,0.1893,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0040644,0.16931,0.23539,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.0076456,0.16922,0.18088,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0096484,0.16911,0.19793,1,1
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.010572,0.16908,0.18881,1,1
4,GO EXCRETION,0.008797,0.16906,0.2414,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.035953,0.16902,0.21628,1,1
4,GO HISTONE METHYLATION,0.0063209,0.16897,0.24168,1,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0057394,0.16884,0.19538,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0012071,0.16866,0.22482,1,1
4,GO ORGANIC ANION TRANSPORT,0.00091199,0.16858,0.21271,1,1
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.045233,0.16853,0.20556,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.019548,0.16824,0.18069,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.0047188,0.16815,0.21981,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.056456,0.16814,0.218,1,1
4,GO REGULATION OF CELL DIFFERENTIATION,0.00332,0.16807,0.21711,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0038653,0.16796,0.187,1,1
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0096484,0.16796,0.20732,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0014241,0.16784,0.22078,1,1
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.0025648,0.16783,0.20851,1,1
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0092139,0.16779,0.18189,1,1
4,GO REGULATION OF MAPK CASCADE,0.0092139,0.16773,0.21849,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00064645,0.16772,0.22603,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.056456,0.1676,0.20065,1,1
4,GO TUBE DEVELOPMENT,0.0080134,0.16757,0.22542,1,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0060238,0.16749,0.19682,1,1
4,GO PEPTIDYL ARGININE MODIFICATION,0.018736,0.16747,0.13318,1,1
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0060238,0.16743,0.18909,1,1
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.01266,0.16725,0.21483,1,1
4,GO TOOTH MINERALIZATION,0.0052065,0.1672,0.34895,1,1
4,GO RESPONSE TO WATER,0.011063,0.16719,0.21344,1,1
4,GO VESICLE LOCALIZATION,0.00054254,0.16715,0.26697,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.033245,0.16714,0.20055,1,1
4,GO PEPTIDYL SERINE MODIFICATION,0.0019699,0.16709,0.23623,1,1
4,GO VESICLE DOCKING,0.00028019,0.16703,0.31834,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.013235,0.16695,0.19727,1,1
4,GO CANONICAL WNT SIGNALING PATHWAY,0.0015882,0.16685,0.21869,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00091199,0.16685,0.21397,1,1
4,GO NEGATIVE REGULATION OF GROWTH,0.0010209,0.16672,0.21631,1,1
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0015041,0.16665,0.24444,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.045233,0.16659,0.16984,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.011063,0.16655,0.16481,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.0025648,0.16642,0.20557,1,1
4,GO CLATHRIN COAT ASSEMBLY,0.012106,0.16638,0.2896,1,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.0031545,0.16638,0.22125,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00040321,0.16629,0.19816,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0021907,0.16624,0.20998,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.033245,0.16622,0.24793,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0044907,0.16622,0.22053,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.010572,0.16606,0.16425,1,1
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.017954,0.16602,0.23303,1,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.021265,0.16593,0.2242,1,1
4,GO NECROTIC CELL DEATH,0.038848,0.16592,0.16422,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.0031545,0.16592,0.2212,1,1
4,GO ANION TRANSPORT,0.00064645,0.16583,0.22985,1,1
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.013834,0.16569,0.23796,1,1
4,GO ACTIN NUCLEATION,0.0034935,0.16563,0.20712,1,1
4,GO PROTEIN POLYMERIZATION,0.00081392,0.16552,0.23566,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00076864,0.16543,0.22733,1,1
4,GO ERBB SIGNALING PATHWAY,0.0096484,0.16541,0.2166,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.027226,0.16541,0.16044,1,1
4,GO IRON ION TRANSPORT,0.00064645,0.16538,0.21725,1,1
4,GO FAT CELL DIFFERENTIATION,0.0063209,0.16531,0.20919,1,1
4,GO ERBB2 SIGNALING PATHWAY,0.0049572,0.16527,0.24392,1,1
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0080134,0.16525,0.26538,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0023095,0.1651,0.30139,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.017954,0.16506,0.21462,1,1
4,GO RESPONSE TO CAMP,0.007293,0.16495,0.20095,1,1
4,GO LIPID HOMEOSTASIS,0.011574,0.16475,0.18478,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0083971,0.16466,0.21635,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00057531,0.16464,0.18852,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.013235,0.16456,0.21548,1,1
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.022172,0.16455,0.18143,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0018673,0.16443,0.23034,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.008797,0.16441,0.20078,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.010572,0.16429,0.20945,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.0017696,0.16414,0.21834,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.0047188,0.16409,0.19934,1,1
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0096484,0.16404,0.20267,1,1
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.014457,0.16402,0.1877,1,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.026142,0.16399,0.21657,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.01266,0.16394,0.20354,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00096503,0.16385,0.21643,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0092139,0.16379,0.23698,1,1
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0040644,0.16369,0.26864,1,1
4,GO OXIDATIVE DEMETHYLATION,0.017954,0.16356,0.23279,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.0018673,0.16335,0.24542,1,1
4,GO OSSIFICATION,0.0057394,0.16334,0.22061,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.010572,0.16327,0.18808,1,1
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0047188,0.16308,0.20399,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0040644,0.16303,0.24593,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.046961,0.16291,0.18486,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0011418,0.16285,0.26527,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.026142,0.16284,0.19621,1,1
4,GO CELL RECOGNITION,0.013235,0.16265,0.20446,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0092139,0.16258,0.26936,1,1
4,GO MUSCLE TISSUE DEVELOPMENT,0.0052065,0.16252,0.20924,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.0080134,0.16248,0.20943,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0096484,0.16242,0.30572,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00076864,0.16242,0.21007,1,1
4,GO RHYTHMIC PROCESS,0.0042727,0.16219,0.20187,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0096484,0.16212,0.21377,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.006955,0.162,0.2112,1,1
4,GO ENDOCRINE PROCESS,0.050584,0.16198,0.1655,1,1
4,GO AMINO SUGAR METABOLIC PROCESS,0.060677,0.16182,0.15693,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0172,0.16178,0.2129,1,1
4,GO ORGANELLE FUSION,0.0012758,0.16169,0.24355,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0080134,0.16145,0.20804,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028457,0.16136,0.22394,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0096484,0.16116,0.22602,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.045233,0.16101,0.18457,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0044907,0.16081,0.21104,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0031545,0.16077,0.20153,1,1
4,GO DNA DEALKYLATION,0.0040644,0.16069,0.17873,1,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.0010798,0.16058,0.19679,1,1
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.034576,0.16046,0.18975,1,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.027226,0.16045,0.20306,1,1
4,GO GASTRIC ACID SECRETION,0.040368,0.16045,0.1464,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.025096,0.16041,0.15741,1,1
4,GO EMBRYO DEVELOPMENT,0.0066311,0.16038,0.19905,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.016475,0.16026,0.2015,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.015104,0.16021,0.19571,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.041938,0.1602,0.19024,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0031545,0.16018,0.22396,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0025648,0.16013,0.20734,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0015882,0.16008,0.22662,1,1
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.052482,0.16003,0.16126,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0044907,0.15989,0.18893,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.013834,0.15984,0.20432,1,1
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.018736,0.15984,0.2777,1,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.0172,0.15979,0.22402,1,1
4,GO ERYTHROCYTE DEVELOPMENT,0.025096,0.15957,0.21077,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008797,0.15944,0.26263,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.017954,0.15933,0.17615,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00091199,0.15927,0.20009,1,1
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.030713,0.15912,0.19429,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.046961,0.1591,0.18957,1,1
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.050584,0.15908,0.13372,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.0038653,0.15901,0.24342,1,1
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.018736,0.159,0.17304,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.026142,0.1589,0.20463,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0036751,0.15887,0.19972,1,1
4,GO P38MAPK CASCADE,0.045233,0.15882,0.21248,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0044907,0.15873,0.18894,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00096503,0.15871,0.23109,1,1
4,GO STEROL METABOLIC PROCESS,0.0057394,0.15868,0.1906,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0042727,0.15846,0.23048,1,1
4,GO SENSORY PERCEPTION OF PAIN,0.013834,0.15838,0.20213,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0013481,0.15836,0.20692,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0038653,0.15835,0.19695,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0012071,0.15829,0.22312,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0052065,0.15826,0.18724,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.026142,0.15815,0.20977,1,1
4,GO ORGAN GROWTH,0.0031545,0.15786,0.2248,1,1
4,GO CARNITINE SHUTTLE,0.0096484,0.15782,0.25232,1,1
4,GO RESPONSE TO ALCOHOL,0.0083971,0.15781,0.19623,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0060238,0.15773,0.20246,1,1
4,GO RESPONSE TO ACIDIC PH,0.011063,0.15771,0.31503,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0040644,0.15768,0.24468,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0080134,0.15753,0.20476,1,1
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.054439,0.15736,0.18389,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0012071,0.15729,0.20498,1,1
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0057394,0.15724,0.20453,1,1
4,GO CELLULAR PIGMENTATION,0.0029965,0.15721,0.22171,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0063209,0.15716,0.18206,1,1
4,GO POLYOL METABOLIC PROCESS,0.00048214,0.15696,0.2334,1,1
4,GO PROTEIN HOMOTETRAMERIZATION,0.013834,0.15683,0.17946,1,1
4,GO REGULATION OF HISTONE MODIFICATION,0.0020776,0.15671,0.22046,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.0025648,0.15668,0.18391,1,1
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.035953,0.15663,0.18931,1,1
4,GO COPII COATED VESICLE BUDDING,0.0038653,0.1566,0.20942,1,1
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0038653,0.1566,0.18705,1,1
4,GO RESPONSE TO MANGANESE ION,0.027226,0.15645,0.18043,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.01266,0.15643,0.21461,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00054254,0.15642,0.24874,1,1
4,GO RESPONSE TO INSULIN,0.0010209,0.15641,0.20898,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0034935,0.15637,0.19181,1,1
4,GO TISSUE MORPHOGENESIS,0.0042727,0.15628,0.21002,1,1
4,GO REGULATION OF PROTEIN ACETYLATION,0.0063209,0.15627,0.19414,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0003797,0.1562,0.24215,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.007293,0.15617,0.21361,1,1
4,GO GLYCOSYLATION,0.0016767,0.15612,0.21753,1,1
4,GO MUSCLE CELL PROLIFERATION,0.043559,0.15608,0.18487,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00054254,0.15598,0.19281,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0040644,0.15572,0.19593,1,1
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.015104,0.15558,0.22567,1,1
4,GO HAIR FOLLICLE MATURATION,0.020391,0.15558,0.23154,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.035953,0.15548,0.21116,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0080134,0.15546,0.18173,1,1
4,GO LIPID STORAGE,0.0092139,0.1554,0.21755,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0034935,0.15538,0.19853,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0016767,0.15537,0.20854,1,1
4,GO PROTEIN ACYLATION,0.0063209,0.15534,0.20702,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.021265,0.15524,0.17447,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0040644,0.1552,0.2037,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.00072571,0.15515,0.19825,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00332,0.15496,0.20718,1,1
4,GO EAR DEVELOPMENT,0.015776,0.15475,0.18164,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00332,0.15474,0.20425,1,1
4,GO DEMETHYLATION,0.0011418,0.15469,0.26391,1,1
4,GO EMBRYONIC MORPHOGENESIS,0.011063,0.15463,0.20479,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00332,0.15446,0.19355,1,1
4,GO DIENCEPHALON DEVELOPMENT,0.0060238,0.15432,0.23256,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0057394,0.15416,0.2023,1,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.027226,0.15401,0.16246,1,1
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0057394,0.15388,0.17374,1,1
4,GO BODY FLUID SECRETION,0.0052065,0.15379,0.19425,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0023095,0.15373,0.21786,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.015776,0.15366,0.2027,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0063209,0.15365,0.18438,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0014241,0.15353,0.21397,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.034576,0.15347,0.19933,1,1
4,GO ZINC ION TRANSPORT,0.00086166,0.15336,0.16878,1,1
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.006955,0.15334,0.21911,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0060238,0.1532,0.24948,1,1
4,GO TERPENOID METABOLIC PROCESS,0.056456,0.15312,0.1239,1,1
4,GO RESPONSE TO LIPID,0.026142,0.153,0.17757,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.008797,0.15295,0.23534,1,1
4,GO SPERM CAPACITATION,0.0083971,0.1529,0.22443,1,1
4,GO MESODERM DEVELOPMENT,0.0029965,0.15285,0.19916,1,1
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0044907,0.15284,0.21425,1,1
4,GO GERM CELL DEVELOPMENT,0.0076456,0.15279,0.18759,1,1
4,GO UV PROTECTION,0.040368,0.15276,0.19501,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0076456,0.15261,0.20084,1,1
4,GO PROTEIN METHYLATION,0.01266,0.15252,0.21086,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.010572,0.15245,0.24437,1,1
4,GO GLUCOSE METABOLIC PROCESS,0.00060992,0.15238,0.21124,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0066311,0.15228,0.18496,1,1
4,GO EMBRYONIC EYE MORPHOGENESIS,0.010101,0.15222,0.26393,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0012071,0.15199,0.22475,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0014241,0.15193,0.21138,1,1
4,GO ERAD PATHWAY,0.0044907,0.15179,0.20997,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.0092139,0.15174,0.20143,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.024086,0.15165,0.25313,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.041938,0.15162,0.11983,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0054671,0.15158,0.20403,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.02951,0.15158,0.16518,1,1
4,GO DNA DEMETHYLATION,0.011574,0.15154,0.1741,1,1
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.012106,0.15152,0.22538,1,1
4,GO RETINAL CONE CELL DIFFERENTIATION,0.015776,0.15148,0.18609,1,1
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0047188,0.15147,0.22183,1,1
4,GO SEXUAL REPRODUCTION,0.0063209,0.15144,0.1841,1,1
4,GO RESPIRATORY SYSTEM PROCESS,0.011063,0.15136,0.27227,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00015974,0.15135,0.20741,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00091199,0.15131,0.21317,1,1
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.011063,0.15126,0.19201,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0054671,0.15094,0.19852,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00072571,0.15088,0.22637,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.0083971,0.15068,0.21872,1,1
4,GO TOXIN METABOLIC PROCESS,0.037377,0.15063,0.18813,1,1
4,GO PROTEOLYSIS,0.0010798,0.15032,0.19886,1,1
4,GO TEMPERATURE HOMEOSTASIS,0.0047188,0.1502,0.19331,1,1
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0080134,0.15015,0.22506,1,1
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.021265,0.15013,0.24749,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.0080134,0.15011,0.15989,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0013481,0.14998,0.24287,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.011574,0.14976,0.19173,1,1
4,GO NUCLEAR BODY ORGANIZATION,0.012106,0.14972,0.21897,1,1
4,GO INTERACTION WITH HOST,0.028348,0.14971,0.18081,1,1
4,GO SECRETION BY TISSUE,0.020391,0.14958,0.16769,1,1
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00068502,0.14947,0.26512,1,1
4,GO POSITIVE REGULATION OF RNA SPLICING,0.033245,0.14942,0.16476,1,1
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.022172,0.14938,0.15628,1,1
4,GO LAMELLIPODIUM ORGANIZATION,0.035953,0.14938,0.18186,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00332,0.14917,0.25019,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.015776,0.14901,0.19243,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0012071,0.14894,0.20898,1,1
4,GO REGULATION OF RNA SPLICING,0.054439,0.14888,0.16134,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.02951,0.14885,0.1727,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015776,0.14884,0.2172,1,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.0038653,0.14878,0.20584,1,1
4,GO PROTEIN HYDROXYLATION,0.010101,0.14871,0.22273,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.0023095,0.14851,0.18345,1,1
4,GO HEART GROWTH,0.00332,0.14842,0.21659,1,1
4,GO REGULATION OF DEPHOSPHORYLATION,0.0060238,0.14836,0.21128,1,1
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.016475,0.14829,0.20963,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.0096484,0.14812,0.17838,1,1
4,GO RETINA HOMEOSTASIS,0.0017696,0.14784,0.22764,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0023095,0.14774,0.18041,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00081392,0.14763,0.19451,1,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0019699,0.14754,0.25306,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0016767,0.14751,0.20387,1,1
4,GO VESICLE ORGANIZATION,0.00051151,0.14746,0.23985,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0031545,0.14741,0.16424,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.024086,0.14738,0.17516,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0018673,0.14713,0.20502,1,1
4,GO DEPHOSPHORYLATION,0.0027019,0.14713,0.22431,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.021265,0.14701,0.16448,1,1
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.0076456,0.14689,0.20465,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0027019,0.1467,0.17509,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0015041,0.14665,0.23022,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0040644,0.1466,0.19229,1,1
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0023095,0.14658,0.27749,1,1
4,GO RESPONSE TO DRUG,0.0023095,0.14656,0.19261,1,1
4,GO COVALENT CHROMATIN MODIFICATION,0.019548,0.14648,0.20972,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.0076456,0.14635,0.2258,1,1
4,GO ORGANELLE ASSEMBLY,0.0047188,0.14633,0.19309,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.025096,0.14619,0.14916,1,1
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0023095,0.14583,0.22017,1,1
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0011418,0.14578,0.22409,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.023112,0.14574,0.24321,1,1
4,GO RESPONSE TO NUTRIENT,0.014457,0.14572,0.19215,1,1
4,GO CARNITINE METABOLIC PROCESS,0.0044907,0.14565,0.2448,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.043559,0.14554,0.19385,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.024086,0.14546,0.16961,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00054254,0.14544,0.2174,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.0052065,0.14529,0.20579,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0020776,0.14526,0.19434,1,1
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0063209,0.14515,0.25265,1,1
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0060238,0.14501,0.18933,1,1
4,GO BONE DEVELOPMENT,0.0172,0.14488,0.22781,1,1
4,GO PH REDUCTION,0.0028457,0.14487,0.17679,1,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.007293,0.14483,0.17236,1,1
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.0092139,0.14475,0.19242,1,1
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0076456,0.14457,0.20775,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.008797,0.14453,0.22826,1,1
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0016767,0.14452,0.22371,1,1
4,GO PLACENTA DEVELOPMENT,0.026142,0.14444,0.18079,1,1
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.007293,0.14429,0.20333,1,1
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.052482,0.14424,0.17551,1,1
4,GO VIRAL BUDDING,0.0025648,0.14416,0.16438,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.056456,0.14407,0.14157,1,1
4,GO ENDOTHELIAL CELL PROLIFERATION,0.034576,0.14388,0.19889,1,1
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.01266,0.14379,0.17747,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0066311,0.14377,0.18439,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.0012071,0.14375,0.17846,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.056456,0.14369,0.20685,1,1
4,GO VACUOLE ORGANIZATION,0.00091199,0.14368,0.2352,1,1
4,GO REGULATION OF AUTOPHAGY,0.00068502,0.14362,0.2294,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0076456,0.14359,0.17693,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.025096,0.14359,0.23132,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.0066311,0.14348,0.15645,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00051151,0.14345,0.18366,1,1
4,GO NEGATIVE REGULATION OF BINDING,0.011063,0.14341,0.17449,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0172,0.14317,0.1834,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.00048214,0.14309,0.25977,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0010209,0.14307,0.22725,1,1
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0096484,0.1428,0.17385,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.0025648,0.14273,0.21917,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0031545,0.14271,0.19046,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00068502,0.14269,0.19182,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.0020776,0.14265,0.17517,1,1
4,GO GLIOGENESIS,0.0031545,0.14254,0.22365,1,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.0031545,0.14254,0.19748,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00029789,0.14243,0.20835,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0020776,0.14239,0.18037,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.045233,0.14233,0.17824,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0092139,0.14232,0.16824,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00068502,0.14231,0.2005,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.0038653,0.14219,0.21416,1,1
4,GO GOLGI ORGANIZATION,0.0080134,0.14218,0.23732,1,1
4,GO SPERMATID DIFFERENTIATION,0.013834,0.14217,0.18832,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.0013481,0.14205,0.17463,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0042727,0.14204,0.18468,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0029965,0.14203,0.20515,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0092139,0.142,0.18379,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0063209,0.14192,0.1879,1,1
4,GO PROTEIN ACETYLATION,0.01266,0.14192,0.19473,1,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.019548,0.14182,0.23034,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0092139,0.14166,0.19692,1,1
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.02951,0.14165,0.18827,1,1
4,GO REGULATION OF CELL MATURATION,0.0066311,0.14162,0.1752,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.00332,0.14161,0.1974,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.013834,0.1416,0.25204,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.00064645,0.14159,0.23777,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.007293,0.14135,0.18262,1,1
4,GO REGULATION OF CELL ADHESION,0.041938,0.14118,0.23323,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00086166,0.14112,0.20701,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.022172,0.14101,0.18456,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.0023095,0.14096,0.19753,1,1
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.041938,0.14092,0.18592,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0015882,0.14091,0.21153,1,1
4,GO HISTONE H3 K4 METHYLATION,0.041938,0.14067,0.19779,1,1
4,GO MULTI ORGANISM PROCESS,0.0031545,0.14048,0.18538,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.017954,0.14047,0.18488,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0036751,0.14019,0.1874,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0014241,0.14016,0.18171,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.021265,0.14014,0.1677,1,1
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0080134,0.14012,0.16054,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.056456,0.14006,0.20495,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.00024771,0.1399,0.20737,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0038653,0.13966,0.19816,1,1
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.016475,0.13945,0.17303,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.00091199,0.1394,0.1912,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0019699,0.13937,0.19629,1,1
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.010572,0.13922,0.23075,1,1
4,GO PROTEIN DEPHOSPHORYLATION,0.0027019,0.1392,0.2097,1,1
4,GO PROTEIN TETRAMERIZATION,0.0049572,0.13901,0.18465,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.0025648,0.13891,0.23768,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0047188,0.13874,0.19397,1,1
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.050584,0.13874,0.15126,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00096503,0.13872,0.20237,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0040644,0.13867,0.24833,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.0040644,0.13846,0.17951,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.011574,0.13846,0.15176,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.01266,0.13814,0.20066,1,1
4,GO SARCOMERE ORGANIZATION,0.0083971,0.13812,0.18367,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0083971,0.13802,0.19041,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00060992,0.13797,0.1982,1,1
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0029965,0.13795,0.27987,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.058535,0.1375,0.13824,1,1
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.017954,0.13749,0.19677,1,1
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.011574,0.13741,0.20209,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00064645,0.13715,0.20331,1,1
4,GO LUNG EPITHELIUM DEVELOPMENT,0.015104,0.13705,0.22904,1,1
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0066311,0.1366,0.20176,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,0.00096503,0.13645,0.1955,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00076864,0.13637,0.19178,1,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.038848,0.13635,0.23814,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.015104,0.13634,0.21802,1,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.022172,0.13619,0.21009,1,1
4,GO GOLGI VESICLE BUDDING,0.0054671,0.13611,0.21073,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.0028457,0.13566,0.21998,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0027019,0.13561,0.21691,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00048214,0.13558,0.1788,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0080134,0.13554,0.2194,1,1
4,GO MITOCHONDRION DISTRIBUTION,0.034576,0.13552,0.24178,1,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0040644,0.13535,0.18691,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.058535,0.13521,0.16297,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0013481,0.13521,0.18169,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00051151,0.13495,0.21498,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.019548,0.13485,0.19861,1,1
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.016475,0.13483,0.21476,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0031545,0.13479,0.16146,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00031664,0.13445,0.21118,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.0038653,0.13434,0.185,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,0.13427,0.18535,1,1
4,GO GAMETE GENERATION,0.0096484,0.13423,0.18021,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0018673,0.1342,0.18822,1,1
4,GO RESPONSE TO CAFFEINE,0.023112,0.13419,0.23876,1,1
4,GO VESICLE TARGETING,0.0040644,0.13417,0.2148,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.010572,0.13416,0.16756,1,1
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.058535,0.13403,0.14714,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.010101,0.13395,0.23287,1,1
4,GO INTERMEMBRANE LIPID TRANSFER,0.015104,0.13378,0.20919,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.011063,0.13369,0.20051,1,1
4,GO REGULATION OF GASTRULATION,0.056456,0.13334,0.17815,1,1
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.014457,0.13322,0.18161,1,1
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.008797,0.13305,0.17801,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0023095,0.13277,0.16725,1,1
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.008797,0.13277,0.18131,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0012758,0.13275,0.18916,1,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.043559,0.13266,0.143,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0020776,0.13253,0.18627,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.013834,0.13248,0.15075,1,1
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.031957,0.13246,0.14375,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.054439,0.13241,0.14685,1,1
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.030713,0.13229,0.17885,1,1
4,GO LIPID METABOLIC PROCESS,0.0021907,0.13216,0.19595,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0023095,0.1321,0.16002,1,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0066311,0.132,0.18035,1,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.028348,0.132,0.16362,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0047188,0.13199,0.14526,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.018736,0.13193,0.17072,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0060238,0.13181,0.20159,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0017696,0.13177,0.18258,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0029965,0.13157,0.19167,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION,0.0012071,0.13151,0.17924,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.0052065,0.13146,0.17954,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0029965,0.13125,0.19442,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00017019,0.13122,0.21949,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0052065,0.13112,0.1892,1,1
4,GO RESPONSE TO GROWTH HORMONE,0.014457,0.13104,0.18725,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0047188,0.13072,0.18809,1,1
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.017954,0.1307,0.1575,1,1
4,GO CYTOSOLIC TRANSPORT,0.0011418,0.13069,0.27209,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0021907,0.13061,0.2293,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0047188,0.1306,0.21358,1,1
4,GO SECONDARY METABOLIC PROCESS,0.0013481,0.13016,0.21848,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.020391,0.12999,0.1847,1,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.033245,0.12997,0.28523,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.052482,0.12983,0.13281,1,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.0076456,0.1296,0.17579,1,1
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.013834,0.12954,0.15641,1,1
4,GO VACUOLAR ACIDIFICATION,0.014457,0.12949,0.17451,1,1
4,GO RNA POLYADENYLATION,0.038848,0.12947,0.19443,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00014062,0.12926,0.22721,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0047188,0.12921,0.18502,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.027226,0.1292,0.19482,1,1
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0049572,0.12902,0.19363,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0047188,0.12898,0.20085,1,1
4,GO ORGANELLE DISASSEMBLY,0.00096503,0.12845,0.21443,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.00064645,0.12836,0.18044,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.034576,0.12819,0.25196,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.01266,0.128,0.16697,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.011574,0.12799,0.17234,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0036751,0.12794,0.19233,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00072571,0.12791,0.21832,1,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.015104,0.12775,0.19554,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.034576,0.12746,0.1626,1,1
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.037377,0.12741,0.15452,1,1
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.014457,0.12732,0.1829,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00086166,0.12719,0.21799,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0038653,0.12707,0.19433,1,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0017696,0.12694,0.18919,1,1
4,GO EMBRYONIC PATTERN SPECIFICATION,0.028348,0.1264,0.19753,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.025096,0.12605,0.17691,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.0036751,0.12575,0.22591,1,1
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00081392,0.12563,0.16264,1,1
4,GO CHROMATIN ORGANIZATION,0.030713,0.12557,0.18922,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0172,0.12537,0.22721,1,1
4,GO REPRODUCTION,0.0036751,0.12526,0.18683,1,1
4,GO PIGMENTATION,0.008797,0.12518,0.22087,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0060238,0.12494,0.18042,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0023095,0.12486,0.18834,1,1
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.018736,0.12484,0.12648,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.058535,0.12458,0.12498,1,1
4,GO MESODERM MORPHOGENESIS,0.0049572,0.12456,0.21308,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.00096503,0.1245,0.22273,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.026142,0.12442,0.20389,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.0024341,0.12397,0.17107,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.011063,0.12393,0.22516,1,1
4,GO REGULATION OF DNA REPAIR,0.054439,0.12391,0.15422,1,1
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.043559,0.12351,0.15056,1,1
4,GO RESPONSE TO LIGHT STIMULUS,0.0060238,0.12339,0.18458,1,1
4,GO SPERM EGG RECOGNITION,0.0049572,0.12338,0.13141,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0027019,0.12336,0.18178,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.011063,0.12324,0.16245,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.01266,0.12319,0.16984,1,1
4,GO IRON ION HOMEOSTASIS,0.038848,0.12316,0.15887,1,1
4,GO METHYLATION,0.033245,0.12301,0.15859,1,1
4,GO REGULATION OF MRNA 3 END PROCESSING,0.058535,0.12276,0.16704,1,1
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.01266,0.12252,0.15615,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.013235,0.12233,0.15858,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.020391,0.12223,0.22816,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.011574,0.12215,0.14411,1,1
4,GO DENDRITIC SPINE MAINTENANCE,0.037377,0.12186,0.21437,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.0083971,0.12178,0.16802,1,1
4,GO ENDOSOMAL TRANSPORT,0.0018673,0.12132,0.23131,1,1
4,GO RESPONSE TO STARVATION,0.0023095,0.12098,0.18041,1,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0066311,0.12081,0.18412,1,1
4,GO STEROID METABOLIC PROCESS,0.0029965,0.12074,0.18298,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0076456,0.12062,0.16902,1,1
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0025648,0.12047,0.19623,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0036751,0.12037,0.18513,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.041938,0.12032,0.14106,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.0054671,0.12024,0.18923,1,1
4,GO FEMALE GAMETE GENERATION,0.02951,0.12005,0.16212,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.028348,0.11958,0.17365,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0018673,0.11932,0.16313,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.0038653,0.11926,0.1778,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.050584,0.11911,0.19316,1,1
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.01266,0.11906,0.13161,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.028348,0.11896,0.19312,1,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.024086,0.11876,0.17729,1,1
4,GO GLUCOSE IMPORT,0.0096484,0.11857,0.18831,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.052482,0.11855,0.15131,1,1
4,GO REGULATION OF HISTONE UBIQUITINATION,0.023112,0.11845,0.16241,1,1
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.038848,0.11824,0.14936,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.043559,0.11823,0.15557,1,1
4,GO RESPONSE TO ETHANOL,0.0076456,0.11759,0.1762,1,1
4,GO MRNA CLEAVAGE,0.028348,0.11726,0.15196,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.012106,0.11653,0.14859,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0076456,0.11644,0.14609,1,1
4,GO ETHER METABOLIC PROCESS,0.011574,0.11639,0.22629,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.016475,0.11609,0.12948,1,1
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.008797,0.11557,0.16349,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0025648,0.11554,0.17768,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0060238,0.11422,0.16929,1,1
4,GO FERTILIZATION,0.011063,0.11392,0.14834,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0083971,0.11362,0.17777,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.050584,0.11362,0.1511,1,1
4,GO B CELL APOPTOTIC PROCESS,0.048745,0.1135,0.15807,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0076456,0.11302,0.1701,1,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.019548,0.11245,0.15401,1,1
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.056456,0.11237,0.15969,1,1
4,GO EMBRYONIC AXIS SPECIFICATION,0.0066311,0.11216,0.18891,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.035953,0.11196,0.18574,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.0083971,0.11145,0.18328,1,1
4,GO APOPTOTIC PROCESS,0.014457,0.11024,0.16893,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.011574,0.11023,0.1774,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0021907,0.1102,0.21692,1,1
4,GO CELLULAR RESPONSE TO DRUG,0.026142,0.11009,0.14585,1,1
4,GO MUSCLE CELL MIGRATION,0.037377,0.11,0.20085,1,1
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.007293,0.10996,0.17412,1,1
4,GO MACROAUTOPHAGY,0.0020776,0.10905,0.20122,1,1
4,GO PROTEIN DESTABILIZATION,0.0057394,0.109,0.18007,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0044907,0.10878,0.22219,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0080134,0.10874,0.17012,1,1
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0172,0.10858,0.15673,1,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.011063,0.10838,0.1702,1,1
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.034576,0.10836,0.15522,1,1
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.050584,0.10822,0.11128,1,1
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0028457,0.10808,0.15605,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.031957,0.10806,0.12297,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0028457,0.10798,0.16352,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,0.0052065,0.10761,0.14715,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.046961,0.10739,0.17298,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.0018673,0.10717,0.18727,1,1
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.037377,0.10695,0.16073,1,1
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.021265,0.10674,0.15546,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.021265,0.10667,0.18416,1,1
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.040368,0.10659,0.24495,1,1
4,GO REGULATION OF CELL DEATH,0.021265,0.10608,0.1644,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.007293,0.10602,0.15582,1,1
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0080134,0.10596,0.17751,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0047188,0.10557,0.2,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.041938,0.10513,0.17166,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.007293,0.10508,0.13578,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.021265,0.10496,0.16122,1,1
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.050584,0.10479,0.1692,1,1
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.060677,0.10462,0.12132,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.045233,0.10431,0.15855,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.020391,0.1042,0.17983,1,1
4,GO PROTEIN FOLDING,0.0034935,0.1042,0.13867,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0083971,0.10396,0.12127,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0057394,0.10392,0.15405,1,1
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0054671,0.1039,0.22325,1,1
4,GO REGULATION OF ORGAN GROWTH,0.031957,0.10366,0.1798,1,1
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.027226,0.10331,0.17926,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.012106,0.10326,0.16478,1,1
4,GO INTRACELLULAR TRANSPORT,0.0054671,0.10309,0.16555,1,1
4,GO ENDOSOME ORGANIZATION,0.0049572,0.10253,0.177,1,1
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.014457,0.10243,0.1677,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0027019,0.10232,0.17119,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.016475,0.1018,0.15619,1,1
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.035953,0.10135,0.166,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.0024341,0.1013,0.16349,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0011418,0.10121,0.12709,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.060677,0.099716,0.19861,1,1
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.037377,0.099414,0.21436,1,1
4,GO RESPONSE TO RADIATION,0.014457,0.09936,0.15418,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.026142,0.099224,0.10101,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.058535,0.09877,0.13326,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.046961,0.098464,0.14569,1,1
4,GO REGENERATION,0.014457,0.098172,0.18635,1,1
4,GO THYMUS DEVELOPMENT,0.028348,0.098028,0.14979,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0020776,0.098009,0.17515,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.020391,0.097429,0.17954,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0042727,0.097117,0.22429,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00057531,0.096944,0.16438,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.024086,0.096176,0.12466,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0063209,0.093815,0.2047,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.034576,0.093511,0.14471,1,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.0080134,0.092978,0.14541,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0076456,0.092961,0.14021,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.01266,0.092649,0.16643,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0060238,0.090013,0.17336,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0019699,0.089846,0.16169,1,1
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.012106,0.088546,0.13859,1,1
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.056456,0.088451,0.14996,1,1
4,GO RESPONSE TO HEAT,0.034576,0.087938,0.13596,1,1
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.022172,0.087683,0.10579,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.024086,0.087456,0.144,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.021265,0.086631,0.14357,1,1
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.022172,0.085971,0.16155,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.007293,0.085643,0.14346,1,1
4,GO FATTY ACYL COA METABOLIC PROCESS,0.048745,0.08525,0.13116,1,1
4,GO PEROXISOMAL TRANSPORT,0.012106,0.08452,0.14354,1,1
4,GO PIGMENT METABOLIC PROCESS,0.024086,0.08428,0.1189,1,1
4,GO OXIDATION REDUCTION PROCESS,0.0013481,0.083907,0.14868,1,1
4,GO PROTEIN SUMOYLATION,0.048745,0.083235,0.14974,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.011574,0.08288,0.16219,1,1
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.048745,0.082398,0.10771,1,1
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.052482,0.082386,0.21052,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.041938,0.082168,0.11535,1,1
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.024086,0.081199,0.17566,1,1
4,GO PEROXISOME ORGANIZATION,0.014457,0.08005,0.15867,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.054439,0.079453,0.21072,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0054671,0.077443,0.12457,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.020391,0.076993,0.16641,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0076456,0.07548,0.12133,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0092139,0.072951,0.12648,1,1
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.037377,0.071667,0.16732,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.033245,0.071523,0.12977,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.058535,0.068558,0.099202,1,1
4,GO VIRION ASSEMBLY,0.0096484,0.064163,0.11798,1,1
